| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A broad spectrum phase II trial with continuous infusion (CI) of recombinant interleukin-2 (IL-2) in metastatic tumors
|
Le Ceane, A
|
|
1993
|
29 |
S6 |
p. S47-
1 p.
|
artikel
|
| 2 |
A canadian national tumor bank/data base for soft tissue sarcoma
|
Bramwell, V
|
|
1993
|
29 |
S6 |
p. S185-
1 p.
|
artikel
|
| 3 |
A case of vaginal reconstruction with a musculus rectus abdominis myocutanbous flap and perineal continent colostomy after posterior pelvectomy
|
Bonnet, F.
|
|
1993
|
29 |
S6 |
p. S129-
1 p.
|
artikel
|
| 4 |
Accelerated hyperfractionation plus concomitant cisplatin for locally advanced head and neck cancer (LAHNC)
|
Arias, F.
|
|
1993
|
29 |
S6 |
p. S148-
1 p.
|
artikel
|
| 5 |
Accuracy of helmet technique in the irradiation of the bran: The role of CT examinations and verification films
|
Kortmann, R.-D.
|
|
1993
|
29 |
S6 |
p. S222-
1 p.
|
artikel
|
| 6 |
“A child with cancer remains a child” nursing education should aim at child-friendly cancer nursing
|
Zoude, P.
|
|
1993
|
29 |
S6 |
p. S261-
1 p.
|
artikel
|
| 7 |
A community-oriented familial cancer consultation service
|
Rennert, G.
|
|
1993
|
29 |
S6 |
p. S126-
1 p.
|
artikel
|
| 8 |
A comparison of aromatase inhibitors by direct isotopic measurement of aromatisation
|
Jacobs, S
|
|
1993
|
29 |
S6 |
p. S87-
1 p.
|
artikel
|
| 9 |
A comparison of the inhibitory effects on DNA-synthesis of cisplatin, doxorubicin and 4-hydroperoxy-cyclophosphamide in cultured human lip carcinoma cells and normal oral keratinocytes
|
Langkjer, S.T.
|
|
1993
|
29 |
S6 |
p. S140-
1 p.
|
artikel
|
| 10 |
A crossover comparative study of aminoglutethimide vs trilostane in advanced postmenopausal breast cancer
|
Williams, C.
|
|
1993
|
29 |
S6 |
p. S86-
1 p.
|
artikel
|
| 11 |
Activation of proto-oncogenes in human cancer: Molecular analysis of thyroid tumors
|
Pierotti, M.A.
|
|
1993
|
29 |
S6 |
p. S4-
1 p.
|
artikel
|
| 12 |
Activity of taxol (T) by 3 h infusion in breast cancer patients (pts) with clinical resistance to anthracyclines (A)
|
Munzone, E.
|
|
1993
|
29 |
S6 |
p. S79-
1 p.
|
artikel
|
| 13 |
Activity of vinorelbine (VIN) in advanced breast cancer: Preliminary results of a phase II trial
|
Demicheli, R.
|
|
1993
|
29 |
S6 |
p. S85-
1 p.
|
artikel
|
| 14 |
Actual indications to endoscopic laser-therapy in the lung cancer non-small cell
|
Mezzetti, M
|
|
1993
|
29 |
S6 |
p. S162-
1 p.
|
artikel
|
| 15 |
Acute disseminated intravascular coagulation (DIC) in cancer patients
|
Pasquini, E.
|
|
1993
|
29 |
S6 |
p. S209-
1 p.
|
artikel
|
| 16 |
Adenocarcinoma of endometrium: Interrelation between etiocholanolone and cholesterol
|
Orlov, E.N.
|
|
1993
|
29 |
S6 |
p. S128-
1 p.
|
artikel
|
| 17 |
Adenocarcinoma of the midstomach. Survival after surgical therapy
|
Valesi, M.G.
|
|
1993
|
29 |
S6 |
p. S106-
1 p.
|
artikel
|
| 18 |
Adhesion receptors and lymphoma dissemination
|
Meijer, C.J.L.M.
|
|
1993
|
29 |
S6 |
p. S22-
1 p.
|
artikel
|
| 19 |
Adjuvant chemotherapy in breast cancer, CMF I.V./3 weeks, impact of dose intensity on treatment outcome
|
Borovik, R.
|
|
1993
|
29 |
S6 |
p. S73-
1 p.
|
artikel
|
| 20 |
Adjuvant chemotherapy in stage III gastric cancer: Preliminary results
|
Cirera, L.
|
|
1993
|
29 |
S6 |
p. S102-
1 p.
|
artikel
|
| 21 |
Adjuvant chemotherapy of renal cell carcinoma
|
Kühböck, J.
|
|
1993
|
29 |
S6 |
p. S234-
1 p.
|
artikel
|
| 22 |
Adjuvant chemotherapy with autologous bone marrow reinfusion in patients with prognostically unfavourable breast cancer
|
de Vries, E.G.E.
|
|
1993
|
29 |
S6 |
p. S76-
1 p.
|
artikel
|
| 23 |
Adjuvant combination chemotherapy (AMF) postpones recurrence in a radical resected carcinoma of the pancreas and papilla of vater
|
Bakkevold, K
|
|
1993
|
29 |
S6 |
p. S108-
1 p.
|
artikel
|
| 24 |
Adjuvant systemic therapy in breast cancer
|
Mouridsen, H.T.
|
|
1993
|
29 |
S6 |
p. S12-
1 p.
|
artikel
|
| 25 |
Adjuvant therapy for non metastatic lung cancer patients: A methodological literature review
|
Paesmans, M.
|
|
1993
|
29 |
S6 |
p. S155-
1 p.
|
artikel
|
| 26 |
Adjuvant treatment in colo-rectal cancer
|
Schlag, P.
|
|
1993
|
29 |
S6 |
p. S9-
1 p.
|
artikel
|
| 27 |
Adjuvant treatment of renal cell tumors
|
Phm, De Mulder
|
|
1993
|
29 |
S6 |
p. S7-
1 p.
|
artikel
|
| 28 |
Adopive immunotherapy with interleukin-2 (IL2) + interferon (αIFN) + IL2-activated lymphocytes (LAK) in metastatic renal cell cancer
|
Goey, S.H.
|
|
1993
|
29 |
S6 |
p. S48-
1 p.
|
artikel
|
| 29 |
Adriamycin (ADR) in hyperthermic antiblastic perfusion (HAP) for high grade (HG) limb sarcomas
|
Rossi, C.R.
|
|
1993
|
29 |
S6 |
p. S186-
1 p.
|
artikel
|
| 30 |
Adriamycin and ifosfamide combination regimen in the treatment of advanced soft tissues sarcomas
|
Comandone, A.
|
|
1993
|
29 |
S6 |
p. S188-
1 p.
|
artikel
|
| 31 |
Adult medulloblastoma: The experience of a single institution
|
Villà, S
|
|
1993
|
29 |
S6 |
p. S192-
1 p.
|
artikel
|
| 32 |
Advanced cervix and endometrium cancer: The use of serial magnetic resonance imaging (MRI) in radiation therapy monitoring
|
Ebert, A
|
|
1993
|
29 |
S6 |
p. S226-
1 p.
|
artikel
|
| 33 |
Advanced gastric cancer: The place of introperative radiotherapy (IORT) +/− post operative external beam radiotherapy (EBRT)
|
Rocher, F.P.
|
|
1993
|
29 |
S6 |
p. S103-
1 p.
|
artikel
|
| 34 |
Age and clinical characteristics in lung cancer
|
Mañé, JM
|
|
1993
|
29 |
S6 |
p. S125-
1 p.
|
artikel
|
| 35 |
Age and dose intensity (DI) of VCR and ACT D are significant prognostic factor in Ewing's sarcoma (ES)
|
Delepine, N.
|
|
1993
|
29 |
S6 |
p. S201-
1 p.
|
artikel
|
| 36 |
Age-related prognostic factor analysis in non-Hodgkin's lymphoma (NHL)
|
Maksymiuk, AW
|
|
1993
|
29 |
S6 |
p. S175-
1 p.
|
artikel
|
| 37 |
Aggressive fibromatoses controlled without surgery 15 advanced cases treated with chemotherapy
|
Fissi, S.
|
|
1993
|
29 |
S6 |
p. S187-
1 p.
|
artikel
|
| 38 |
AIDS associated non nosgkin lymphomas (NHL): Retrospective analysis
|
Schmilovich, A.
|
|
1993
|
29 |
S6 |
p. S45-
1 p.
|
artikel
|
| 39 |
Albumin decrease is a deleterous prognostic sign in chronic lymphactic leukemia (B-CLL)
|
Mahon, G.
|
|
1993
|
29 |
S6 |
p. S151-
1 p.
|
artikel
|
| 40 |
Allelic distribution of DRB locus of II class major histocompatibility complex genes is associated with tumour size, nodal involvement, stage of disease and age of patients in breast cancer group
|
Knyazev, P.G.
|
|
1993
|
29 |
S6 |
p. S195-
1 p.
|
artikel
|
| 41 |
Allogeneic bone marrow transplantation for chronic myelogenous leukemia
|
van Aelst, F.
|
|
1993
|
29 |
S6 |
p. S150-
1 p.
|
artikel
|
| 42 |
Alteration of the proto-oncogene HER2/neu in correlation to the clinical pathological factors in gastrointestinal adenocarcinoma
|
Ben-Aharon, U
|
|
1993
|
29 |
S6 |
p. S196-
1 p.
|
artikel
|
| 43 |
Alternative treatment initiated by parents for children with cancer
|
Ramholt, Bente
|
|
1993
|
29 |
S6 |
p. S268-
1 p.
|
artikel
|
| 44 |
A mathematical model of growth and probability of metastatic dissemination of breast cancer
|
Shochat, E
|
|
1993
|
29 |
S6 |
p. S60-
1 p.
|
artikel
|
| 45 |
Ambulatory infusional cancer chemotherapy (ICC): Principles for nursing management at the Cancer Center of Boston (TCC Boston)
|
Lokich, J.
|
|
1993
|
29 |
S6 |
p. S264-
1 p.
|
artikel
|
| 46 |
Ambulatory intravenous treatment for children with cancer
|
Wissniewsky, G.
|
|
1993
|
29 |
S6 |
p. S252-
1 p.
|
artikel
|
| 47 |
Amiodarone as modulator of drug-resistance of doxorubicin, vincristine and mitoxantrone
|
Van der Graaf, WTA
|
|
1993
|
29 |
S6 |
p. S113-
1 p.
|
artikel
|
| 48 |
A multi-center comparison of pap-smear results in Israel
|
Fisher, M.
|
|
1993
|
29 |
S6 |
p. S130-
1 p.
|
artikel
|
| 49 |
A multicenter randomized trial comparing cyclophosphamide +platinum(CP)with platinum(P)alone in advanced ovarian cancer(AOC)
|
Bolis, G.
|
|
1993
|
29 |
S6 |
p. S136-
1 p.
|
artikel
|
| 50 |
Analogies to radiosensitivity of the epithelium in the human oral cavity
|
Ljubenov, T.
|
|
1993
|
29 |
S6 |
p. S221-
1 p.
|
artikel
|
| 51 |
Analyses of long term survival in small cell lung cancer (SCLC)
|
Wolf, M
|
|
1993
|
29 |
S6 |
p. S157-
1 p.
|
artikel
|
| 52 |
Analysis of serum tumor markers for diagnosis of skeletal metastases
|
Aydiner, A.
|
|
1993
|
29 |
S6 |
p. S249-
1 p.
|
artikel
|
| 53 |
An analysis of the Swedish oncology nirsing education
|
Grønnevik, Svein
|
|
1993
|
29 |
S6 |
p. S263-
1 p.
|
artikel
|
| 54 |
Anatomical approach in urological oncology surgery
|
Bartsch, G.
|
|
1993
|
29 |
S6 |
p. S21-
1 p.
|
artikel
|
| 55 |
An epidemiologic study on lung cancer in Turkey: Evaluation of 4508 cases
|
İöztek,
|
|
1993
|
29 |
S6 |
p. S124-
1 p.
|
artikel
|
| 56 |
A new class of drug able to modify the impact of low let radiotherapy
|
Gramaglia, A.
|
|
1993
|
29 |
S6 |
p. S219-
1 p.
|
artikel
|
| 57 |
An information video on radiotherapy for children
|
Vandevelde, G.
|
|
1993
|
29 |
S6 |
p. S260-
1 p.
|
artikel
|
| 58 |
An iridium applicator for vaginal vault brachy-therapy
|
Töre, G
|
|
1993
|
29 |
S6 |
p. S227-
1 p.
|
artikel
|
| 59 |
An observation of the use of kytril (granisetron) in clinical practice in Switzerland
|
Terrey, J-P.
|
|
1993
|
29 |
S6 |
p. S208-
1 p.
|
artikel
|
| 60 |
Antibiotic dosages using central venous catheters (CVC) or direct poeripheral blood puncture (DPBP) in neutopenic patients: A comparative study
|
Troncy, J.
|
|
1993
|
29 |
S6 |
p. S209-
1 p.
|
artikel
|
| 61 |
Anticancer agents of similar chemical structure show different mutagenic activities
|
Voutsinas, G.
|
|
1993
|
29 |
S6 |
p. S88-
1 p.
|
artikel
|
| 62 |
Anti cancer drugs: The effect on tumor metabolism
|
Vaalburg, W.
|
|
1993
|
29 |
S6 |
p. S27-
1 p.
|
artikel
|
| 63 |
Anti-cea immunoscintigraphy (IS) might be more useful than computed tomography (CT) in the pre-operative thoracic evaluation of lung cancer (LC): A comparison between planar IS, single photon-emission CT (SPECT), and radiographic CT
|
Bucchari, G.F.
|
|
1993
|
29 |
S6 |
p. S159-
1 p.
|
artikel
|
| 64 |
Antiemetic efficacy of ondansetron and corticosteroid in patients receiving chemotherapy for malignant lymphoma
|
Victor, M.A.
|
|
1993
|
29 |
S6 |
p. S210-
1 p.
|
artikel
|
| 65 |
Anti-emetic efficacy of ondansetron in pediatric chemotherapy patients: An interim evaluation
|
Olgun, N.
|
|
1993
|
29 |
S6 |
p. S199-
1 p.
|
artikel
|
| 66 |
Antiemetic efficacy of tropisetron (TRO) in patients with small cell lung cancer (SCLC)
|
Gosse, H
|
|
1993
|
29 |
S6 |
p. S158-
1 p.
|
artikel
|
| 67 |
Anti-emetic efficacy & tolerability of tropisetron in patients (PTS) conditioned with high dose chemoradiotherapy (HDC) pre-bone marrow transplantation (BMT)
|
Drakos, P
|
|
1993
|
29 |
S6 |
p. S207-
1 p.
|
artikel
|
| 68 |
Antimetastatic effect of tumor irradiation and r-IL-2 on lung metastases in the rat
|
Eljuga, D
|
|
1993
|
29 |
S6 |
p. S51-
1 p.
|
artikel
|
| 69 |
Antiphospholipid syndrome associated with immunotherapy for patients with melanoma
|
Becker, Jürgen C.
|
|
1993
|
29 |
S6 |
p. S48-
1 p.
|
artikel
|
| 70 |
Antiprogestins in the treatment of breast cancer
|
Michna, H.
|
|
1993
|
29 |
S6 |
p. S23-
1 p.
|
artikel
|
| 71 |
Antiproliferative effect of retinoids and interferon α in combination with irradiation on human tumor cell lines
|
Hoffmann, W.
|
|
1993
|
29 |
S6 |
p. S48-
1 p.
|
artikel
|
| 72 |
A phase I and pharmacokinetic study of RP 60475F administered as a one hour IV infusion every 3 weeks in solid tumors
|
Abigerges, D
|
|
1993
|
29 |
S6 |
p. S120-
1 p.
|
artikel
|
| 73 |
A phase I and pharmacokinetic trial of KW-2149, a mitomycin C analogue, in patients with solid tumours
|
Dirix, LY
|
|
1993
|
29 |
S6 |
p. S118-
1 p.
|
artikel
|
| 74 |
A phase III study comparing induction chemotherapy by carboplatin (CBDCA) and 5 fluorouracile (5 FU) before locoregional treatment (LRT) versus locoregional treatment alone in head and neck carcinomas
|
Martin, M.
|
|
1993
|
29 |
S6 |
p. S139-
1 p.
|
artikel
|
| 75 |
A phase III trial of neoadjuvant chemotherapy in head and neck cancer
|
Paccagnella, A.
|
|
1993
|
29 |
S6 |
p. S138-
1 p.
|
artikel
|
| 76 |
A phase II study of cisplatin, carboplatin and methotrexate in patients with metastatic or locally recurrent transitional cell carcinoma of the urothelium
|
Sengeløv, L
|
|
1993
|
29 |
S6 |
p. S231-
1 p.
|
artikel
|
| 77 |
A phase II study of cisplatin (P)and low dose continous oral etoposide (V) in advanced non small cell lung cancer (NSCLC)
|
Alvarez, I.
|
|
1993
|
29 |
S6 |
p. S162-
1 p.
|
artikel
|
| 78 |
A phase II study of continuous intravenous infusion (CIVI) recombinant IL-2 and subcutaneous α-interferon by sequential administration in advanced renal cell cancer
|
Besana, C
|
|
1993
|
29 |
S6 |
p. S50-
1 p.
|
artikel
|
| 79 |
A phase II study of losoxantrone (dup 941) in advanced breast cancer
|
Ten Bokkel Muinink, W.
|
|
1993
|
29 |
S6 |
p. S78-
1 p.
|
artikel
|
| 80 |
A phase II study of taxotere in patients with advanced head and neck cancer
|
Catimel, G
|
|
1993
|
29 |
S6 |
p. S139-
1 p.
|
artikel
|
| 81 |
A phase II study of topotecan administered intravenously as 5 daily infusions every 21 days to women with refractory epithelial ovarian carcinoma
|
Kudelka, A.
|
|
1993
|
29 |
S6 |
p. S132-
1 p.
|
artikel
|
| 82 |
A phase II study of vinorelbine in metastatic pancreatic adenocarcinoma
|
Etiennel, PL
|
|
1993
|
29 |
S6 |
p. S105-
1 p.
|
artikel
|
| 83 |
A phase II study with 5-FU, leucovorin and cisplatin in metastatic gastric cancer
|
Ychou, M.
|
|
1993
|
29 |
S6 |
p. S106-
1 p.
|
artikel
|
| 84 |
A phase II trial of carboplatin (C), ifosfamide (I), etoposide (E) and vincristine (V) in small cell lung cancer
|
Garrido, P.
|
|
1993
|
29 |
S6 |
p. S157-
1 p.
|
artikel
|
| 85 |
A phase II trial of induction chemotherapy followed by intensification with high-dose (H.D.) chemotherapy or concurrent chemo-radiotherapy and recombinant G-CSF in extensive (E.D.) and limited (L.D.) small cell lung cancer (SCLC)
|
Meacci, M.
|
|
1993
|
29 |
S6 |
p. S156-
1 p.
|
artikel
|
| 86 |
A phase II trial with D-Trp-6 (decapeptyl) in premenopausal RH+, hormonal untreated advanced breast cancer patients
|
Garcia-Giralt, E.
|
|
1993
|
29 |
S6 |
p. S86-
1 p.
|
artikel
|
| 87 |
A phase I pharmacokinetic trial of zilascorb(2H) in patients with advanced malignancies
|
Semb, KA
|
|
1993
|
29 |
S6 |
p. S118-
1 p.
|
artikel
|
| 88 |
A pilot study of accelerated CEF plus G-CSF as adjuvant therapy in early breast cancer (EBC)
|
Del Mastro, L
|
|
1993
|
29 |
S6 |
p. S56-
1 p.
|
artikel
|
| 89 |
A pilot study of intraarterial chemotherapy (IAC) in metastatic colorectal carcinoma (CC)
|
Cyjon, A.
|
|
1993
|
29 |
S6 |
p. S93-
1 p.
|
artikel
|
| 90 |
A pilot study on tolerability of dose intensification of carboplatin + cyclophosphamide combination with or without G-CSF in advanced ovarian cancer
|
Martoni, A.
|
|
1993
|
29 |
S6 |
p. S136-
1 p.
|
artikel
|
| 91 |
A placebo controlled double-blind randomised crossover study comparing granisetron with granisetron plus dexamethasone
|
Kirchner, V.
|
|
1993
|
29 |
S6 |
p. S208-
1 p.
|
artikel
|
| 92 |
Application of LQ model on our craniopharyngioma pati̇ents
|
Gürkaynak, M.
|
|
1993
|
29 |
S6 |
p. S227-
1 p.
|
artikel
|
| 93 |
A preparation and rehabilitation program (P.R.P.) for patients undergoing bone marrow transplantation (B.M.T.): development of an intervention module
|
Jaivenois, M-F.
|
|
1993
|
29 |
S6 |
p. S267-
1 p.
|
artikel
|
| 94 |
A pre-peritoneal continent ileal reservoir with hydraulic valve in the treatment of bladder carcinoma
|
Ronzoni, G.
|
|
1993
|
29 |
S6 |
p. S230-
1 p.
|
artikel
|
| 95 |
A prognostic index in patients with metastatic or recurrent transitional cell carcinoma of the urothelium (TCU)
|
Sengeløv, L
|
|
1993
|
29 |
S6 |
p. S229-
1 p.
|
artikel
|
| 96 |
A proposal to use grids for “skin sparing” in electron beam radiotherapy
|
Kalish, Y.
|
|
1993
|
29 |
S6 |
p. S223-
1 p.
|
artikel
|
| 97 |
A prospective study of combined intraluminal brachytherapy (ILB) and external beam radiotherapy (EBRT) in locally advanced esophageal cancer
|
Blank, L.
|
|
1993
|
29 |
S6 |
p. S100-
1 p.
|
artikel
|
| 98 |
A randomised trial of adjuvant versus neoadjuvant endocrine chemotherapy of operable breast cancer
|
Powles, TJ
|
|
1993
|
29 |
S6 |
p. S74-
1 p.
|
artikel
|
| 99 |
A randomised trial of maintenance therapy for non metastatic inflammatory breast cancer (IBC)
|
Janvier,
|
|
1993
|
29 |
S6 |
p. S72-
1 p.
|
artikel
|
| 100 |
A randomized comparison of two types of vascular access ports: viggo “vascu-port” versus pharmacia “port-a-cath”
|
Kampmann, K
|
|
1993
|
29 |
S6 |
p. S259-
1 p.
|
artikel
|
| 101 |
A randomized double-blind placebo-controlled study of org 2766, an acth (4–9) analogue, for the prevention of neuropathy induced by cisplatin (P) with or without vincaalcaloids (VA) combination chemotherapy (CT)
|
Chraibi, Y.
|
|
1993
|
29 |
S6 |
p. S206-
1 p.
|
artikel
|
| 102 |
A randomized, multicentre trial evaluating aredia in breast cancer patients with bone metastases
|
Conte, P.F.
|
|
1993
|
29 |
S6 |
p. S77-
1 p.
|
artikel
|
| 103 |
A randomized trial comparing in small cell lung cancer (SCLC) induction chemotherapy by ifosfamide and etoposide with adriamycin (IVA) or epirubicine (IVE): An European lung cancer working party report
|
Sculier, J.P.
|
|
1993
|
29 |
S6 |
p. S155-
1 p.
|
artikel
|
| 104 |
A randomized trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancer
|
Buccheri, G.F.
|
|
1993
|
29 |
S6 |
p. S160-
1 p.
|
artikel
|
| 105 |
Are 5HT3 antagonists fully cross-resistant? A pilot experience
|
de Boer, M.
|
|
1993
|
29 |
S6 |
p. S265-
1 p.
|
artikel
|
| 106 |
Are
α
β
ratios derived from hypoxic tumors too high?
|
Guttenberger, R.
|
|
1993
|
29 |
S6 |
p. S219-
1 p.
|
artikel
|
| 107 |
A research project based on experiences of home nurses using a pain assessment chart
|
Bosch, A
|
|
1993
|
29 |
S6 |
p. S264-
1 p.
|
artikel
|
| 108 |
A retrospective analysis of 201 nasopharyngeal carcinoma PTS to compare staging classifications
|
Licitra, L
|
|
1993
|
29 |
S6 |
p. S138-
1 p.
|
artikel
|
| 109 |
Aromatase inhibitors in the treatment of breast cancer
|
Paridaens, R.J.
|
|
1993
|
29 |
S6 |
p. S23-
1 p.
|
artikel
|
| 110 |
Arterial chemoembolisation of rat tissue-isolated tumours with microcapsules containing cisplatin and SR423
|
Lambin, P.
|
|
1993
|
29 |
S6 |
p. S121-
1 p.
|
artikel
|
| 111 |
A single-centre experience with continuous intravenous infusion of recombinant interleukin-2 ± lak cells in metastatic renal cell cancer
|
Besana, C
|
|
1993
|
29 |
S6 |
p. S50-
1 p.
|
artikel
|
| 112 |
A slight inhibition of cellular protein synthesis by the oncostatic agent zilascorb(2H) strongly inhibits cell cycle progression
|
Melvik, JE
|
|
1993
|
29 |
S6 |
p. S122-
1 p.
|
artikel
|
| 113 |
A small change in a radiation tolerance limit can produce a large change in tumor dose
|
Langer, M.
|
|
1993
|
29 |
S6 |
p. S223-
1 p.
|
artikel
|
| 114 |
Aspects of altered immunefunctions in breast cancer patients
|
Kreiner, M.
|
|
1993
|
29 |
S6 |
p. S64-
1 p.
|
artikel
|
| 115 |
Assessing of quality of life (QOL) in a Turkish oncology setting
|
Ozyilkan, O
|
|
1993
|
29 |
S6 |
p. S214-
1 p.
|
artikel
|
| 116 |
Assessing radiation-induced lung injury: Whole versus partial organ endpoints
|
Marks, LB
|
|
1993
|
29 |
S6 |
p. S223-
1 p.
|
artikel
|
| 117 |
Assessment of quality of life during second line chemotherapy for advanced breast cancer
|
Voest, E.E.
|
|
1993
|
29 |
S6 |
p. S85-
1 p.
|
artikel
|
| 118 |
Assessment of TPS in breast cancer during palliative and adjuvant chemotherapy
|
Jönsson, P-E
|
|
1993
|
29 |
S6 |
p. S246-
1 p.
|
artikel
|
| 119 |
Association between the expression of cell adhesion molecules and the development of metastases in melanoma
|
Johnson, J.P.
|
|
1993
|
29 |
S6 |
p. S22-
1 p.
|
artikel
|
| 120 |
Association of lytic effector cell function with high expression of HER-2 expression in breast cancer patients
|
Wiltschke, C.
|
|
1993
|
29 |
S6 |
p. S64-
1 p.
|
artikel
|
| 121 |
A study of rehabilitation in a specialist oncology centre
|
David, JA
|
|
1993
|
29 |
S6 |
p. S266-
1 p.
|
artikel
|
| 122 |
A study of renal function of four infusions of Pamidronate 90 mg given over 60 minutes one week apart
|
Tyrrell, CJ
|
|
1993
|
29 |
S6 |
p. S57-
1 p.
|
artikel
|
| 123 |
A survey of hospice staff smoking behaviour and their opinions on smoking at work
|
David, JA
|
|
1993
|
29 |
S6 |
p. S262-
1 p.
|
artikel
|
| 124 |
A survey of the opinions on ‘informed consent’ of women attending a breast unit
|
Maslin, AM
|
|
1993
|
29 |
S6 |
p. S254-
1 p.
|
artikel
|
| 125 |
Author index
|
|
|
1993
|
29 |
S6 |
p. S271-S300
30 p.
|
artikel
|
| 126 |
Autologous bone marrow transplant (ABMT) in acute non-lymphocytic leukemia
|
Ortega, J.J.
|
|
1993
|
29 |
S6 |
p. S34-
1 p.
|
artikel
|
| 127 |
Autologous bone marrow transplantation (ABMT) for non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD): The role of immunotherapy
|
Nagler, A.
|
|
1993
|
29 |
S6 |
p. S173-
1 p.
|
artikel
|
| 128 |
Autologous bone marrow transplantation and radiotherapy in patients with Hodgkin's disease
|
Price, A
|
|
1993
|
29 |
S6 |
p. S168-
1 p.
|
artikel
|
| 129 |
Autologous bone marrow transplantation in children with solid tumors
|
Dini, G.
|
|
1993
|
29 |
S6 |
p. S34-
1 p.
|
artikel
|
| 130 |
Autologous versus allogeneic blood transfusions and prognosis in colorectal cancer patients
|
Busch, CRC
|
|
1993
|
29 |
S6 |
p. S90-
1 p.
|
artikel
|
| 131 |
Axillary nodal metastases from an occult primary consistent with breast origin
|
van Ooijen, B
|
|
1993
|
29 |
S6 |
p. S67-
1 p.
|
artikel
|
| 132 |
Base excision DNA repair
|
Dianov, Grigory
|
|
1993
|
29 |
S6 |
p. S32-
1 p.
|
artikel
|
| 133 |
Basic fibrobiast growth factor and its receptors (bFGF-R) in human breast cancer
|
Bonneterre, J.
|
|
1993
|
29 |
S6 |
p. S23-
1 p.
|
artikel
|
| 134 |
BHRF1 — An epstein barr virus gene product which has homology with BCL2 — Is similarly localised
|
Hickish, T.
|
|
1993
|
29 |
S6 |
p. S195-
1 p.
|
artikel
|
| 135 |
Binding characteristics of cytotoxic analog of luteinizing-hormone releasing hormone (LH-RH) in membrane from human and MXT mammary cancer
|
Radulović, S.
|
|
1993
|
29 |
S6 |
p. S123-
1 p.
|
artikel
|
| 136 |
Biochemical findings in human brain tumors
|
Jeske, J
|
|
1993
|
29 |
S6 |
p. S193-
1 p.
|
artikel
|
| 137 |
Biochemotherapy with dtic and thymosin-α1 (TA1) + interleukin-2 (IL-2) in patients (PTS) with metastatic melanoma (MM)
|
Carpano, S
|
|
1993
|
29 |
S6 |
p. S182-
1 p.
|
artikel
|
| 138 |
Biological effects of changing the dose-rate — A study of clinical outcome
|
Ågren Cronqvist, AK
|
|
1993
|
29 |
S6 |
p. S36-
1 p.
|
artikel
|
| 139 |
Biological markers in the management of urothelial tumors
|
Chopin, Dominique K.
|
|
1993
|
29 |
S6 |
p. S21-
1 p.
|
artikel
|
| 140 |
Biological markers relevant for the clinical management of prostate cancer
|
Mahler, Ch.
|
|
1993
|
29 |
S6 |
p. S21-
1 p.
|
artikel
|
| 141 |
Biologic basis for hyper- and accelerated fractionation
|
Withers, H.R.
|
|
1993
|
29 |
S6 |
p. S43-
1 p.
|
artikel
|
| 142 |
Bioreductive drugs in phase I — How to evaluate
|
Workman, P.
|
|
1993
|
29 |
S6 |
p. S35-
1 p.
|
artikel
|
| 143 |
Bone involvement in childhood Hodgkin's disease
|
Büyükpamukçu, M
|
|
1993
|
29 |
S6 |
p. S170-
1 p.
|
artikel
|
| 144 |
Bonemarrow damage and recovery after high dose irradiation investigated with immunoscintigraphy
|
Gripp, S
|
|
1993
|
29 |
S6 |
p. S224-
1 p.
|
artikel
|
| 145 |
Brachytherapy in the treatment of clear cell adenocarcinoma of vagina or cervix. Institut gustave-roussy experience on 30 patients
|
Gerbaulet, A.
|
|
1993
|
29 |
S6 |
p. S127-
1 p.
|
artikel
|
| 146 |
Brachytherapy quality assurance: patients' satisfaction related to the quality nursing cares
|
Aporta, Y.
|
|
1993
|
29 |
S6 |
p. S259-
1 p.
|
artikel
|
| 147 |
Breast cancer associated brachial plexopathy: Still a diagnostic and treatment challange
|
Merimsky, O.
|
|
1993
|
29 |
S6 |
p. S59-
1 p.
|
artikel
|
| 148 |
Breast cancer in 341 elderly women: A retrospective analysis from a single institution
|
Repetto, L
|
|
1993
|
29 |
S6 |
p. S69-
1 p.
|
artikel
|
| 149 |
Breast cancer: Influence of age on treatment choice of surgeon and radiation oncologist
|
De Winter, K
|
|
1993
|
29 |
S6 |
p. S73-
1 p.
|
artikel
|
| 150 |
Breast cancer mass screening
|
Aspegren, Knut
|
|
1993
|
29 |
S6 |
p. S2-
1 p.
|
artikel
|
| 151 |
Breast cancer screening in the context of disease natural history
|
Duffy, S.W.
|
|
1993
|
29 |
S6 |
p. S25-
1 p.
|
artikel
|
| 152 |
Breast conservation — State of the art
|
J.A. van, Dongen
|
|
1993
|
29 |
S6 |
p. S6-
1 p.
|
artikel
|
| 153 |
Breast tumour cytogenetics
|
Heim, S
|
|
1993
|
29 |
S6 |
p. S30-
1 p.
|
artikel
|
| 154 |
Bromocriptin (B) and lanreotide (L) in advanced breast cancer: A phase II study
|
Bonneterre, J.
|
|
1993
|
29 |
S6 |
p. S84-
1 p.
|
artikel
|
| 155 |
Bronchoalveolar lavage in the diagnosis of pneumocystis carinii pneumonia in patients with hematologic malignancies
|
Vorlíček, J.
|
|
1993
|
29 |
S6 |
p. S208-
1 p.
|
artikel
|
| 156 |
Burnout syndrome among spanish oncologists
|
Espinosa, E.
|
|
1993
|
29 |
S6 |
p. S215-
1 p.
|
artikel
|
| 157 |
Busulfan-melphalan conditioning prior to bone marrow transplantation for poor-risk leukemia
|
Mehta, J
|
|
1993
|
29 |
S6 |
p. S152-
1 p.
|
artikel
|
| 158 |
Cadom (cyclophosphamide, adriamycin, dacarbazine, vincristine and methotrexate) protocol for advanced soft tissue sarcomas
|
Pfeffer, M.R.
|
|
1993
|
29 |
S6 |
p. S184-
1 p.
|
artikel
|
| 159 |
Caesium-137 implantations in solitary bladder cancer: The arnhem experience
|
v.d. Steen-Banasik, E.M.
|
|
1993
|
29 |
S6 |
p. S230-
1 p.
|
artikel
|
| 160 |
CA 19-9 high level in idiopathic pulmonary fibrosis
|
Otto, J.
|
|
1993
|
29 |
S6 |
p. S249-
1 p.
|
artikel
|
| 161 |
CA 125 in advanced breast cancer (BC). A sensitive marker for lung involvement and significant predictor for survival
|
Tampellini, M.
|
|
1993
|
29 |
S6 |
p. S248-
1 p.
|
artikel
|
| 162 |
CA 125 is an unreliable marker for monitoring response to taxol therapy in patients with relapsed ovarian cancer
|
Van der Burg, MEL
|
|
1993
|
29 |
S6 |
p. S133-
1 p.
|
artikel
|
| 163 |
Calculation and evaluation of
α
β
values for late reacting tissues from clinical trials
|
Warszawski, N
|
|
1993
|
29 |
S6 |
p. S222-
1 p.
|
artikel
|
| 164 |
Can a single serum test provide similar or even superior diagnostic information than total body CT, or anti-CEA planar and spect immunoscintigraphy? Value of measuring tissue polypetide antigen (TPA) in the preoperative evaluation of lung cancer
|
Buccheri, G.F.
|
|
1993
|
29 |
S6 |
p. S244-
1 p.
|
artikel
|
| 165 |
Can CD platinum be a treatment of choice in high grade soft tissue sarcomas?
|
Červek, J
|
|
1993
|
29 |
S6 |
p. S187-
1 p.
|
artikel
|
| 166 |
Cancer across the lifespan
|
Redmond, K.
|
|
1993
|
29 |
S6 |
p. S260-
1 p.
|
artikel
|
| 167 |
Cancer control by family history
|
Weber, W.
|
|
1993
|
29 |
S6 |
p. S14-
1 p.
|
artikel
|
| 168 |
Cancer genetics: Tumor biology and genome technology converge
|
Shiloh, Y.
|
|
1993
|
29 |
S6 |
p. S9-
1 p.
|
artikel
|
| 169 |
Cancer incidence in estonian migrants to Sweden—A comparison between Estonian migrants and the total Swedish and Estonian populations
|
Nilsson, B
|
|
1993
|
29 |
S6 |
p. S125-
1 p.
|
artikel
|
| 170 |
Cancer in Sweden derived from fallout after the chernobyl accident
|
Ekman, M.
|
|
1993
|
29 |
S6 |
p. S124-
1 p.
|
artikel
|
| 171 |
Can spect-SCC-immunoscintigraphy improve the radiation therapy planning of squamous cell carcinoma of head and neck?
|
Adamietz, I.A.
|
|
1993
|
29 |
S6 |
p. S138-
1 p.
|
artikel
|
| 172 |
Can tumour hypoxia be predicted?
|
Kallinowski, F
|
|
1993
|
29 |
S6 |
p. S19-
1 p.
|
artikel
|
| 173 |
Carbogen and unconventional irradiation schedule in glioblastoma: A method to ensure stability of 02 and CO2 concentrations
|
Fatigante, L.
|
|
1993
|
29 |
S6 |
p. S224-
1 p.
|
artikel
|
| 174 |
Carboplatin and fluorouracil in cervix tumors
|
Bertetto, O.
|
|
1993
|
29 |
S6 |
p. S130-
1 p.
|
artikel
|
| 175 |
Carboplatin and VM26 during radiotherapy in high grade gliomas
|
Brandes, A.
|
|
1993
|
29 |
S6 |
p. S189-
1 p.
|
artikel
|
| 176 |
Carboplatin-based chemotherapy in good prognosis metastatic non seminoma of the testis (NSGCT): An interim report of an MRC/EORTC randomised trial
|
Horwich, A
|
|
1993
|
29 |
S6 |
p. S240-
1 p.
|
artikel
|
| 177 |
Carboplatin (Ca) and oral etoposide (E) in previously untreated patients with small cell lung cancer
|
Pfeiffer, P
|
|
1993
|
29 |
S6 |
p. S156-
1 p.
|
artikel
|
| 178 |
Carboplatin (CBDCA) plus etoposide (VP-16) in non small cell lung cancer (NSCLC) treatment
|
Bernardo, G.
|
|
1993
|
29 |
S6 |
p. S164-
1 p.
|
artikel
|
| 179 |
Carboplatin(C), 5-FU(F), and leucovorin(L) in patients with recurrent squamous cell carcinoma of the head and neck (SCC H&N)
|
Jeremic, B.
|
|
1993
|
29 |
S6 |
p. S139-
1 p.
|
artikel
|
| 180 |
Carboplatin, cisplatin and cyclophosphamide (C.C.C.) as a first line chemotherapy in stage IIIC epithelial ovarian cancer
|
Edelmann, DZ
|
|
1993
|
29 |
S6 |
p. S135-
1 p.
|
artikel
|
| 181 |
Carboplatin, 5-fluorouracil and folinic acid in advanced and recurrent squamous carcinoma of the head and neck
|
Junor, EJ
|
|
1993
|
29 |
S6 |
p. S140-
1 p.
|
artikel
|
| 182 |
Carboplatin, ifosfamide, etoposide, and GM-CSF in advanced ovarian carcinoma, previously treated with cisplatinum
|
Botto, H.G.
|
|
1993
|
29 |
S6 |
p. S136-
1 p.
|
artikel
|
| 183 |
Carboplatin, mitoxantrone, vinblastine, methotrexate and leucovorin combination chemotherapy for urinary bladder carcinoma
|
Gez, E
|
|
1993
|
29 |
S6 |
p. S232-
1 p.
|
artikel
|
| 184 |
Carboplatin plus epirubicin plus VP-16, concurrent radiotherapy and “adjuvant surgery” for limited small cell lung cancer (SCLC)
|
Gridelli, C.
|
|
1993
|
29 |
S6 |
p. S156-
1 p.
|
artikel
|
| 185 |
Carcinoma of the gallbladder
|
Roisman, I.
|
|
1993
|
29 |
S6 |
p. S107-
1 p.
|
artikel
|
| 186 |
Cathepsin D as a marker of breast cancer metastasis
|
Rochefort, H.
|
|
1993
|
29 |
S6 |
p. S31-
1 p.
|
artikel
|
| 187 |
Cathepsin-D in ovarian cancer. Correlation with oestrogen receptors, progesteron receptors and epidermal growth factor receptors
|
Filipović, B.
|
|
1993
|
29 |
S6 |
p. S133-
1 p.
|
artikel
|
| 188 |
CBDCA in continue infusion and concomitant radiotherapy in patients with locally advanced NSCLC
|
Balducci, M
|
|
1993
|
29 |
S6 |
p. S167-
1 p.
|
artikel
|
| 189 |
CDDP+5-FU and reirradiation in the treatment of locally recurrent head and neck cancer
|
Airoldi, M
|
|
1993
|
29 |
S6 |
p. S145-
1 p.
|
artikel
|
| 190 |
CD44 splice variants in tumor metastasis
|
Kaufmann, M.
|
|
1993
|
29 |
S6 |
p. S8-
1 p.
|
artikel
|
| 191 |
Cell kinetics and response to drugs
|
Silvestrini, R.
|
|
1993
|
29 |
S6 |
p. S40-
1 p.
|
artikel
|
| 192 |
Cellular biology of retinoids
|
Bollag, W.
|
|
1993
|
29 |
S6 |
p. S42-
1 p.
|
artikel
|
| 193 |
Cellular immunity and cancer
|
Trainin, N
|
|
1993
|
29 |
S6 |
p. S2-
1 p.
|
artikel
|
| 194 |
Cellular resistance to DNA topoisomerase II inhibitors
|
Jacquemin-Sablon, A.
|
|
1993
|
29 |
S6 |
p. S18-
1 p.
|
artikel
|
| 195 |
Central nervous system metastases in Wilms' tumor
|
Akyüz, C
|
|
1993
|
29 |
S6 |
p. S191-
1 p.
|
artikel
|
| 196 |
Central small size breast cancer: How to overcome the problem of nipple and areola involvement
|
Galimberti, V
|
|
1993
|
29 |
S6 |
p. S66-
1 p.
|
artikel
|
| 197 |
C-erbB2 gene amplification, an independent prognostic indicator in node-positive and node-negative breast cancers
|
Prost, S
|
|
1993
|
29 |
S6 |
p. S58-
1 p.
|
artikel
|
| 198 |
Ceromosome 17q linkage studies of 20 french breast and/or ovarian cancer families
|
Sobol, H.
|
|
1993
|
29 |
S6 |
p. S194-
1 p.
|
artikel
|
| 199 |
Cervical cancer screening in Europe: International variation in practice and effect
|
Lynge, E
|
|
1993
|
29 |
S6 |
p. S25-
1 p.
|
artikel
|
| 200 |
Changes in serum lipids in postmenopausal patients with node-positive breast cancer treated with tamoxifen
|
Vrbanec, D
|
|
1993
|
29 |
S6 |
p. S75-
1 p.
|
artikel
|
| 201 |
Changing dose rate in LDR interstitial therapy
|
Mazeron, J.J.
|
|
1993
|
29 |
S6 |
p. S36-
1 p.
|
artikel
|
| 202 |
Changing nursing attitudes and approaches towards caring for the patient with cancer
|
Gilligan, M.B.
|
|
1993
|
29 |
S6 |
p. S266-
1 p.
|
artikel
|
| 203 |
Chemofiltration (CF) for locally advanced cancer
|
Inbar, M.
|
|
1993
|
29 |
S6 |
p. S115-
1 p.
|
artikel
|
| 204 |
Chemotherapy and hyperfractionated radiotherapy in stage III non-small cell lung cancer (NSCLC)
|
Valerdi, J.J.
|
|
1993
|
29 |
S6 |
p. S167-
1 p.
|
artikel
|
| 205 |
Chemotherapy (CAP) for the treatment of advanced ovarian cancer and second-effort surgery in the second-look. A ten years results
|
Ojeda, B
|
|
1993
|
29 |
S6 |
p. S132-
1 p.
|
artikel
|
| 206 |
Chemotherapy combined with medroxy-progesterone acetate in advanced breast cancer. Two randomized studies
|
Gundersen, S.
|
|
1993
|
29 |
S6 |
p. S85-
1 p.
|
artikel
|
| 207 |
Chemotherapy (CT) dose intensification in ovarian cancer (OC) with recombinant human interleukin-3 (RHIL-3)
|
Gameren, MM
|
|
1993
|
29 |
S6 |
p. S54-
1 p.
|
artikel
|
| 208 |
Chemotherapy (CT) with cisplatin (DDP) +continous 5 fluoruracil (5FUc) in the treatment of advanced anal squamous cell carcinoma (SCCa)
|
Ferreira, M.
|
|
1993
|
29 |
S6 |
p. S104-
1 p.
|
artikel
|
| 209 |
Chemotherapy (CT) with cisplatinum (P), methotrexate (A), mitomycin C (M) and bleomycin (B) [PAMB] in unresectable or metastatic penile carcinoma (PC)
|
Malsyner, A.
|
|
1993
|
29 |
S6 |
p. S235-
1 p.
|
artikel
|
| 210 |
Chemotherapy in pediatric intracranial germ cell tumor
|
Lee, ACW
|
|
1993
|
29 |
S6 |
p. S190-
1 p.
|
artikel
|
| 211 |
Chemotherapy in the elderly
|
Monfardini, S.
|
|
1993
|
29 |
S6 |
p. S5-
1 p.
|
artikel
|
| 212 |
Choice of therapy in non Hodgkin's lymphoma taking into consideration the data of lymphocytes resistance research in vitro
|
Dolidze, T.
|
|
1993
|
29 |
S6 |
p. S178-
1 p.
|
artikel
|
| 213 |
Chop in the United Kingdom: A survey of dose-intensity
|
Sebag-Montefiore, D
|
|
1993
|
29 |
S6 |
p. S175-
1 p.
|
artikel
|
| 214 |
Chop treatment in eighty cases of intermediate and high grade non-Hodgkin's lymphomas
|
Dallavalle, G.
|
|
1993
|
29 |
S6 |
p. S177-
1 p.
|
artikel
|
| 215 |
Circadian modulated continuous infusion of fudr in patients with disseminated renal cell cancer (RCC)
|
RL, Poorter
|
|
1993
|
29 |
S6 |
p. S116-
1 p.
|
artikel
|
| 216 |
Cisplatin and treosulfane chemotherapy in the treatment of metastatic ovarian cancer
|
Bähr, I.
|
|
1993
|
29 |
S6 |
p. S133-
1 p.
|
artikel
|
| 217 |
Cisplatin and treosulfane chemotherapy in the treatment of metastatic ovarian cancer — low versus high dose
|
Merkle, E.
|
|
1993
|
29 |
S6 |
p. S133-
1 p.
|
artikel
|
| 218 |
Cisplatin-bleomycin (C-B) as neoadjuvant therapy of squamous-cell carcinoma of oral cavity and lip (SCOL)
|
Grau, JJ
|
|
1993
|
29 |
S6 |
p. S142-
1 p.
|
artikel
|
| 219 |
Cisplatin (CDDP), epirubicin (EDX) and vindesine (VDS) +/− lonidamina (LND) in advanced NSCLC
|
Ianniello, G.P.
|
|
1993
|
29 |
S6 |
p. S167-
1 p.
|
artikel
|
| 220 |
Cisplatin (CDDP)-etoposide VS DCCP-mitomycin-vindesine VS CDDP-mitomycin-iphosphamide in advanced non small cell lung cancer (NSCLC). A prospective randomized trial of the Italian oncology group for clinical research. (GOIRC)
|
Crinò, L.
|
|
1993
|
29 |
S6 |
p. S159-
1 p.
|
artikel
|
| 221 |
Cisplatin (CDDP), fluorouracil (FU) and L-folinic acid (L-FA) in advanced head and neck carcinoma (HNC):An outpatient schedule
|
Meli, M.
|
|
1993
|
29 |
S6 |
p. S141-
1 p.
|
artikel
|
| 222 |
Cisplatin (CDP) + mitomycin C (MIT-C) + Vindesine (VDS) as a salvage treatment in advanced breast cancer (ABC) patients (PTS)
|
Leonardi, V.
|
|
1993
|
29 |
S6 |
p. S81-
1 p.
|
artikel
|
| 223 |
Cisplatin (P)/fluorouracil (FU) and escalating doses of vinorelbine (VNB) for non small cell lung cancer (NSCLC)
|
Monnet, I.
|
|
1993
|
29 |
S6 |
p. S163-
1 p.
|
artikel
|
| 224 |
Cisplatinum (CDDP) and etoposide (VP16) in “poor risk” small cell lung carcinoma (SCLCA)
|
Casadio, M.
|
|
1993
|
29 |
S6 |
p. S158-
1 p.
|
artikel
|
| 225 |
Clinical characteristics and long-term outcome after cisplatin-based chemotherapy for primary extragonadal germ cell tumors
|
Gerl, A
|
|
1993
|
29 |
S6 |
p. S240-
1 p.
|
artikel
|
| 226 |
Clinical evaluation of common serum tumor markers (TM) in patients (PTS) with bladder carcinoma (BC)
|
Bafaloukos, D.
|
|
1993
|
29 |
S6 |
p. S248-
1 p.
|
artikel
|
| 227 |
Clinical evaluation of the new ELSA-CA125 II assay
|
Clément, M.
|
|
1993
|
29 |
S6 |
p. S244-
1 p.
|
artikel
|
| 228 |
Clinical expectations from basic clinical research in lung cancer
|
Skovgaard Poulsen, H.
|
|
1993
|
29 |
S6 |
p. S7-
1 p.
|
artikel
|
| 229 |
Clinical experience of changing dose rate
|
Hunter, R
|
|
1993
|
29 |
S6 |
p. S36-
1 p.
|
artikel
|
| 230 |
Clinical experiences in multi-institutional trials-RTOG
|
Fu, K.K.
|
|
1993
|
29 |
S6 |
p. S43-
1 p.
|
artikel
|
| 231 |
Clinical experiences with 53 cases of fallopian tube carcinomas
|
Ebert, A
|
|
1993
|
29 |
S6 |
p. S130-
1 p.
|
artikel
|
| 232 |
Clinical experiences with 140 cases of uterine sarcomas
|
Goetze, Birgit
|
|
1993
|
29 |
S6 |
p. S127-
1 p.
|
artikel
|
| 233 |
Clinical experience with tebafur and low dose oral leucovorin: A phase I study
|
Nogué, M.
|
|
1993
|
29 |
S6 |
p. S119-
1 p.
|
artikel
|
| 234 |
Clinical long-term toxicity after intensive cytotoxic treatment for malignant germ-cell tumors (GCT)
|
Wanderås, EH
|
|
1993
|
29 |
S6 |
p. S241-
1 p.
|
artikel
|
| 235 |
Clinical pharmacodynamics of 5FU. Significant relationship between response to treatment and systemic dose intensity
|
Milano, G.
|
|
1993
|
29 |
S6 |
p. S109-
1 p.
|
artikel
|
| 236 |
Clinical prognostic factors for local control in oropharyngeal carcinoma. A multifactorial analysis
|
Regueiro, CA
|
|
1993
|
29 |
S6 |
p. S143-
1 p.
|
artikel
|
| 237 |
Clinical relevance of local control
|
Tubiana, M.
|
|
1993
|
29 |
S6 |
p. S33-
1 p.
|
artikel
|
| 238 |
Clinical relevance of P-glycoprotein in leukemia-patients
|
Nuessler, V
|
|
1993
|
29 |
S6 |
p. S112-
1 p.
|
artikel
|
| 239 |
Clinical response is not a good predictor of histological response in breast cancer neoadjuvant chemotherapy
|
Delva, R.
|
|
1993
|
29 |
S6 |
p. S79-
1 p.
|
artikel
|
| 240 |
CLL in three sisters: Preferred usage of specific IG gene segments
|
Hakim, I.
|
|
1993
|
29 |
S6 |
p. S38-
1 p.
|
artikel
|
| 241 |
CMF versus oophorectomy in premenopausal (preMP) stage II breast cancer (BC)
|
Everington, D
|
|
1993
|
29 |
S6 |
p. S71-
1 p.
|
artikel
|
| 242 |
Coeliac plexus neurolysis in terminally ill patients
|
Aliaga, L
|
|
1993
|
29 |
S6 |
p. S204-
1 p.
|
artikel
|
| 243 |
Collaboration between hospice in-patient and hospice home-care programs
|
Braf, S.
|
|
1993
|
29 |
S6 |
p. S267-
1 p.
|
artikel
|
| 244 |
Colorectal cancer (CRC) screening in Israel
|
Rozen, P.
|
|
1993
|
29 |
S6 |
p. S25-
1 p.
|
artikel
|
| 245 |
Colorectal carcinoma in young people
|
Bandettini, L.
|
|
1993
|
29 |
S6 |
p. S96-
1 p.
|
artikel
|
| 246 |
Combination chemotherapy containing cisplatin/ifosfamide and vinblastine or etoposide in bulky seminoma
|
Clemm, Ch.
|
|
1993
|
29 |
S6 |
p. S240-
1 p.
|
artikel
|
| 247 |
Combination chemotherapy of metastatic breast cancer with mitoxantrone, leucovorin and 5fluorouracil
|
Krazakowski, M.
|
|
1993
|
29 |
S6 |
p. S82-
1 p.
|
artikel
|
| 248 |
Combination 5-fluorouracil (FU), folinic acid (FA) and alpha-interferon 28 (IFN) in advanced gastric cancer
|
Jäger-Arand, E.
|
|
1993
|
29 |
S6 |
p. S101-
1 p.
|
artikel
|
| 249 |
Combination of hyperthermia (HT) and chemotherapy (CT) for hepatic tumors (HT) a phase I study
|
Tsamas, A.
|
|
1993
|
29 |
S6 |
p. S119-
1 p.
|
artikel
|
| 250 |
Combined antineoplastic and antiretroviral theraphy for patients with Hodgkin's disease and HIV infection (HD-HIV): A prospective study in 17 patients
|
Tirelli, U.
|
|
1993
|
29 |
S6 |
p. S168-
1 p.
|
artikel
|
| 251 |
Combined approach in the conservative management of rectal cancer
|
Calitchi, E.
|
|
1993
|
29 |
S6 |
p. S98-
1 p.
|
artikel
|
| 252 |
Combined bifractionated radiotherapy and CDDP-5FU chemotherapy (BIRCF) in locally advanced inoperable pharyngeal carcinomas — a phase II study
|
Bensadoun, RJ
|
|
1993
|
29 |
S6 |
p. S139-
1 p.
|
artikel
|
| 253 |
Combined chemo and radiotherapy for small cell lung cancer (SCLC). Long term survival
|
Dómine, M
|
|
1993
|
29 |
S6 |
p. S158-
1 p.
|
artikel
|
| 254 |
Combined chemo-radiotherapy in the treatment of invasive bladder cancer
|
Rubinov, R.
|
|
1993
|
29 |
S6 |
p. S230-
1 p.
|
artikel
|
| 255 |
Combined chemoradiotherapy of bladder cancer (preliminary report)
|
Karyakin, OB
|
|
1993
|
29 |
S6 |
p. S231-
1 p.
|
artikel
|
| 256 |
Combined chemoradiotherapy with or without surgery of non-metastatic squamous oesophagous carcinoma
|
Isla, M.D.
|
|
1993
|
29 |
S6 |
p. S107-
1 p.
|
artikel
|
| 257 |
Combined experience of 3 centers in Israel in the treatment of carcinoma of the uterine cervix
|
Cohen, Y
|
|
1993
|
29 |
S6 |
p. S128-
1 p.
|
artikel
|
| 258 |
Combined modality therapy for primary gastro-intestinal non-Hodgkin's lymphoma (GI-NHL)
|
Tondini, C
|
|
1993
|
29 |
S6 |
p. S173-
1 p.
|
artikel
|
| 259 |
Combined postoperative radiotherapy and PVC-chemotherapy (procarbazine, CCNU and vincristine) in managing anaplastic astrocytoma — A long-term follow-up
|
Ron, I.G.
|
|
1993
|
29 |
S6 |
p. S193-
1 p.
|
artikel
|
| 260 |
Combined systemic CDDP-interferon alpha (IFNα) in advanced pleural malignant mesothelioma (MM)
|
Soulié, P.
|
|
1993
|
29 |
S6 |
p. S56-
1 p.
|
artikel
|
| 261 |
Combined treatment for advanced epidermoid carcinoma of lung
|
Dómine, M
|
|
1993
|
29 |
S6 |
p. S165-
1 p.
|
artikel
|
| 262 |
Combined treatment for invasive bladder cancer
|
Čufer, T
|
|
1993
|
29 |
S6 |
p. S232-
1 p.
|
artikel
|
| 263 |
Combined treatment of metastatic melanoma with dacarbazine and recombinant alpha 2b interferon: Results of a mexican study
|
Palma, F
|
|
1993
|
29 |
S6 |
p. S182-
1 p.
|
artikel
|
| 264 |
Comparative evaluation of S9788, verapamil and cyclosporine a on multidrug resistant cells from patients with hematological malignancies
|
Merlin, J.L.
|
|
1993
|
29 |
S6 |
p. S115-
1 p.
|
artikel
|
| 265 |
Comparative study between half body irradiation (HBI) and Sr89 in multiple bone metastasis from cancer of the prostate
|
Antonadou, D.
|
|
1993
|
29 |
S6 |
p. S204-
1 p.
|
artikel
|
| 266 |
Comparative study of exclusive RT or combined with surgery in stage IIa and IIb proximal carcinoma of the uterine cervix
|
Antonadou, D
|
|
1993
|
29 |
S6 |
p. S129-
1 p.
|
artikel
|
| 267 |
Comparison of 5 day (12 mg/m2) versus single high dose (100 mg/m2) mitoxantrone regimen as induction therapy for AML
|
Bezwoda, W.R.
|
|
1993
|
29 |
S6 |
p. S149-
1 p.
|
artikel
|
| 268 |
Comparison of high dose estracyt and mitomycin C in the treatment of hormone relapsed prostate cancer
|
|
|
1993
|
29 |
S6 |
p. S236-
1 p.
|
artikel
|
| 269 |
Comparison of P-glycoprotein expression and daunorubicin cellular accumulation in adult and childhood acute leukemias
|
Merlin, J.L.
|
|
1993
|
29 |
S6 |
p. S115-
1 p.
|
artikel
|
| 270 |
Comparison of salvage chemoitherapy proioools ifosfamide+mesna+eioposide versus ifosfamide+epirubicin in cases with stage IV preast carcinoma
|
Kiraz, S.
|
|
1993
|
29 |
S6 |
p. S79-
1 p.
|
artikel
|
| 271 |
Comparison of S 9788, a new modulating agent, to verapamil and cyclosporin in reversing multidrug resistance (MDR)
|
Bizzari, JP
|
|
1993
|
29 |
S6 |
p. S113-
1 p.
|
artikel
|
| 272 |
Comparison of two different methods for determination of ER, IN·648 breast cancer (B.C.) patients
|
Molino, A.
|
|
1993
|
29 |
S6 |
p. S61-
1 p.
|
artikel
|
| 273 |
Comparisons and significance of immunohistochemistry and cytosol p53 assay in matched breast cancer samples
|
Kovarik, J.
|
|
1993
|
29 |
S6 |
p. S195-
1 p.
|
artikel
|
| 274 |
Complex hormono-chemo-radiotherapy of local and advanced cancer
|
Sviridova, TV
|
|
1993
|
29 |
S6 |
p. S239-
1 p.
|
artikel
|
| 275 |
Complications of long-term central venous access in hematological and bone marrow transplant patients
|
Chao, C.
|
|
1993
|
29 |
S6 |
p. S258-
1 p.
|
artikel
|
| 276 |
Complications with the use of totally implantable catheters in cancer patients followed in a department of Medical oncology
|
Rossi, P.
|
|
1993
|
29 |
S6 |
p. S230-
1 p.
|
artikel
|
| 277 |
Computed fusion of MRI and anti-CEA immunoscintigraphy in the follow up of operated rectal cancer
|
Kronberger Jr., L.
|
|
1993
|
29 |
S6 |
p. S97-
1 p.
|
artikel
|
| 278 |
Concepts of multistage evolution of neoplasia
|
Bannasch, P.
|
|
1993
|
29 |
S6 |
p. S39-
1 p.
|
artikel
|
| 279 |
Concomitant chemo-radiotherapy with carboplatin (CART) in continuous prolonged infusion in head and neck cancer (HNC)
|
Marmiroli, L
|
|
1993
|
29 |
S6 |
p. S145-
1 p.
|
artikel
|
| 280 |
Concomitant cisplatin, etoposide and radiotherapy for locally advanced non-small cell lung cancer (NSCLC)
|
Reboul, F.
|
|
1993
|
29 |
S6 |
p. S159-
1 p.
|
artikel
|
| 281 |
Concomitant radio-chemotherapy for liver metastases in breast cancer patients
|
Nardone, L
|
|
1993
|
29 |
S6 |
p. S84-
1 p.
|
artikel
|
| 282 |
Concomitant radiotherapy and chemotherapy of inoperable head and neck squamous cell carcinomas
|
Zakotnik, B
|
|
1993
|
29 |
S6 |
p. S226-
1 p.
|
artikel
|
| 283 |
Concomitant radiotherapy and cisplatin in advanced head and neck cancer
|
Olmi, P.
|
|
1993
|
29 |
S6 |
p. S143-
1 p.
|
artikel
|
| 284 |
Concurrent chemo-radiotherapy in advanced vulvar cancer
|
Landoni, F.
|
|
1993
|
29 |
S6 |
p. S131-
1 p.
|
artikel
|
| 285 |
Confirmatory activity of gemcitabine in non small cell lung cancer (NSCLC)
|
Le Chevalier, T
|
|
1993
|
29 |
S6 |
p. S160-
1 p.
|
artikel
|
| 286 |
Conformal therapy: Potential gains and pitfalls
|
Bartelink, H.
|
|
1993
|
29 |
S6 |
p. S28-
1 p.
|
artikel
|
| 287 |
Conservation therapy in primary breast cancer: The experience of northern Israel oncology center 1981–1988
|
Fried, G.
|
|
1993
|
29 |
S6 |
p. S67-
1 p.
|
artikel
|
| 288 |
Conservative treatment of breast cancer: Irradiation technique for women with large breasts
|
Zierhut, D.
|
|
1993
|
29 |
S6 |
p. S69-
1 p.
|
artikel
|
| 289 |
Conservative treatment of infraclinical breast cancer: Analyses of 184 cases
|
Cutuli, B.
|
|
1993
|
29 |
S6 |
p. S67-
1 p.
|
artikel
|
| 290 |
Conservative treatment of oesophagral cancer first results about 213 patients treated by concomitant radiotherapy (split course) and chemotherapy
|
Jacob, J.H.
|
|
1993
|
29 |
S6 |
p. S220-
1 p.
|
artikel
|
| 291 |
Continuous, hyperfractionated, accelerated radiotherapy (chart)
|
Dische, S
|
|
1993
|
29 |
S6 |
p. S43-
1 p.
|
artikel
|
| 292 |
Continuous infusion 5 fluorouracil (5FU) for hormone refractory prostatic CA. A pilot study
|
Rath, P
|
|
1993
|
29 |
S6 |
p. S236-
1 p.
|
artikel
|
| 293 |
Contrast-enhanced MRI in the diagnosis of breast tumours
|
Fjösne, HE
|
|
1993
|
29 |
S6 |
p. S65-
1 p.
|
artikel
|
| 294 |
Control of left ventricular ejection fraction (LVEF) in low vs high dose-epirubicin (E) therapy
|
Berchem, G.
|
|
1993
|
29 |
S6 |
p. S111-
1 p.
|
artikel
|
| 295 |
Control of oncogene expression by sense and antisense oligonucleotides. Non-sense or reality?
|
Helene, Claude
|
|
1993
|
29 |
S6 |
p. S3-
1 p.
|
artikel
|
| 296 |
Coordination in cancer care between the hospital and the community
|
Caroline, Häggmark
|
|
1993
|
29 |
S6 |
p. S254-
1 p.
|
artikel
|
| 297 |
Coping among cancer patients in chemotherapy: The influences of supportive educational groups
|
Kopp, Kirsten
|
|
1993
|
29 |
S6 |
p. S263-
1 p.
|
artikel
|
| 298 |
Coping with cancer stressors: a salutogenic approach
|
Antonovsky, Aaron
|
|
1993
|
29 |
S6 |
p. S262-
1 p.
|
artikel
|
| 299 |
Correlations between margins and local recurrence rate in surgery for osteosarcomas (OS)
|
Delepine, G.
|
|
1993
|
29 |
S6 |
p. S187-
1 p.
|
artikel
|
| 300 |
Costs and benefits of chemo-endocrine treatments for operable breast cancer
|
Goldhirsch, A.
|
|
1993
|
29 |
S6 |
p. S41-
1 p.
|
artikel
|
| 301 |
CPT 11: Phase II-pharmacokinetic study in breast cancer patients
|
Lokiec, F
|
|
1993
|
29 |
S6 |
p. S111-
1 p.
|
artikel
|
| 302 |
Critical care unit nurses' approach to orthotopic liver transplanted oncologic patients
|
Allemano, M.C.
|
|
1993
|
29 |
S6 |
p. S253-
1 p.
|
artikel
|
| 303 |
Cryodestruction. Cisplatin and interferon alpha-2b (INF-2b) for control of malignant pleura mesotheliomas (MM)
|
Zakharychev, V.
|
|
1993
|
29 |
S6 |
p. S160-
1 p.
|
artikel
|
| 304 |
C-thymidine: A novel approach for studying tumour proliferation invivo?
|
van Eijkeren, M.E.M.
|
|
1993
|
29 |
S6 |
p. S27-
1 p.
|
artikel
|
| 305 |
Cultural aspects of cancer nursing care in Israel
|
Delbar, V
|
|
1993
|
29 |
S6 |
p. S270-
1 p.
|
artikel
|
| 306 |
Curative vs. Palliative treatment in oncology
|
Zittoun, R.
|
|
1993
|
29 |
S6 |
p. S17-
1 p.
|
artikel
|
| 307 |
Cure in advanced gastric cancer
|
Michailakis, E.
|
|
1993
|
29 |
S6 |
p. S103-
1 p.
|
artikel
|
| 308 |
Cutaneous melanoma is less frightening if treated in outpatient regime
|
Zurrida, S
|
|
1993
|
29 |
S6 |
p. S179-
1 p.
|
artikel
|
| 309 |
Cyclophosphamide, doxorubicin and cisplatin (CAP) and second look for advanced ovarian cancer
|
Salud, A
|
|
1993
|
29 |
S6 |
p. S135-
1 p.
|
artikel
|
| 310 |
Cytarabine (ARA-C) and cisplatin (CDDP) as salvage therapy in advanced colorectal cancer. A French northern oncology group (FNOG) study
|
Adenis, A
|
|
1993
|
29 |
S6 |
p. S96-
1 p.
|
artikel
|
| 311 |
Cytogenetic aberations in therapy related myeloid luekemia (T-ML) in children
|
Stark, B.
|
|
1993
|
29 |
S6 |
p. S151-
1 p.
|
artikel
|
| 312 |
Cytogenetic alterations in benign and malignant colorectal tumors
|
Muleris, M.
|
|
1993
|
29 |
S6 |
p. S30-
1 p.
|
artikel
|
| 313 |
Cytogenetics of mesenchymal tumours
|
Limon, J
|
|
1993
|
29 |
S6 |
p. S30-
1 p.
|
artikel
|
| 314 |
Cytogenetics of testicular germ cell tumors
|
Castedo, Sérgio
|
|
1993
|
29 |
S6 |
p. S30-
1 p.
|
artikel
|
| 315 |
Cytokine gene-transduced tumor cells in cancer therapy: Tumor inhibition by non-specific and specific immune mechanisms
|
Parmiani, G.
|
|
1993
|
29 |
S6 |
p. S15-
1 p.
|
artikel
|
| 316 |
Cytokinetic effects of interferon (IFN) in colorectal tumors. Implications for the design of 5FU/IFN regimens
|
Cascinu, S
|
|
1993
|
29 |
S6 |
p. S91-
1 p.
|
artikel
|
| 317 |
D14 anti-CEA monoclonal antibody in the estimation of neoplastic sequence in human colon
|
Ślesak, B.
|
|
1993
|
29 |
S6 |
p. S248-
1 p.
|
artikel
|
| 318 |
Daunorubicin accumulation is correlated with treatment outcome in adult acute leukemias
|
Guerci, A.
|
|
1993
|
29 |
S6 |
p. S114-
1 p.
|
artikel
|
| 319 |
3D conformal radiotherapy by dynamic proton beam scanning on a compact isocentric gantry: The pilot facility at PSI is near completion
|
Pedroni, E
|
|
1993
|
29 |
S6 |
p. S218-
1 p.
|
artikel
|
| 320 |
5′-Deoxy-5-fluorouridine acts as an multidrug resistance reversal agent
|
van der Heyden, S
|
|
1993
|
29 |
S6 |
p. S113-
1 p.
|
artikel
|
| 321 |
Design and conduct of clinical trials in breast cancer. Reporting of the results
|
|
|
1993
|
29 |
S6 |
p. S41-
1 p.
|
artikel
|
| 322 |
Detection of brain metastases of lung carcinoma: Comparison of contrast enhanced M.R. with enhanced C.T.
|
Lemiere, C
|
|
1993
|
29 |
S6 |
p. S164-
1 p.
|
artikel
|
| 323 |
Detection of the multidrug resistance gene (MDR-1) expression by non-radioactive quantitative polymerase chain reaction
|
Lion, T.
|
|
1993
|
29 |
S6 |
p. S114-
1 p.
|
artikel
|
| 324 |
Detection of wild and mutant type p53 in human germ cell tumors by histo-chemistry staining
|
Rüther, U.
|
|
1993
|
29 |
S6 |
p. S195-
1 p.
|
artikel
|
| 325 |
Determination of cisplatinum DNA adducts by specific antibodies in vitro and in vivo: Genetic polymorphism in DNA repair as a predictive factor for accurate drug dosimetry
|
Slor, H.
|
|
1993
|
29 |
S6 |
p. S40-
1 p.
|
artikel
|
| 326 |
Developing cancer education and prevention programmes: a national initiative
|
Weston, R
|
|
1993
|
29 |
S6 |
p. S262-
1 p.
|
artikel
|
| 327 |
Developing the role of the breast care nurse
|
Tait, A.
|
|
1993
|
29 |
S6 |
p. S260-
1 p.
|
artikel
|
| 328 |
Development of colon cancer
|
|
|
1993
|
29 |
S6 |
p. S39-
1 p.
|
artikel
|
| 329 |
Dexametasone toxicity in brain tumor patients
|
Jeremic, B.
|
|
1993
|
29 |
S6 |
p. S202-
1 p.
|
artikel
|
| 330 |
Dexamethasone (DEX) improves the efficacy of granisetron (GRAN) in the first 24 hours following high dose cisplatin (HDCP) chemotherapy
|
Latreille, J.
|
|
1993
|
29 |
S6 |
p. S208-
1 p.
|
artikel
|
| 331 |
Diagnosis and treatment of neuro-endocrine tumors
|
Schlumberger, M
|
|
1993
|
29 |
S6 |
p. S5-
1 p.
|
artikel
|
| 332 |
Diagnostic assessment and factors influencing deambulation in spinal cord compression
|
Cervantes, A.
|
|
1993
|
29 |
S6 |
p. S269-
1 p.
|
artikel
|
| 333 |
Diagnostic imaging in the follow-up of patients with brain glioblastoma (GBM) recriving postoperative preirradiation chemotherapy (CHT)
|
Gornish, M
|
|
1993
|
29 |
S6 |
p. S189-
1 p.
|
artikel
|
| 334 |
Diagnostic value of fibronectin in differential diagnosis of ascites
|
Arslan, Mehmet
|
|
1993
|
29 |
S6 |
p. S247-
1 p.
|
artikel
|
| 335 |
Diagnostic work-up (DW) in staging and evaluation of response in hepatocellular carcinoma (HCC) treated with chemoembolization (CE)
|
De Franco, A
|
|
1993
|
29 |
S6 |
p. S104-
1 p.
|
artikel
|
| 336 |
Differences in activity of mitoxantrone (DHAD) plus ifosfamide (IFO) according to previous platinum-compound (PC) responsiveness in advanced ovarian cancer (AOC). An I.T.M.O. group study
|
Bajetta, E.
|
|
1993
|
29 |
S6 |
p. S135-
1 p.
|
artikel
|
| 337 |
Differential influence of prognostic factors on the occurence of metastases at various anatomical sites in patients with breast cancer
|
Kamby, C
|
|
1993
|
29 |
S6 |
p. S59-
1 p.
|
artikel
|
| 338 |
Differential therapy of acute lymphoblastic leukemia (ALL) in adults
|
Volkova, M.
|
|
1993
|
29 |
S6 |
p. S151-
1 p.
|
artikel
|
| 339 |
Distant metastazes in ovarian carcinoma
|
Dinger, M
|
|
1993
|
29 |
S6 |
p. S137-
1 p.
|
artikel
|
| 340 |
DNA amplification and antimetabolite resistance
|
Calvert, A.H.
|
|
1993
|
29 |
S6 |
p. S18-
1 p.
|
artikel
|
| 341 |
DNA coment flow cytometric analysis in bladder cancer
|
Quigley, M.
|
|
1993
|
29 |
S6 |
p. S230-
1 p.
|
artikel
|
| 342 |
DNA content and phases cells fraction in breast cancer patients without nodal involvement
|
Muñoz, M.
|
|
1993
|
29 |
S6 |
p. S62-
1 p.
|
artikel
|
| 343 |
DNA content, distribution of cell cycle phases and EGFR in resected non-small cell lung cancer. Its prognostic significance
|
Alberola, V
|
|
1993
|
29 |
S6 |
p. S166-
1 p.
|
artikel
|
| 344 |
DNA-ploidy (DI) and S-phase fraction (SPF) as prognostic and predictive factors in endometrial cancer
|
Minckwitz, Gv
|
|
1993
|
29 |
S6 |
p. S127-
1 p.
|
artikel
|
| 345 |
DNA repair defects and cancer proneness
|
Stefanini, M.
|
|
1993
|
29 |
S6 |
p. S32-
1 p.
|
artikel
|
| 346 |
Does nursing really make a difference?
|
Ensing, H
|
|
1993
|
29 |
S6 |
p. S261-
1 p.
|
artikel
|
| 347 |
Does preoperative radiotherapy alter the clinical outcome among patients with locally recurrent rectal cancer?
|
Holm, T
|
|
1993
|
29 |
S6 |
p. S90-
1 p.
|
artikel
|
| 348 |
Does work in the oncology department reguire special personality qualities of the hospital staff
|
Vorlíčková, H.
|
|
1993
|
29 |
S6 |
p. S257-
1 p.
|
artikel
|
| 349 |
Do mastectomy and lumpectomy patients differ in quality of life?
|
Kreitler, S.
|
|
1993
|
29 |
S6 |
p. S213-
1 p.
|
artikel
|
| 350 |
Dose-intensification of mitomycin (MMC), methotrexate (MTX), mitoxantrone (NOV) (3 M regimen) with G-GSF rescue as first line therapy of metastatic breast cancer
|
Pedrazzoli, P.
|
|
1993
|
29 |
S6 |
p. S92-
1 p.
|
artikel
|
| 351 |
Dose intensive treatment of osteogenic sarcoma. The “big mac” pilot study
|
Cohen, IJ
|
|
1993
|
29 |
S6 |
p. S186-
1 p.
|
artikel
|
| 352 |
Dose-rate effects in brachytherapy
|
Steel, GG
|
|
1993
|
29 |
S6 |
p. S36-
1 p.
|
artikel
|
| 353 |
Dose-volume histogram analysis for mantle-field irradiation in Hodgkin's disease
|
Stücklschweiger, G.
|
|
1993
|
29 |
S6 |
p. S171-
1 p.
|
artikel
|
| 354 |
Double alternate modulation of high dose fluorouracil (5FU) by interferon alpha (IFNα) and phosphonacetyl-L-aspartic acid (pala) in patients with advanced colorectal cancer (ACC). A multicenter phase II study
|
Punt, CJA
|
|
1993
|
29 |
S6 |
p. S93-
1 p.
|
artikel
|
| 355 |
Double biochemical modulation of 5-fluorouracil (5FU) with methotrexate (MTX) and levo-folinic acid (LFA) in the treatment of patients with advanced digestive mailgnancies
|
Comella, P.
|
|
1993
|
29 |
S6 |
p. S98-
1 p.
|
artikel
|
| 356 |
Do we know the costs involved in the preparation and activation of a new trial in the hospital ?
|
Kesteloot, K.
|
|
1993
|
29 |
S6 |
p. S124-
1 p.
|
artikel
|
| 357 |
D-TRP-6-LHRH (decapeptyl) in advanced ovarian cancer
|
Parmar, H
|
|
1993
|
29 |
S6 |
p. S134-
1 p.
|
artikel
|
| 358 |
Ductal carcinoma in situ (DCIS) of breast: A review of 58 cases
|
G-Pastrana, F.
|
|
1993
|
29 |
S6 |
p. S68-
1 p.
|
artikel
|
| 359 |
Ductal carcinoma in situ of the breast: Results of treatment by conservative surgery and definitive irradiation
|
Ray, G.R.
|
|
1993
|
29 |
S6 |
p. S69-
1 p.
|
artikel
|
| 360 |
Early delayed gastric emptying after esophageal substitution: Is the pyloric sphincter to blame?
|
Bemelman, WA
|
|
1993
|
29 |
S6 |
p. S100-
1 p.
|
artikel
|
| 361 |
Early detection of breast cancer in Israel
|
Rennert, G.
|
|
1993
|
29 |
S6 |
p. S62-
1 p.
|
artikel
|
| 362 |
Early detection of superficial bladder cancer in vivo and combi ned treatment using transurethral surgery and recombinant alpha 2b interferon
|
Gerosa, J
|
|
1993
|
29 |
S6 |
p. S229-
1 p.
|
artikel
|
| 363 |
Early stages of Hodgkin's disease treated with a decreased dose of radiotherapy: Prognostic value of beta2-microlobulin
|
Tortochaux, J.
|
|
1993
|
29 |
S6 |
p. S169-
1 p.
|
artikel
|
| 364 |
Early study of olinical effects of RH Tumor Necrosis Factor in patients with non Hodgkin's lymphoma
|
Muc, M.
|
|
1993
|
29 |
S6 |
p. S175-
1 p.
|
artikel
|
| 365 |
E-cadherin versus tumor invasion
|
Van Roy, F.
|
|
1993
|
29 |
S6 |
p. S22-
1 p.
|
artikel
|
| 366 |
Echocardiography in breast cancer
|
Costa, LAM
|
|
1993
|
29 |
S6 |
p. S60-
1 p.
|
artikel
|
| 367 |
Edidence supporting H19 as a tumor suppressor gene in hydatidiform mole but not in choriocarcinoma cell line
|
Goshen, R
|
|
1993
|
29 |
S6 |
p. S196-
1 p.
|
artikel
|
| 368 |
Educational approach of critical care nurses having to manage medical anticancer treatment in clinical trials
|
Markiewicz, E.
|
|
1993
|
29 |
S6 |
p. S257-
1 p.
|
artikel
|
| 369 |
Effective cisplatin-vinca alkaloid combinations as neoadjuvant chemotherapy for stage III non small cell lung cancer (NSCLC)
|
Ciuleanu, T.
|
|
1993
|
29 |
S6 |
p. S159-
1 p.
|
artikel
|
| 370 |
Effectiveness of boost doses given to poor responders in PTS with squamous cell carcinoma of the glottis treated Co-60
|
Szutkowski, Z.
|
|
1993
|
29 |
S6 |
p. S223-
1 p.
|
artikel
|
| 371 |
Effective removal of breast cancer cells from bone marrow
|
Fodstad, Ø
|
|
1993
|
29 |
S6 |
p. S74-
1 p.
|
artikel
|
| 372 |
Effective removal of SCLC tumor cells from bone marrow
|
Myklebust, AT
|
|
1993
|
29 |
S6 |
p. S154-
1 p.
|
artikel
|
| 373 |
Effect of adriamycin, verapamil and tamoxifen on WEHI 164 murine fibrosarcoma cells and a multidrug-resistant subline determined by protion NMR spectroscopy on PCA-extracted metabolites
|
Høe, AL
|
|
1993
|
29 |
S6 |
p. S114-
1 p.
|
artikel
|
| 374 |
Effect of calcium-channel blockers and protein kinase C inhibitors on melanoma cell growth and directional migration in vitro
|
R, Fink-Puches
|
|
1993
|
29 |
S6 |
p. S179-
1 p.
|
artikel
|
| 375 |
Effect of decapeptyl alone or in combination with antiestrogens and progestins on the growth of breast cancer cell lines
|
Marini, L
|
|
1993
|
29 |
S6 |
p. S122-
1 p.
|
artikel
|
| 376 |
Effect of hyperthermia combined with radiation on refractory tumors. Preliminary data
|
Facchini, G.
|
|
1993
|
29 |
S6 |
p. S227-
1 p.
|
artikel
|
| 377 |
Effect of liposomal allogeneic melanoma vaccine with IL-2 on cellular immune responses
|
Adler, A.
|
|
1993
|
29 |
S6 |
p. S48-
1 p.
|
artikel
|
| 378 |
Effect of recombinant β-interferon on oncogene expression in human breast cancer cells
|
Sica, G
|
|
1993
|
29 |
S6 |
p. S196-
1 p.
|
artikel
|
| 379 |
Effect of salt on carcinogen penetration to proliferative cells in the rat gastric mucosa
|
Sørbye, H
|
|
1993
|
29 |
S6 |
p. S88-
1 p.
|
artikel
|
| 380 |
Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after five years
|
Love, RR
|
|
1993
|
29 |
S6 |
p. S77-
1 p.
|
artikel
|
| 381 |
Effect of thymic extract “TFX-thymomodulin” on T lymphocyte subsets during postoperative radiotherapy for breast cancer
|
Jevremović, M.
|
|
1993
|
29 |
S6 |
p. S74-
1 p.
|
artikel
|
| 382 |
Effect of vinblastine (bolus versus split dose) on SA-1 ascitic tumor cells in mice
|
Serša, G
|
|
1993
|
29 |
S6 |
p. S117-
1 p.
|
artikel
|
| 383 |
Effects of interferon and tamoxifen on in-vivo tumour biologic variables in breast cancer basic and clinical observations
|
Bezwoda, W.R.
|
|
1993
|
29 |
S6 |
p. S59-
1 p.
|
artikel
|
| 384 |
Effects of oestrogens and progestogens on the membrane permeability and growth of human prostatic carcinoma cells (PC-3) in vitro
|
Widmark, A
|
|
1993
|
29 |
S6 |
p. S237-
1 p.
|
artikel
|
| 385 |
Effects of radiation treatment of cerebral metastases ivaluation by 99mlc-MM-PAO SPECT imaging
|
Fila, G.
|
|
1993
|
29 |
S6 |
p. S225-
1 p.
|
artikel
|
| 386 |
Effects of superoxide dismutase (SOD) on late radiofibrosis following conservative treatment for breast cancer: A clinical and laboratory study
|
Gez, E
|
|
1993
|
29 |
S6 |
p. S225-
1 p.
|
artikel
|
| 387 |
Efficacy and safety of gemcitabine in non small cell lung cancer (NSCLC)
|
Abratt, R
|
|
1993
|
29 |
S6 |
p. S161-
1 p.
|
artikel
|
| 388 |
Efficacy and tolerability of a new 5HT3-antagonist, DAU 6215 CL, on emesis occurring in the first 24 HRS after cisplatin administration
|
Del Favero, A.
|
|
1993
|
29 |
S6 |
p. S207-
1 p.
|
artikel
|
| 389 |
Efficacy of different approaches for the treatment of myelodysplastic syndrome (MDS) in children
|
Nikitin, D
|
|
1993
|
29 |
S6 |
p. S201-
1 p.
|
artikel
|
| 390 |
Efficacy of high dose chemotherapy with/without BCNU for autologous bone marrow transplantation (ABMT) in breast cancer
|
Drakos, P
|
|
1993
|
29 |
S6 |
p. S83-
1 p.
|
artikel
|
| 391 |
Efficacy of las 30451 in the prevention of cisplatin induced emesis
|
Vadell, C
|
|
1993
|
29 |
S6 |
p. S209-
1 p.
|
artikel
|
| 392 |
Efficacy of lenograstim on hematological tolerance to maid chemotherapy in sarcoma patients and impact on dose intensity
|
Chevallier, B.
|
|
1993
|
29 |
S6 |
p. S186-
1 p.
|
artikel
|
| 393 |
Efficiency of the cooling cap in patients receiving anthracycline therapy
|
Bachelet, H.
|
|
1993
|
29 |
S6 |
p. S269-
1 p.
|
artikel
|
| 394 |
EGF-R in locally advanced breast cancer patients
|
Nešković-Konstantinović, Z
|
|
1993
|
29 |
S6 |
p. S65-
1 p.
|
artikel
|
| 395 |
Elevated biliary CEA levels in colorectal cancer patients: A prognostic factor?
|
Paul, MA
|
|
1993
|
29 |
S6 |
p. S244-
1 p.
|
artikel
|
| 396 |
Elevated serum levels of circulating intercellular adhesion molecule I in patients with liver disease treated with thymostimulin
|
Paluieri, G.
|
|
1993
|
29 |
S6 |
p. S49-
1 p.
|
artikel
|
| 397 |
Emergency project in oncological nursing: Experience at the national cancer institute of Milan
|
Maino, E.
|
|
1993
|
29 |
S6 |
p. S256-
1 p.
|
artikel
|
| 398 |
Emesis related to chemotherapy: a survey
|
Nieweg, M.B.
|
|
1993
|
29 |
S6 |
p. S263-
1 p.
|
artikel
|
| 399 |
Encouraging survival for stage IIIB-IV non-small cell lung cancer (NSCLC) patients after sequential treatment with ifosfamide, epirubicin, cisplatin and radiation therapy
|
Araujo, C.E.
|
|
1993
|
29 |
S6 |
p. S164-
1 p.
|
artikel
|
| 400 |
Endobronchial laser therapy in advanced lung cancer
|
Špásová, I.
|
|
1993
|
29 |
S6 |
p. S202-
1 p.
|
artikel
|
| 401 |
Endocrine and clinical evaluation of 4-hydroxy-androstenedione in postmenopausal patients with advanced breast cancer (BC)
|
Scanni, A.
|
|
1993
|
29 |
S6 |
p. S82-
1 p.
|
artikel
|
| 402 |
Eortc-gimema AML8 protocol. Parallel phase III trials in acute myelogenous leukemia (AML)
|
Zittoun, R.
|
|
1993
|
29 |
S6 |
p. S150-
1 p.
|
artikel
|
| 403 |
Eostrogen production by epithelial ovarian tumours in elderly women: A potentially useful marker of an early stage disease
|
Biran, H
|
|
1993
|
29 |
S6 |
p. S134-
1 p.
|
artikel
|
| 404 |
Epidemiological study of head & neck squamous cell carcinomas (HNSCC)
|
Lefebvre, J.L.
|
|
1993
|
29 |
S6 |
p. S125-
1 p.
|
artikel
|
| 405 |
Epidemiology of myeloma multiplex in Low Silesia(Poland)
|
Waszkiewicz, L.
|
|
1993
|
29 |
S6 |
p. S126-
1 p.
|
artikel
|
| 406 |
Epideric kaposi's sarcom: Experience at the johameseurg hospital (1977–1990)
|
Stein, M.E.
|
|
1993
|
29 |
S6 |
p. S45-
1 p.
|
artikel
|
| 407 |
Epidermal growth factor receptor, OV632 and OC125 expression in smears of ovarian carcinomas
|
Athanassiadou, P.
|
|
1993
|
29 |
S6 |
p. S249-
1 p.
|
artikel
|
| 408 |
Epithelial ovarian cancer (EOC): Rational intervention using tumour markers
|
Fisken, J.
|
|
1993
|
29 |
S6 |
p. S246-
1 p.
|
artikel
|
| 409 |
ER and PgR in breast cancer, 1993, more than a question of positivity versus negativity
|
Thorpe, S.M.
|
|
1993
|
29 |
S6 |
p. S31-
1 p.
|
artikel
|
| 410 |
Erlangen tumor marker study on breast cancer
|
Jäger, W
|
|
1993
|
29 |
S6 |
p. S84-
1 p.
|
artikel
|
| 411 |
Erythropoietih (rHuEPO) in chbmotherapy-induced anbnia
|
Ganucci, T
|
|
1993
|
29 |
S6 |
p. S54-
1 p.
|
artikel
|
| 412 |
Erythropoietin (r-HuEPO) treatment in cancer patients with anaemia
|
Bösze, P.
|
|
1993
|
29 |
S6 |
p. S210-
1 p.
|
artikel
|
| 413 |
Ethnic related pattern of non-Hodgkin's lymphoma in northern Israel. 20 Year experience in a single institution
|
Cohen, Y.
|
|
1993
|
29 |
S6 |
p. S174-
1 p.
|
artikel
|
| 414 |
Etoposide phosphate (EP): A comparative intrapatient bio-equivalence study with etoposide(E)
|
Bailey, N
|
|
1993
|
29 |
S6 |
p. S108-
1 p.
|
artikel
|
| 415 |
Etoposide/vincristine (EV)
+
−
carboplatin (C) in extensive stage small cell lung cancer — A phase III-trial
|
Gatzemeier, U.
|
|
1993
|
29 |
S6 |
p. S153-
1 p.
|
artikel
|
| 416 |
Etoposide (VP-16) scheduling in small cell lung cancer (SCLC), laboratory rationale and clinical results
|
Falk, S.J.
|
|
1993
|
29 |
S6 |
p. S154-
1 p.
|
artikel
|
| 417 |
Etretinate (E) and interfenon-alpha (IFM): A phase I–II study in souamous cell carcinomas (SCC) and transitional cell carcinomas (TCC)
|
Roth, AD
|
|
1993
|
29 |
S6 |
p. S47-
1 p.
|
artikel
|
| 418 |
European ethanidazole trial in head and neck cancer
|
Chassagne, D.
|
|
1993
|
29 |
S6 |
p. S19-
1 p.
|
artikel
|
| 419 |
Evaluation of cyfra 21-1 as tumor marker at the diagnosis step in the primary lung cancer
|
Rastel, D.
|
|
1993
|
29 |
S6 |
p. S243-
1 p.
|
artikel
|
| 420 |
Evaluation of G-CSF activity given by intramuscolar (I.M.) route in ovarian cancer patients receiving mitoxantrone (DHAD) + ifosfamide (IFO) as second-line (SL) therapy
|
Di Leo, A.
|
|
1993
|
29 |
S6 |
p. S53-
1 p.
|
artikel
|
| 421 |
Evaluation of prognostic factors in Hodgkin's disease
|
Patrício, M.B.
|
|
1993
|
29 |
S6 |
p. S169-
1 p.
|
artikel
|
| 422 |
Evaluation of sleep disorders for patients in palliative and pain unit
|
Saita, L.
|
|
1993
|
29 |
S6 |
p. S267-
1 p.
|
artikel
|
| 423 |
Evidence for a favorable effect of surgical resection of residual metastatic renal cell carcinoma (RCC) following biological therapy (BT)
|
Sella, A.
|
|
1993
|
29 |
S6 |
p. S233-
1 p.
|
artikel
|
| 424 |
Evidence of DNA of HSV (I+II), HHV6 and CMV in the mocous membrane of bronchial carcinoma, pleuramesothelioma, morbus boeck and bronchial asthma
|
Nunnensiek, C.
|
|
1993
|
29 |
S6 |
p. S88-
1 p.
|
artikel
|
| 425 |
Evidence of EBV DNA and adenovirus 2 E1A (Types 2 and 5) in the mucous membrane of bromchial carcinoma and pleuramesothelioma
|
Rüther, U.
|
|
1993
|
29 |
S6 |
p. S89-
1 p.
|
artikel
|
| 426 |
Excision of the humeral tumors in children with the rotated clavicle reconstruction
|
Woániak, W.
|
|
1993
|
29 |
S6 |
p. S200-
1 p.
|
artikel
|
| 427 |
Exclusive brachytherapy as radiotherapeutic treatment after conservative surgery for breast cancer
|
Pacini, P.
|
|
1993
|
29 |
S6 |
p. S70-
1 p.
|
artikel
|
| 428 |
Experience with prevention of toxicity of taxotere in 1 ECTG centre
|
Schrijvers, D.
|
|
1993
|
29 |
S6 |
p. S209-
1 p.
|
artikel
|
| 429 |
Experimental pharmacology of vorozole, a non-steroidal aromatase inhibitor
|
De Coster, R.
|
|
1993
|
29 |
S6 |
p. S76-
1 p.
|
artikel
|
| 430 |
Expression of markers of differentiation in normal bronchial epithelium and bronchial dysplasia
|
Pendleton, N
|
|
1993
|
29 |
S6 |
p. S243-
1 p.
|
artikel
|
| 431 |
Expression of MDR-1 and GSTII gene in human sarcomas
|
Cany, L
|
|
1993
|
29 |
S6 |
p. S113-
1 p.
|
artikel
|
| 432 |
Expression of melanoma-associated-antigens (MAAs), HLA I & II and of lymphocyte markers in biopsies of metastatic and primary melanoma
|
Lotem, M.
|
|
1993
|
29 |
S6 |
p. S248-
1 p.
|
artikel
|
| 433 |
Expression of tenascin in the rat prostate after androgen ablation by cyproter one acetate
|
Michna, H
|
|
1993
|
29 |
S6 |
p. S235-
1 p.
|
artikel
|
| 434 |
Expression of the retinoblastoma gene in human high grade non-Hodgkin's lymphomas
|
Weide, R
|
|
1993
|
29 |
S6 |
p. S172-
1 p.
|
artikel
|
| 435 |
Exstended surgery or palliation for advanced gastric cancer?
|
Verreet, P.R.
|
|
1993
|
29 |
S6 |
p. S106-
1 p.
|
artikel
|
| 436 |
Extracellular ATP reverses drug efflux mediated by the P-glycoprotein
|
Abraham, E.H.
|
|
1993
|
29 |
S6 |
p. S112-
1 p.
|
artikel
|
| 437 |
Extragonadal germinal tumors (EGT). Instituto angel H. Roffo's experience
|
Mickiewicz, E.
|
|
1993
|
29 |
S6 |
p. S242-
1 p.
|
artikel
|
| 438 |
Facilitier for activities of daily living for patients with a short life expectancy
|
Hesselman, G
|
|
1993
|
29 |
S6 |
p. S267-
1 p.
|
artikel
|
| 439 |
Factors influencing the radiation tolerance of slowly dividing normal tissues
|
van der Kogel, A.J.
|
|
1993
|
29 |
S6 |
p. S12-
1 p.
|
artikel
|
| 440 |
Familial clustering of lung cancer and other smoking related cancers
|
Radzikowska, E.
|
|
1993
|
29 |
S6 |
p. S14-
1 p.
|
artikel
|
| 441 |
Familial predisposition to colorectal cancer
|
Meera Khan, P.
|
|
1993
|
29 |
S6 |
p. S14-
1 p.
|
artikel
|
| 442 |
Familial risk in testicular cancer
|
Heimdal, K
|
|
1993
|
29 |
S6 |
p. S242-
1 p.
|
artikel
|
| 443 |
Family aggregation and the risk of prostate cancer
|
Hobisch, A.
|
|
1993
|
29 |
S6 |
p. S235-
1 p.
|
artikel
|
| 444 |
Family cancer screening
|
Vasen, H.F.A.
|
|
1993
|
29 |
S6 |
p. S25-
1 p.
|
artikel
|
| 445 |
Fasting is a prerequisite for reliable FDG-PET in patients with cancer
|
Minn, H
|
|
1993
|
29 |
S6 |
p. S27-
1 p.
|
artikel
|
| 446 |
Fast neutron therapy in advanced head and neck cancer, a cooperative NTCWG-MRC randomized trial
|
Maor, MH
|
|
1993
|
29 |
S6 |
p. S221-
1 p.
|
artikel
|
| 447 |
Fatty acid and antioxidant status in plasma deteriorates during high dose chemotherapy
|
Dürken, M.
|
|
1993
|
29 |
S6 |
p. S117-
1 p.
|
artikel
|
| 448 |
Feasibility and toxicity of high-dose chemotherapy with/without BCNU for autologous bone marrow transplantation (ABMT) in breast carcinoma
|
Drakos, P
|
|
1993
|
29 |
S6 |
p. S82-
1 p.
|
artikel
|
| 449 |
Feasibility of an intensive combined approach in advanced Hodgkin's disease (HD)
|
Bonfante, V.
|
|
1993
|
29 |
S6 |
p. S168-
1 p.
|
artikel
|
| 450 |
Feasibility study of high dose ifosfamide (I) plus cisplatin (C) combined with rh-GCSF every 2 weeks in advanced solid tumors
|
Planting, A.
|
|
1993
|
29 |
S6 |
p. S56-
1 p.
|
artikel
|
| 451 |
Feelings, a valued nursing tool?
|
Humer, M
|
|
1993
|
29 |
S6 |
p. S268-
1 p.
|
artikel
|
| 452 |
Filgrastim with dose intensified CDE chemotherapy in small cell lung cancer
|
Green, JA
|
|
1993
|
29 |
S6 |
p. S57-
1 p.
|
artikel
|
| 453 |
Fine needle aspiration biopsy of palpable breast lesion, review and statistical analysis
|
Rubinov, R.
|
|
1993
|
29 |
S6 |
p. S61-
1 p.
|
artikel
|
| 454 |
Fine needle cytology diagnosis and histological confrontation of 691 salivary gland tumors
|
Klijanienko, J.
|
|
1993
|
29 |
S6 |
p. S144-
1 p.
|
artikel
|
| 455 |
Five years experience in chemoembolizatio of non-resectable primary hepatocellular carcinoa (HCC)
|
Schmoll, E.
|
|
1993
|
29 |
S6 |
p. S101-
1 p.
|
artikel
|
| 456 |
Five year survivors after radical operation for esophageal carcinoma: Influence of pathological findings
|
Fekete, F.
|
|
1993
|
29 |
S6 |
p. S29-
1 p.
|
artikel
|
| 457 |
Fixed dose stereotactic radiotherapy for vascular malformations of the brain: Factors influencing outcome
|
Sebag-Montefiore, D
|
|
1993
|
29 |
S6 |
p. S190-
1 p.
|
artikel
|
| 458 |
Flow cytometric analysis of fresh human tumor tissue: A new separation system for identification of single tumor cells and application to analysis of tumor-asssociated proteases
|
Harbeck, N.
|
|
1993
|
29 |
S6 |
p. S64-
1 p.
|
artikel
|
| 459 |
Flowcytometric detection of P-glycoprotein in hematologic disorders
|
Gheuens, E.E.O.
|
|
1993
|
29 |
S6 |
p. S113-
1 p.
|
artikel
|
| 460 |
Flow cytometric DNA analysis and BrdUrd labelling index in brain tumours
|
Gasińska, A.
|
|
1993
|
29 |
S6 |
p. S218-
1 p.
|
artikel
|
| 461 |
Flow cytometry DNA ploidy analysis in children with rhabdomyosarcoma and soft tissue sarcoma
|
Goshen, Y.
|
|
1993
|
29 |
S6 |
p. S186-
1 p.
|
artikel
|
| 462 |
Flow cytometry DNA ploidy and N myc genomic content as prognostic indicators in neuroblastoma
|
Yaniv, I.
|
|
1993
|
29 |
S6 |
p. S196-
1 p.
|
artikel
|
| 463 |
Flow cytometry (FCM) of gliomas (Gr-III–IV) for predicting response to chemotherapy (CHT)
|
Loven, D
|
|
1993
|
29 |
S6 |
p. S191-
1 p.
|
artikel
|
| 464 |
Fludarabine a major new drug in chronic lymphocytic leukemia (CLL)
|
Keating, MJ
|
|
1993
|
29 |
S6 |
p. S149-
1 p.
|
artikel
|
| 465 |
Fludarabine + ARA-C + G-CSF (FLAG) treatment of newly-diagnosed AML and MDS
|
Estey, E
|
|
1993
|
29 |
S6 |
p. S149-
1 p.
|
artikel
|
| 466 |
Fludarabine in the treatment of refractory lymphocytic leukemia (CLL) and low grade lymphoma (LGL)
|
Gillis, S.
|
|
1993
|
29 |
S6 |
p. S153-
1 p.
|
artikel
|
| 467 |
Flunarizine and lonidamine as modulators of anticancer drug activity in human colon adenocarcinoma cells
|
Orlandl, L.
|
|
1993
|
29 |
S6 |
p. S114-
1 p.
|
artikel
|
| 468 |
Fluorouracil, epirubicin, cyclophosphamide (FEC) primary chemotherapy to avoid mastectomy in operable breast cancer
|
Pedrazzoli, P.
|
|
1993
|
29 |
S6 |
p. S73-
1 p.
|
artikel
|
| 469 |
5 Fluorouracil, etoposide, epirubicin, cisplatin in treatment of advanced gastric cancer
|
Bouillet, T
|
|
1993
|
29 |
S6 |
p. S105-
1 p.
|
artikel
|
| 470 |
Fluorouracil, folinic acid and interferon alpha or fluorouracil and folinic acid alone in ambulatory palliative treatment of metastatic colorectal cancer
|
Stoffregen, C
|
|
1993
|
29 |
S6 |
p. S98-
1 p.
|
artikel
|
| 471 |
5-fluorouracil (FU) and folinic acid (FA) plus beta — Interferon (b-IFN) for treatment of metastatic colo-rectal cancer
|
Pavesi, L.
|
|
1993
|
29 |
S6 |
p. S92-
1 p.
|
artikel
|
| 472 |
Fluorouracil (5-FU) and follinic acid (FA) with or without a2b-interferon (IFN) in advanced colorectal cancer (ACC). A prospective randomized trial
|
Kosmidis, P.
|
|
1993
|
29 |
S6 |
p. S99-
1 p.
|
artikel
|
| 473 |
5-Fluorouracil (5-FU) combined with the [6S]-stereoisomer of folinic acid ([6S]-FA) for patients with advanced colorectal carcinoma (CRC)
|
Machover, D
|
|
1993
|
29 |
S6 |
p. S109-
1 p.
|
artikel
|
| 474 |
5-Fluorouracil (5FU) plus levdfolinic acid (1-FA) and hydroxyurea (HU) on a weekly schedule in the treatment of metastatic and/or recurrent colorectal adenocarcinoma (CA)
|
Gebbia, V
|
|
1993
|
29 |
S6 |
p. S94-
1 p.
|
artikel
|
| 475 |
5Fluorouracil (5FU) with low dose leucovorin (LCV) in advanced colorectal carcinoma (CC)
|
Figer, A.
|
|
1993
|
29 |
S6 |
p. S93-
1 p.
|
artikel
|
| 476 |
Fluorouracilo (FU) versus combination of FU with higher or low dose of leucovorin(LV) and plus or minus interferon (IFN) in advanced colo-rectal cancer
|
Botto, H.G.
|
|
1993
|
29 |
S6 |
p. S93-
1 p.
|
artikel
|
| 477 |
Fluorouracll (F), with and without high-dose folinic acid (HDFA) plus epirubicin (E) and cyclophosphamide (C): FEC versus HDFA-FEC plus or minus thymostimulin (TS) in metastatic breast cancer: results of a multicenter study
|
Pavesi, L.
|
|
1993
|
29 |
S6 |
p. S77-
1 p.
|
artikel
|
| 478 |
Follow-up of the serum ferritin values in the patients with non Hodgkin lymphomas
|
Pejčić, I.
|
|
1993
|
29 |
S6 |
p. S177-
1 p.
|
artikel
|
| 479 |
Fotemustine in the treatment of disseminated malignant melanoma: A retrospective analysis
|
Khayat, D.
|
|
1993
|
29 |
S6 |
p. S182-
1 p.
|
artikel
|
| 480 |
Frequency of HLA class I antigens in Israeli-Jewish patients with advanced melanoma
|
Klein, T.
|
|
1993
|
29 |
S6 |
p. S179-
1 p.
|
artikel
|
| 481 |
Frequent mutations, deletions and nuclear overexpression of p53 gene in node metastases from head and neck carcinoma
|
Ahomadegbe, JC
|
|
1993
|
29 |
S6 |
p. S194-
1 p.
|
artikel
|
| 482 |
From strandquist to L-Q formula— Is human skin cancer a good model for radiobiology
|
Maciejewski, B.
|
|
1993
|
29 |
S6 |
p. S219-
1 p.
|
artikel
|
| 483 |
Full dose oxaliplatin (L-OHP) in 49 patients (PTS) with renal function impairment (RFI)
|
Brienza, S.
|
|
1993
|
29 |
S6 |
p. S109-
1 p.
|
artikel
|
| 484 |
Functional hepatic reserve after arterial lipiodol-carboplatinum therapy in cirrhotic patients with hepatoma
|
Grieco, A
|
|
1993
|
29 |
S6 |
p. S104-
1 p.
|
artikel
|
| 485 |
Gastric cancer patients preoperative immune state correction
|
Yaunalksne, I.
|
|
1993
|
29 |
S6 |
p. S107-
1 p.
|
artikel
|
| 486 |
Gastric carcinoma: Continuous infusion 5-fluorouracil plus cisplatinum: Dose intensification study
|
Weitzen, R
|
|
1993
|
29 |
S6 |
p. S104-
1 p.
|
artikel
|
| 487 |
Gastrinoma: Clinico-morphological forms
|
Bereznitsky, Ya.S.
|
|
1993
|
29 |
S6 |
p. S102-
1 p.
|
artikel
|
| 488 |
Gastro — duodenal lymphoma — AIDS related
|
Venezia, P.
|
|
1993
|
29 |
S6 |
p. S175-
1 p.
|
artikel
|
| 489 |
GBM: A review of 118 patients
|
Botturi, M.
|
|
1993
|
29 |
S6 |
p. S193-
1 p.
|
artikel
|
| 490 |
Gene alterations and response to drugs
|
Bourhis, Jean
|
|
1993
|
29 |
S6 |
p. S40-
1 p.
|
artikel
|
| 491 |
General oncological aspects of laparoscopic surgery
|
Herfarth, Ch.
|
|
1993
|
29 |
S6 |
p. S20-
1 p.
|
artikel
|
| 492 |
Genes coding for tumor rejection antigens. Perspectives for cancer immunotherapy
|
Boon, T.
|
|
1993
|
29 |
S6 |
p. S1-
1 p.
|
artikel
|
| 493 |
Genetic alterations in children with neuroblastoma (NBL) — Relevance to prognosis
|
Avigad, S.
|
|
1993
|
29 |
S6 |
p. S194-
1 p.
|
artikel
|
| 494 |
Genomic integration of EBV in Burkitt's lymphoma cells alters latent viral gene expression
|
Wolf, J
|
|
1993
|
29 |
S6 |
p. S197-
1 p.
|
artikel
|
| 495 |
Germ-line P53 mutations and Li-Fraumeni syndrome
|
Brugières, L.
|
|
1993
|
29 |
S6 |
p. S38-
1 p.
|
artikel
|
| 496 |
Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines
|
Kaiser, U.
|
|
1993
|
29 |
S6 |
p. S161-
1 p.
|
artikel
|
| 497 |
Goserelin versus goserelin plus mitomycin C in advanced (stabe D) previously untreated prostatic cancer. A randomized study
|
Bertetto, O.
|
|
1993
|
29 |
S6 |
p. S238-
1 p.
|
artikel
|
| 498 |
G.P. consultative service in home care
|
Gill, K.
|
|
1993
|
29 |
S6 |
p. S203-
1 p.
|
artikel
|
| 499 |
Granisetron as prophylaxis in the control of nausea and vomiting in patients undergoing hemibody irradiation
|
Van Zyl, A.J.
|
|
1993
|
29 |
S6 |
p. S223-
1 p.
|
artikel
|
| 500 |
Granulocyte colony stimulating factor (G-CSF) activity in prevention of infections in neutropenic patients
|
Comandone, A.
|
|
1993
|
29 |
S6 |
p. S55-
1 p.
|
artikel
|
| 501 |
Growth factors in cancer therapy: The control of hematopoiesis as a model system
|
Sachs, L.
|
|
1993
|
29 |
S6 |
p. S3-
1 p.
|
artikel
|
| 502 |
Growth hormone deficit induced by chemotherapy (CT) in children with cancer
|
Homan, J
|
|
1993
|
29 |
S6 |
p. S198-
1 p.
|
artikel
|
| 503 |
Haematological, cytogenetic and molecular response in CKL patients treated with high-dose chemotherapy at diagnosis, in the accelerated phase or blastic crisis
|
Liberati, A.M.
|
|
1993
|
29 |
S6 |
p. S152-
1 p.
|
artikel
|
| 504 |
Haemopoietic growth factors - what for?
|
W, Steward
|
|
1993
|
29 |
S6 |
p. S10-
1 p.
|
artikel
|
| 505 |
Hand VS stapled anastomosis in anterior resection
|
Kingston, RD
|
|
1993
|
29 |
S6 |
p. S95-
1 p.
|
artikel
|
| 506 |
HDR afterloading in the treatment of the cervical stump carcinoma — Our experience and results
|
Čikarić, S.
|
|
1993
|
29 |
S6 |
p. S224-
1 p.
|
artikel
|
| 507 |
Head and neck cancer (HNC) registry in Northern France (1984–1991)
|
Lefebyre, J.L.
|
|
1993
|
29 |
S6 |
p. S125-
1 p.
|
artikel
|
| 508 |
Head and neck cancer:Neoadjuvant therapy with ifosfamide and carboplatin
|
Bruno, M.
|
|
1993
|
29 |
S6 |
p. S142-
1 p.
|
artikel
|
| 509 |
Health care professionals attitudes towards elderly women with breast cancer
|
Miller, CM
|
|
1993
|
29 |
S6 |
p. S261-
1 p.
|
artikel
|
| 510 |
Heart and lungfunction in patients with pulmonary metastases of osteosarcoma treated with metastatectomy and 20 gy postoperative irradiation
|
Nooy, MA
|
|
1993
|
29 |
S6 |
p. S184-
1 p.
|
artikel
|
| 511 |
Heat shock protein HSP70 protects cells from heat shock, oxidative stress and x-ray irradiation
|
Li, Gloria C.
|
|
1993
|
29 |
S6 |
p. S217-
1 p.
|
artikel
|
| 512 |
Heat transfer, temperature distribution and control in hyperthermic isolated limb perfusion
|
Pace, M.
|
|
1993
|
29 |
S6 |
p. S116-
1 p.
|
artikel
|
| 513 |
Heavy charged particles: A possibility for presise delivery of a high radiation dose
|
Castro, J.R.
|
|
1993
|
29 |
S6 |
p. S28-
1 p.
|
artikel
|
| 514 |
Hepatic infiltration in hairy cell leukemia. Effects of the treatment with interferon Alfa-2b (IFN) (intron A)
|
Bezares, R.F.
|
|
1993
|
29 |
S6 |
p. S151-
1 p.
|
artikel
|
| 515 |
Hickman line practice in patients with solid tumours
|
Harrington, KJ
|
|
1993
|
29 |
S6 |
p. S209-
1 p.
|
artikel
|
| 516 |
High complete response in advanced nasopharyngeal carcinoma
|
Merrick, Y.
|
|
1993
|
29 |
S6 |
p. S148-
1 p.
|
artikel
|
| 517 |
High-dose chemotherapy and GM-CSF apter standard chemotherapy polloved by autologous transplantation of peripheral blood stem cells
|
Liberati, AM
|
|
1993
|
29 |
S6 |
p. S55-
1 p.
|
artikel
|
| 518 |
High dose chemotherapy (HDCT) VP-16, cyclophosphamide, carboplatin and autologous bone marrow transplantation (ABMT) with G-CSF in patients with breast cancer (BC). Preliminary results
|
Vassilomanolakis, M.
|
|
1993
|
29 |
S6 |
p. S54-
1 p.
|
artikel
|
| 519 |
High dose chemotherapy (HDCT) with mitoxantrone, cyclophosphamide, vinblastine or carboplatin with bone marrow support in metastatic breast cancer (MBC): Role of autologous peripheral blood stem cell transplantation (PBSCT) and cytokines
|
Nabholtz, J.M.
|
|
1993
|
29 |
S6 |
p. S83-
1 p.
|
artikel
|
| 520 |
High-dose chemotherapy (HDC) with autologous progenitor cell support (APCS) for breast cancer patients with high risk stage II–III, and stage IV with no evidence of disease (NED)
|
Stemmer, S.M.
|
|
1993
|
29 |
S6 |
p. S71-
1 p.
|
artikel
|
| 521 |
High dose chemotherapy in ovarian carcinoma
|
Héron, J.F.
|
|
1993
|
29 |
S6 |
p. S137-
1 p.
|
artikel
|
| 522 |
High dose chemotherapy with epirubicin (E) and cyclophosphamide (C) plus hemopoietic colony stimulating factors in locally advanced (LABC) or metastatic (MBC) breast cancer. A phase I–II trial
|
Perrone, F.
|
|
1993
|
29 |
S6 |
p. S57-
1 p.
|
artikel
|
| 523 |
High-dose epirubicin (HD-E) in a 2-week (W) schedule in advanced breast cancer (ABC)
|
Ries, F.
|
|
1993
|
29 |
S6 |
p. S82-
1 p.
|
artikel
|
| 524 |
High-dose epirubicin(HD-EPI) plus cisplatin(CDDP) and rHu-GM-CSF in advanced non-small cell lung cancer(NSCLC)
|
Galvez, C.A.
|
|
1993
|
29 |
S6 |
p. S167-
1 p.
|
artikel
|
| 525 |
High - dose folinic acid (HDFA) and fluorouracll (FU) plus or minus thymostimulin (TS) for treatment of metastatic colorectal cancer (MCRC): a randomized multicentric study
|
Mustacchi, G.
|
|
1993
|
29 |
S6 |
p. S89-
1 p.
|
artikel
|
| 526 |
High dose ifosfamide (IFOS) and mesna (M) in refractory pediatric solid tumors after previous exposure to “conventional” IFOS
|
Epelman, S
|
|
1993
|
29 |
S6 |
p. S198-
1 p.
|
artikel
|
| 527 |
High dose ifospamide as a single agent and in combination with cisplatinom in the treatment of advanced/recurrent SQ. cell CA. of head and neck
|
Pai, VR
|
|
1993
|
29 |
S6 |
p. S147-
1 p.
|
artikel
|
| 528 |
High dose intensity of CPT-11 administered as single dose every 3 weeks: The instittut gustave roussy experience
|
Abigerges, D.
|
|
1993
|
29 |
S6 |
p. S118-
1 p.
|
artikel
|
| 529 |
High dose intra-arterial plus intraperitoneal chemotherapy combined with hemofiltration in liver metastases from colorectal cancer
|
Dazzi, C.
|
|
1993
|
29 |
S6 |
p. S99-
1 p.
|
artikel
|
| 530 |
High dose irradiation in the treatment of prostate cancer
|
Lo, T.C.M.
|
|
1993
|
29 |
S6 |
p. S236-
1 p.
|
artikel
|
| 531 |
High dose rate brachytherapy for malignant endobronchial tumors
|
Hayes, J.L.
|
|
1993
|
29 |
S6 |
p. S160-
1 p.
|
artikel
|
| 532 |
High dose rate interstitial brachytherapy of lower gynecological tract cancer
|
Donath, D.
|
|
1993
|
29 |
S6 |
p. S129-
1 p.
|
artikel
|
| 533 |
High doses of new antiestrogen toremifene in advanced renal cell carcinoma
|
Gershanovich, M.
|
|
1993
|
29 |
S6 |
p. S233-
1 p.
|
artikel
|
| 534 |
High-dose taxol (HDT) with G-CSF in patients with advanced breast cancer (ABC) refractory to anthracycline (ANT) therapy
|
Vermorken, JB
|
|
1993
|
29 |
S6 |
p. S83-
1 p.
|
artikel
|
| 535 |
High response rate of a chemotherapy using carboplatin (CARBO) + cisplatin (CDDP) + 5-fluorouracil (5-FU) for advanced oesophageal cancer
|
Curé, H.
|
|
1993
|
29 |
S6 |
p. S104-
1 p.
|
artikel
|
| 536 |
High value of drug intensity (D.L.) and seric intensity (S.I.) in osteogenic osteosarcoma. Results of DD1 protocol at 5 years
|
Delepine, N.
|
|
1993
|
29 |
S6 |
p. S201-
1 p.
|
artikel
|
| 537 |
HLA expression on tumor cells and serum levels of soluble IL-2 receptor in colorectal cancer
|
Torlone, N.
|
|
1993
|
29 |
S6 |
p. S99-
1 p.
|
artikel
|
| 538 |
Hodgkin derived cell lines L540 and L540cy grow disseminatedly in severe combined immunodeficient (SCID) mice
|
Kapp, U
|
|
1993
|
29 |
S6 |
p. S168-
1 p.
|
artikel
|
| 539 |
Hodgkin's disease: A study of prognostic factors in a group of 308 patients treated at a single centre
|
Lopez Lopez, JJ
|
|
1993
|
29 |
S6 |
p. S169-
1 p.
|
artikel
|
| 540 |
Hodgkin's disease (HD) patients, clinical stage (CS) I and II, with particular clinical features: staging and therapeutic implications
|
Ponticell, P.
|
|
1993
|
29 |
S6 |
p. S170-
1 p.
|
artikel
|
| 541 |
Hodgkin's disease in children—Reduced tailored chemotherapy for stage I–II disease
|
Yaniv, I.
|
|
1993
|
29 |
S6 |
p. S170-
1 p.
|
artikel
|
| 542 |
Home care for advanced cancer patients: The efficacy of domiciliary assistance
|
Brivio, E.
|
|
1993
|
29 |
S6 |
p. S203-
1 p.
|
artikel
|
| 543 |
Home care technology for patients with cancer or infectious disease
|
Boxtel van, A.
|
|
1993
|
29 |
S6 |
p. S268-
1 p.
|
artikel
|
| 544 |
Home-care treatment for selected acute leukemic elderly patients by low dose ARA-C
|
Abbedemea, A
|
|
1993
|
29 |
S6 |
p. S261-
1 p.
|
artikel
|
| 545 |
Home hospice care, an oncology service
|
Steiner, M.
|
|
1993
|
29 |
S6 |
p. S203-
1 p.
|
artikel
|
| 546 |
Hopes and expectations of swedish cancer patients: Contradictions surrounding satisfaction with care
|
Tishelman, C.
|
|
1993
|
29 |
S6 |
p. S215-
1 p.
|
artikel
|
| 547 |
Hormonal control of breast cancer cell proliferation
|
Coombes, RC
|
|
1993
|
29 |
S6 |
p. S23-
1 p.
|
artikel
|
| 548 |
Hormonal manipulation in advanced prostate carcinoma
|
Rubinov, R.
|
|
1993
|
29 |
S6 |
p. S237-
1 p.
|
artikel
|
| 549 |
Hormonal receptors as prognostic factors for development of bone metastases in breast cancer
|
Piperkova, E.N.
|
|
1993
|
29 |
S6 |
p. S60-
1 p.
|
artikel
|
| 550 |
Hormonal therapy of advanced adenocarcinoma of the pancreas with somatostatin and GNRH analogs
|
Barni, S.
|
|
1993
|
29 |
S6 |
p. S107-
1 p.
|
artikel
|
| 551 |
How often does serum prostatic specific antigen (PSA) increase prior to clinical progression of prostate cancer (PC)?
|
Josefsen, D.
|
|
1993
|
29 |
S6 |
p. S237-
1 p.
|
artikel
|
| 552 |
How often is medication taken as prescribed?
|
Wit, R.de
|
|
1993
|
29 |
S6 |
p. S260-
1 p.
|
artikel
|
| 553 |
How quality of life can help decision making in oncology
|
da Silva, Fernando Calais
|
|
1993
|
29 |
S6 |
p. S17-
1 p.
|
artikel
|
| 554 |
How should nicotinamide be used clinically to overcome hypoxic cell radioresistance in human tumours?
|
Horsman, M.R.
|
|
1993
|
29 |
S6 |
p. S218-
1 p.
|
artikel
|
| 555 |
How to set up a palliative care programme at the national or regional level
|
Gomez-Batiste, X.
|
|
1993
|
29 |
S6 |
p. S37-
1 p.
|
artikel
|
| 556 |
How to take good care of the patient, handling a pharmacokinetic study as a research nurse in a small teamwork, testing the use of Calvert's formula
|
Østergaard Nielsen, K
|
|
1993
|
29 |
S6 |
p. S257-
1 p.
|
artikel
|
| 557 |
How will the role of radiotherapy in early breast cancer change over the next ten years?
|
Kurtz, J.
|
|
1993
|
29 |
S6 |
p. S71-
1 p.
|
artikel
|
| 558 |
Human lung cancer: Alterations of parenchymal α1-adrenergic receptors
|
Kondratenko, T.
|
|
1993
|
29 |
S6 |
p. S160-
1 p.
|
artikel
|
| 559 |
Human papillomavirus as oncogenic initiator in anal carcinoma
|
Tanum, G.
|
|
1993
|
29 |
S6 |
p. S90-
1 p.
|
artikel
|
| 560 |
4-Hydroxyandrostenedione (4-OHA) as first line treatment in postmenopausal patients with advanced breast cancer(ABC)
|
Zilembo, N.
|
|
1993
|
29 |
S6 |
p. S77-
1 p.
|
artikel
|
| 561 |
Hyperfractionated intracavitary accelerated radiotherapy (HicART) for carcinoma of the cervix
|
Kelly, SA
|
|
1993
|
29 |
S6 |
p. S127-
1 p.
|
artikel
|
| 562 |
Hyperfractionated radiotherapy and tegafur in local relapse of adenocarcinoma of the rectum: A pilot study
|
Romero, J.
|
|
1993
|
29 |
S6 |
p. S94-
1 p.
|
artikel
|
| 563 |
Hypersensitivity reactions to carboplatin
|
Weidmann, B
|
|
1993
|
29 |
S6 |
p. S208-
1 p.
|
artikel
|
| 564 |
Hyperthermia in the chest wall recurrence in breast cancer
|
Corti, L.
|
|
1993
|
29 |
S6 |
p. S67-
1 p.
|
artikel
|
| 565 |
Hypothalamus-pituttary function following radiotherapy for tumors not related to the adenohypophysis
|
Schmeets, ILO
|
|
1993
|
29 |
S6 |
p. S225-
1 p.
|
artikel
|
| 566 |
Hypothermia in prevention of alopecia in patients in antracyclin-containing protocols
|
Jelečanin, D.
|
|
1993
|
29 |
S6 |
p. S256-
1 p.
|
artikel
|
| 567 |
ICIF-187 significantly influences Ca++, Fe++, Ph+++, Mg++ and HCO3- levels in humans
|
Russo, A.
|
|
1993
|
29 |
S6 |
p. S210-
1 p.
|
artikel
|
| 568 |
Ifosfamide plus carboplatin for the treatment of advanced head and neck cancer. Preliminary report
|
Cervellino, J.C.
|
|
1993
|
29 |
S6 |
p. S141-
1 p.
|
artikel
|
| 569 |
Ifosfamide, Vincristine, Epirubicin (IVE) as third line salvage chemotherapy for recurrent anthracycline-naive postmenopausai metastatic breast cancer
|
Da Prada, G.A.
|
|
1993
|
29 |
S6 |
p. S80-
1 p.
|
artikel
|
| 570 |
Ifosfamide, vindesine and recombinant alphainterferone combination chemotherapy for patients (PTS) with progressive metastatic renal cell carcinoma (RCC)
|
König, H.J.
|
|
1993
|
29 |
S6 |
p. S234-
1 p.
|
artikel
|
| 571 |
IL-4 effect on adhesion molecules on the farage human B-cell lymphoma line
|
Shubinsky, G.
|
|
1993
|
29 |
S6 |
p. S53-
1 p.
|
artikel
|
| 572 |
Immune disregulation in colon cancer
|
Berghella, A.M.
|
|
1993
|
29 |
S6 |
p. S97-
1 p.
|
artikel
|
| 573 |
Immunity in children with brain tumor
|
Hajnžić, TF
|
|
1993
|
29 |
S6 |
p. S192-
1 p.
|
artikel
|
| 574 |
Immunocytometric detection of the α-and β-isoforms of DNA topoisomerase II (topo II) in human ovarian cancers
|
Oliani, C.
|
|
1993
|
29 |
S6 |
p. S136-
1 p.
|
artikel
|
| 575 |
Immunodiagnosis of breast cancer by cellscan
|
Rubin, M.
|
|
1993
|
29 |
S6 |
p. S60-
1 p.
|
artikel
|
| 576 |
Immunologic changes in children with bone and soft tissue sarcomas
|
Kebudi, R
|
|
1993
|
29 |
S6 |
p. S199-
1 p.
|
artikel
|
| 577 |
Immunomodulatory effect of roferon in patients with disseminated melanoma
|
Hadjikirova, M.
|
|
1993
|
29 |
S6 |
p. S49-
1 p.
|
artikel
|
| 578 |
Immunosuppressive acidic protein serum levels in breast cancer patients, in reference to CA 15-3 levels
|
Cohen, A
|
|
1993
|
29 |
S6 |
p. S245-
1 p.
|
artikel
|
| 579 |
Impact of antiemetics in cancer treatment: The eortc experience
|
Gisle, L.
|
|
1993
|
29 |
S6 |
p. S206-
1 p.
|
artikel
|
| 580 |
Implantable port-catheter system for chemotherapy cancer treatment
|
Levin, Dr.M.
|
|
1993
|
29 |
S6 |
p. S207-
1 p.
|
artikel
|
| 581 |
Implementation of quality of life assessment in health care settings
|
Cull, A.
|
|
1993
|
29 |
S6 |
p. S17-
1 p.
|
artikel
|
| 582 |
Implications of chemotherapy in the results of local treatment in Ewing's sarcoma (EW)
|
Delepine, G.
|
|
1993
|
29 |
S6 |
p. S200-
1 p.
|
artikel
|
| 583 |
Impoprtance of the tumour marker Ca-125 for diagnosis and therapy of lymphangioleiomyomatosis
|
Zahner, J.
|
|
1993
|
29 |
S6 |
p. S244-
1 p.
|
artikel
|
| 584 |
Improved prognosis of intracranial germ cell-tumors (GCTs): Results of the makei 89 study
|
Calaminus, G
|
|
1993
|
29 |
S6 |
p. S197-
1 p.
|
artikel
|
| 585 |
Improved survival after neoadjuvent carboplatin/5 FU in resectable stage II and III squamous cell carcinomas of the oral cavity and the tonsil
|
Schröder, M.
|
|
1993
|
29 |
S6 |
p. S144-
1 p.
|
artikel
|
| 586 |
Improved therapeutic index of cisplatin (DDP) by procainamide (Pd)
|
Esposito, M.
|
|
1993
|
29 |
S6 |
p. S123-
1 p.
|
artikel
|
| 587 |
Improvement in the prognostic value of nuclear components of cytological-histological MSBR grading and its dependent relationship to ploidy and S-phase status in primary operable breast carcinoma
|
Le Doussal, V
|
|
1993
|
29 |
S6 |
p. S58-
1 p.
|
artikel
|
| 588 |
Improvement of supportive nursing care in cancer patients autotransplanted with bone marrow and peripheral blood hematopoietic progenitors
|
Greco, MG
|
|
1993
|
29 |
S6 |
p. S252-
1 p.
|
artikel
|
| 589 |
Improving quality of antiemetic therapy (AT)
|
Ramm, K.
|
|
1993
|
29 |
S6 |
p. S209-
1 p.
|
artikel
|
| 590 |
Improving the teaching and learning process
|
Borras, N.
|
|
1993
|
29 |
S6 |
p. S253-
1 p.
|
artikel
|
| 591 |
Improving the yield of needle localization biopsies for nonpalpable breast carcinoma in women
|
Sibirsky, O.
|
|
1993
|
29 |
S6 |
p. S58-
1 p.
|
artikel
|
| 592 |
Incidence of childhood malignant solid tumor in northern Israel, 1973–1990
|
Rogeen, A
|
|
1993
|
29 |
S6 |
p. S199-
1 p.
|
artikel
|
| 593 |
Incidence of hypothyroidism in patients treated for head and neck cancer by conventional radiotherapy
|
Lewensohn, R.
|
|
1993
|
29 |
S6 |
p. S227-
1 p.
|
artikel
|
| 594 |
Increased cancer incidence in physicians, dentists and health care workers
|
Eriksson, M
|
|
1993
|
29 |
S6 |
p. S125-
1 p.
|
artikel
|
| 595 |
Increase in CEA in dependence of the estrogen receptor status in patients with metastatic breast cancer
|
Weinländer, G.
|
|
1993
|
29 |
S6 |
p. S61-
1 p.
|
artikel
|
| 596 |
111In-CYT-103 scintigraphy for patients with colorectal carcinoma: Diagnostic value
|
de la Gándara, I.
|
|
1993
|
29 |
S6 |
p. S96-
1 p.
|
artikel
|
| 597 |
Individual in vitro fibroblast sensitivity predicts for normal tissue response to radiotherapy
|
Burnet, N
|
|
1993
|
29 |
S6 |
p. S216-
1 p.
|
artikel
|
| 598 |
Individualized HDR-afterloading and percutan radiation therapy management in cervix and endometrium cancer: The use of radiologic imaging techniques
|
Birgit, Goetze
|
|
1993
|
29 |
S6 |
p. S226-
1 p.
|
artikel
|
| 599 |
Indwelling central venous access devices (ICAD): Comparison between externalized catheters and implanted ports: A retrospective analysis in childhood
|
Rosenthal, J
|
|
1993
|
29 |
S6 |
p. S199-
1 p.
|
artikel
|
| 600 |
Inflammatory breast cancer: Combined treatment with chemotherapy plus lonidamine, surgery and radiotherapy
|
de Matteis, A.
|
|
1993
|
29 |
S6 |
p. S73-
1 p.
|
artikel
|
| 601 |
Influence of G-CSF on fludarabine and ARA-C metabolism in AML blasts during therapy
|
Plunkett, W
|
|
1993
|
29 |
S6 |
p. S109-
1 p.
|
artikel
|
| 602 |
Influence of hematocrit on tumor oxygenation and sensitivity to radiation
|
Lavey, RS
|
|
1993
|
29 |
S6 |
p. S216-
1 p.
|
artikel
|
| 603 |
Influence of histological subtypes on the prognosis and survival of the childhood osteosarcoma (OS)
|
García-Foncillas, J
|
|
1993
|
29 |
S6 |
p. S201-
1 p.
|
artikel
|
| 604 |
Influence of radiations on laryngeal carcinoma in Spain
|
Espinosa, J.
|
|
1993
|
29 |
S6 |
p. S126-
1 p.
|
artikel
|
| 605 |
Influence of size of a postoperative residual tumor on survival of patients with ovarian carcinoma, treated postoperatively with chemotherapy
|
Čolaković, S.
|
|
1993
|
29 |
S6 |
p. S136-
1 p.
|
artikel
|
| 606 |
Influence of temperature on action and pharmacokinetics of ifosfamide a preclinical study
|
Wagner, Th.
|
|
1993
|
29 |
S6 |
p. S122-
1 p.
|
artikel
|
| 607 |
Informed consent in european multicentric randomised clinical trials
|
Zwitter, M
|
|
1993
|
29 |
S6 |
p. S212-
1 p.
|
artikel
|
| 608 |
Inhibition of human breast cancer cell growth by N-(4-hydroxyphenyl) retinamide and 13-cis-retinoic acid alone and in combination with tamoxifen
|
Lama, G
|
|
1993
|
29 |
S6 |
p. S122-
1 p.
|
artikel
|
| 609 |
Initial DNA damage double strand breaks cellular radiosensitivity
|
Ruiz de Almodóvar, JM
|
|
1993
|
29 |
S6 |
p. S219-
1 p.
|
artikel
|
| 610 |
111-in-pentetreotide tumor-imaging in malignant lymphoma
|
Boog, SB
|
|
1993
|
29 |
S6 |
p. S170-
1 p.
|
artikel
|
| 611 |
Integrins and metastasis
|
Imhof, B.A.
|
|
1993
|
29 |
S6 |
p. S22-
1 p.
|
artikel
|
| 612 |
Intensified and accelerated concomitant chemoradiotherapy and G-CSF for locally advanced head and neck cancer
|
Vokes, EE
|
|
1993
|
29 |
S6 |
p. S146-
1 p.
|
artikel
|
| 613 |
Intensive chemotherapy(CT) after remission induction with all-trans-retinoic acid (ATRA) in acute promyelocytic leukemia (APL)
|
Sousa, AB
|
|
1993
|
29 |
S6 |
p. S150-
1 p.
|
artikel
|
| 614 |
Intensive chemotherapy with fluorouracil, epirubicin, cyclophosphamide (FBC) day 1–8 in metastatic breast cancer
|
Bolognesi, A
|
|
1993
|
29 |
S6 |
p. S85-
1 p.
|
artikel
|
| 615 |
Intensive simultaneous chemoradiotherapy (CT-RT) in locally advanced head and neck squamous cell carcinoma (HNSCC)
|
Bensmaine, A.
|
|
1993
|
29 |
S6 |
p. S138-
1 p.
|
artikel
|
| 616 |
Interaction of etoposide and radiation in a C3H mammary carcinoma and the feet of CDF1 mice
|
Grau, C
|
|
1993
|
29 |
S6 |
p. S216-
1 p.
|
artikel
|
| 617 |
Interactions of vinca alkaloids with hepato-cellular methotrexate transport
|
Bremnes, R.M.
|
|
1993
|
29 |
S6 |
p. S123-
1 p.
|
artikel
|
| 618 |
Interferon alpha 2b (IFN) improves duration of complete remission (CR) and survival as maintenance therapy in patients with diffuse large cell lymphoma (DLCL)
|
Avilés, A.
|
|
1993
|
29 |
S6 |
p. S174-
1 p.
|
artikel
|
| 619 |
Interferon-alpha (IFN-a) in combination with carboplatin (C) vinblastine (V) and bleomycin (B) in metastatic malignant melanoma (M.M.)
|
Bafaloukos, D.
|
|
1993
|
29 |
S6 |
p. S181-
1 p.
|
artikel
|
| 620 |
Interferon (IFN) and tamoxifen (TAM) for patients with advanced breast cancer and negative estrogen receptors (ER)
|
Peretz, T.
|
|
1993
|
29 |
S6 |
p. S87-
1 p.
|
artikel
|
| 621 |
Interferon α increases toxicity of cisplatin + 5-fluorouracil in patients with relapsed squamous cell carcinoma of the head and neck
|
Nicolson, MC
|
|
1993
|
29 |
S6 |
p. S142-
1 p.
|
artikel
|
| 622 |
Interferon vinblastine and epirubicin in metastatic renal cancer
|
Kirkrali, Z.
|
|
1993
|
29 |
S6 |
p. S234-
1 p.
|
artikel
|
| 623 |
α interferon VS placebo random study in early colorectal cancer
|
Cigolari, S.
|
|
1993
|
29 |
S6 |
p. S96-
1 p.
|
artikel
|
| 624 |
Interleukin2-alpha-interferon combined with cis-platyl therapy in metastatic malignant melanoma (MMM) patients: Results of two consecutive trials
|
Khayat, D.
|
|
1993
|
29 |
S6 |
p. S179-
1 p.
|
artikel
|
| 625 |
Interleukin-2 and interferon in advanced renal and ovarian cancer
|
Selby, P.
|
|
1993
|
29 |
S6 |
p. S15-
1 p.
|
artikel
|
| 626 |
Interleukin-6 as antitumour agent in renal cell carcinoma
|
Stouthard, JML
|
|
1993
|
29 |
S6 |
p. S234-
1 p.
|
artikel
|
| 627 |
Interleukin-2 intravesical continuous perfusion in the prevention of post tur relapse of operated superficial bladder cancer
|
Ferlazzo, G.
|
|
1993
|
29 |
S6 |
p. S232-
1 p.
|
artikel
|
| 628 |
International strategies and experiences in the use of labelled Phase I/II anti-cancer drugs for the in vivo study of normal tissue, tumour pharmacokinetics and dosimetry in man
|
Jones, T
|
|
1993
|
29 |
S6 |
p. S27-
1 p.
|
artikel
|
| 629 |
Interrelationship between the cellular and humoral immunity indices and the pituitary hormone levels in the blood of young patients with breast cancer
|
Chobanvan, NS
|
|
1993
|
29 |
S6 |
p. S61-
1 p.
|
artikel
|
| 630 |
Interstitial brain brachytherapy
|
Shehata, W.M.
|
|
1993
|
29 |
S6 |
p. S194-
1 p.
|
artikel
|
| 631 |
Interstitial high dose rate (HDR) brachytherapy (BT) in patients with cancer (CA) of the head & neck (H&N)
|
Yu, L
|
|
1993
|
29 |
S6 |
p. S142-
1 p.
|
artikel
|
| 632 |
Interstitial VS. External radiation boost in 417 breast cancers treated by breast conservation therapy
|
Aron, B
|
|
1993
|
29 |
S6 |
p. S70-
1 p.
|
artikel
|
| 633 |
Intervention debulking surgery (IDS) does increase survival in advanced epithelial ovarian cancer (OC); an EORTC gynecological cancer cooperative group (GCCG) study
|
Van der Burg, MEL
|
|
1993
|
29 |
S6 |
p. S132-
1 p.
|
artikel
|
| 634 |
Intervention program for patients with hematologic malignancies receiving chemotherapy
|
Smadar, N.
|
|
1993
|
29 |
S6 |
p. S264-
1 p.
|
artikel
|
| 635 |
Intestinal radiation damage after radiotherapy and chemotherapy (experiment on dogs)
|
Lukič, F.
|
|
1993
|
29 |
S6 |
p. S94-
1 p.
|
artikel
|
| 636 |
Intra-aortic infusion chemotherapy in advanced penile squamous cell carcinoma
|
Sheen, M.C.
|
|
1993
|
29 |
S6 |
p. S116-
1 p.
|
artikel
|
| 637 |
Intra-arterial (IAH) cisplatin for the treatment of liver malignancies-pharmacokinetics and pharmacodynamics
|
Gorodetsky, R
|
|
1993
|
29 |
S6 |
p. S109-
1 p.
|
artikel
|
| 638 |
Intracavitary Cf-252 neutron therapy in the rectal cancer treatment
|
Atkoćius, V.
|
|
1993
|
29 |
S6 |
p. S225-
1 p.
|
artikel
|
| 639 |
Intracranial ependymomas
|
Zorlu, F.
|
|
1993
|
29 |
S6 |
p. S194-
1 p.
|
artikel
|
| 640 |
Intraductal carcinoma of the breast: Long-term results with breast-conserving surgery and definitive irradiation
|
Solin, L.
|
|
1993
|
29 |
S6 |
p. S66-
1 p.
|
artikel
|
| 641 |
Intraoperative brachytherapy in the treatment of soft tissue sarcomas
|
Cionini, L.
|
|
1993
|
29 |
S6 |
p. S185-
1 p.
|
artikel
|
| 642 |
Intraoperative radiation therapy (IORT): Clinincal experiences in non-small-cell lung cancer. (NSCLC)
|
Geyer, E.
|
|
1993
|
29 |
S6 |
p. S166-
1 p.
|
artikel
|
| 643 |
Intrapericardial cisplatin in patients with malignant pericardial effusion
|
Tomkowski, W.
|
|
1993
|
29 |
S6 |
p. S110-
1 p.
|
artikel
|
| 644 |
Intraperitoneal administration (I.P.) of interferon-a (IFN-a) in patients with ovarian CA, in clinical complete remission (cCR) following chemotherapy with high doses of carboplatin (C) and haemopoetic growth factors (H.G.F.)
|
Kosmidis, P.
|
|
1993
|
29 |
S6 |
p. S135-
1 p.
|
artikel
|
| 645 |
Intraperitoneal (I.P.) infusion of tumor necrosis factor (TNF) and mitoxantrone in patients with neoplastic ascites: A phase I study
|
Garrone, O
|
|
1993
|
29 |
S6 |
p. S119-
1 p.
|
artikel
|
| 646 |
Intrapleurally instilled mitoxantrone in metastatic pleural effusion
|
Norum, J
|
|
1993
|
29 |
S6 |
p. S203-
1 p.
|
artikel
|
| 647 |
Intratrial polychemotherapy for rectal cancer
|
Braun, E.M.
|
|
1993
|
29 |
S6 |
p. S95-
1 p.
|
artikel
|
| 648 |
Intravsical bacillus calmette-guerin therapy for patients with superficak bladder tumors who failed thiotepa therapy
|
Winkler, HZ
|
|
1993
|
29 |
S6 |
p. S228-
1 p.
|
artikel
|
| 649 |
Invasive treatments in pain control. Do they have a role?
|
Birkhahn, H.J.
|
|
1993
|
29 |
S6 |
p. S37-
1 p.
|
artikel
|
| 650 |
In vitro activity of a cisplatinum conjugated anti CA-125 antibody against human ovarian cancer cell lines
|
Beck, E
|
|
1993
|
29 |
S6 |
p. S121-
1 p.
|
artikel
|
| 651 |
In vitro assessed synergic effect of fotemustine and ionizing radiation on 3 cell lines of non small cell lung carcinoma (NSCLC)
|
Pellen, P.
|
|
1993
|
29 |
S6 |
p. S217-
1 p.
|
artikel
|
| 652 |
In vitro evaluation of biological activity of synthetic thymopentin/Tp5/and its analogs human/HSp5/and bovine splenopentins/BSp5/
|
Antcheva, M.
|
|
1993
|
29 |
S6 |
p. S50-
1 p.
|
artikel
|
| 653 |
In vitro pharmacological monitoring of phase I–II trials of S 9788. A multidrug resistance (MDR) reversing agent
|
Soudon, J.
|
|
1993
|
29 |
S6 |
p. S114-
1 p.
|
artikel
|
| 654 |
In vitro radiosensitivity of normal human skin fibroblasts correlates with the development of subcutaneous fibrosis after radiotherapy
|
Johansen, J
|
|
1993
|
29 |
S6 |
p. S216-
1 p.
|
artikel
|
| 655 |
In vitro studies of stem cell factor (SCF) and interleukin-11 (IL-11) in normal and “preleukemic” haematopoiesis
|
Bammer, T.
|
|
1993
|
29 |
S6 |
p. S52-
1 p.
|
artikel
|
| 656 |
In vivo kinetic study and biodistribution of Tc-99m-F(ab′)2 of antimelanoma antibody
|
Sergieva, S.
|
|
1993
|
29 |
S6 |
p. S180-
1 p.
|
artikel
|
| 657 |
Involvement of DNA topoisomerases in recombination and DNA repair
|
Christiansen, K.
|
|
1993
|
29 |
S6 |
p. S32-
1 p.
|
artikel
|
| 658 |
Involvement of p53 in cell fate and cancer
|
Oren, M.
|
|
1993
|
29 |
S6 |
p. S11-
1 p.
|
artikel
|
| 659 |
Iridium-192 interstitial implant in the treatment of advanced squamous cell carcinoma of the tonsil region: Treatment planning, technique, and clinical results
|
Hayes, JK
|
|
1993
|
29 |
S6 |
p. S148-
1 p.
|
artikel
|
| 660 |
Is conservative treatment a safe alternative to mastectomy for locally advanced breast cancer?
|
Calais, G.
|
|
1993
|
29 |
S6 |
p. S69-
1 p.
|
artikel
|
| 661 |
Is creatinine clearance a sufficient measurement for GFR in carboplatin dose calculation?
|
Sørensen, BT
|
|
1993
|
29 |
S6 |
p. S110-
1 p.
|
artikel
|
| 662 |
Is it acceptable to give a doses of 50 Gy in the conservative breast cancer treatment ?
|
Minguell, J
|
|
1993
|
29 |
S6 |
p. S69-
1 p.
|
artikel
|
| 663 |
Isolated limb perfusion (ILP) with high dose TNF-α, gamma-IFN and melphalan in patients with irresectable soft tissue sarcomas: A highly effective limb saving procedure
|
Schraffordt Koops, H
|
|
1993
|
29 |
S6 |
p. S183-
1 p.
|
artikel
|
| 664 |
Isolation perfusion with RTNFα + RIFNγ + melphalan for in transit metastases of malignant melanoma. Update of a pilot study
|
Lejeune, F
|
|
1993
|
29 |
S6 |
p. S117-
1 p.
|
artikel
|
| 665 |
Is there a volume effect for acute side-effects following pelvic radiotherapy?
|
Wynne, CI
|
|
1993
|
29 |
S6 |
p. S220-
1 p.
|
artikel
|
| 666 |
Is the “second-look” old fashion ?
|
Batel-Copel, L.
|
|
1993
|
29 |
S6 |
p. S132-
1 p.
|
artikel
|
| 667 |
IV granisetron in children: A randomized comparison against chlorpromazine plus dexamethasone in prevention of ifosfamide-induced emesis
|
Hählen, K
|
|
1993
|
29 |
S6 |
p. S200-
1 p.
|
artikel
|
| 668 |
IV Granisetron in children receiving highly emetogenic chemotherapy: A double-blind dose-ranging study
|
Pinkerton, CR
|
|
1993
|
29 |
S6 |
p. S200-
1 p.
|
artikel
|
| 669 |
IV granisetron VS IV granisetron plus IV dexamethasone in the prophylaxis of emesis induced by cytotoxic chemotherapy
|
Carmicheal, J
|
|
1993
|
29 |
S6 |
p. S206-
1 p.
|
artikel
|
| 670 |
Karyotype and prognosis in non-Hodgkin lymphomas
|
Marosi, Ch
|
|
1993
|
29 |
S6 |
p. S172-
1 p.
|
artikel
|
| 671 |
Knowledge of diagnosis in Italian patients with advanced cancer
|
Pronzato, P.
|
|
1993
|
29 |
S6 |
p. S212-
1 p.
|
artikel
|
| 672 |
Kvaluation of the phagocytosis during subcutanrous recombinant IL-2 treatment
|
Abbate, I
|
|
1993
|
29 |
S6 |
p. S51-
1 p.
|
artikel
|
| 673 |
Lack of prognostic value of EGF receptor in a series of 229
T1
T2
,
N0
N1
, M0 breast carcinomas with well defined prognostic parameters. A definitive analysis
|
Bolla, M.
|
|
1993
|
29 |
S6 |
p. S52-
1 p.
|
artikel
|
| 674 |
Laparoscopic guided brachytherapy implant insertion for rectal cancer
|
Szold, A.
|
|
1993
|
29 |
S6 |
p. S94-
1 p.
|
artikel
|
| 675 |
Larynx preservation
|
Lefebvre, JL
|
|
1993
|
29 |
S6 |
p. S16-
1 p.
|
artikel
|
| 676 |
Laser therapy of esophageal cancer
|
Spinelli, P.
|
|
1993
|
29 |
S6 |
p. S29-
1 p.
|
artikel
|
| 677 |
Late cardiac effects after moderate doses of anthracyclines
|
Daniël, De Wolf
|
|
1993
|
29 |
S6 |
p. S198-
1 p.
|
artikel
|
| 678 |
Late intensification (LI) after induction chemotherapy (ICT) for stage IIIB small cell lung cancer (SCLC)
|
Salvini, P.M.
|
|
1993
|
29 |
S6 |
p. S154-
1 p.
|
artikel
|
| 679 |
Late result of surgical treatment of rectal cancer
|
Gruca, Z.
|
|
1993
|
29 |
S6 |
p. S91-
1 p.
|
artikel
|
| 680 |
Late sequelae following treatment of childhood brain tumors
|
Golubičic, I.
|
|
1993
|
29 |
S6 |
p. S191-
1 p.
|
artikel
|
| 681 |
Late side effects of radiotherapy treatment in advanced cervix carcinoma
|
Frim, O.
|
|
1993
|
29 |
S6 |
p. S129-
1 p.
|
artikel
|
| 682 |
Lessons learned from the analysis of P53 in familial and childhood cancer
|
Kovar, H
|
|
1993
|
29 |
S6 |
p. S14-
1 p.
|
artikel
|
| 683 |
Levamisole associated alterations of phagocytic activity in children with brain tumor
|
Hajnžić, TF
|
|
1993
|
29 |
S6 |
p. S191-
1 p.
|
artikel
|
| 684 |
L-folinic acid (FA), fluorouracil (F), epirubicin (E), cyclophosphamide (C) and G-CSF in advanced breast cancer (ABC)
|
Colucci, G.
|
|
1993
|
29 |
S6 |
p. S83-
1 p.
|
artikel
|
| 685 |
Liarozole fumarate, an inhibitor of retinoic acid (RA) metabolism with antitumoral activity
|
De Coster, R.
|
|
1993
|
29 |
S6 |
p. S123-
1 p.
|
artikel
|
| 686 |
Liarozole-hydrochloride (R 75251), a novel treatment in hormone-resistant prostatic cancer: Response on PSA
|
Denis, L.
|
|
1993
|
29 |
S6 |
p. S236-
1 p.
|
artikel
|
| 687 |
Lidocaine test in cancer patients with liver metastases
|
Sanz, A
|
|
1993
|
29 |
S6 |
p. S105-
1 p.
|
artikel
|
| 688 |
Life-threatening myocardial impairment induced by 5-fluorouracil (5-FU)
|
Weidmann, B
|
|
1993
|
29 |
S6 |
p. S111-
1 p.
|
artikel
|
| 689 |
Limb preservation in soft tissue sarcoma (STS)
|
Budach, V.
|
|
1993
|
29 |
S6 |
p. S16-
1 p.
|
artikel
|
| 690 |
Limb salvage in bone sarcomas (BS) about 357 cases treated by our monocentric multidisciplinary study
|
Delepine, G.
|
|
1993
|
29 |
S6 |
p. S187-
1 p.
|
artikel
|
| 691 |
Limb salvage in fractured bone sarcomas
|
Delepine, G.
|
|
1993
|
29 |
S6 |
p. S187-
1 p.
|
artikel
|
| 692 |
Liver metastasis from colorectal neoplasia: Treatment with percutaneous ethanol injection (PEI) under ultrasoud (US) guidance
|
Perrone, S.
|
|
1993
|
29 |
S6 |
p. S204-
1 p.
|
artikel
|
| 693 |
Liver transplantation (OLT) for small hepatocellular carcinoma (HCC) in cirrhosis
|
Mazzaferro, V.
|
|
1993
|
29 |
S6 |
p. S101-
1 p.
|
artikel
|
| 694 |
Local control in cancer treatment
|
Holmberg, L.
|
|
1993
|
29 |
S6 |
p. S33-
1 p.
|
artikel
|
| 695 |
Local hyperthermia combined with radiotherapy in the treatment of locally advanced prostate cancer
|
Winkler, HZ
|
|
1993
|
29 |
S6 |
p. S238-
1 p.
|
artikel
|
| 696 |
Local recurrence and long term survival in patients with gastric cancer. Analysis of possible impact of histopathological parameters
|
Athlin, L
|
|
1993
|
29 |
S6 |
p. S106-
1 p.
|
artikel
|
| 697 |
Local recurrences (L.R.) after breast conservative therapy (B.C.T.): Diagnosis, treatment, prognosis
|
Cutuli, B.
|
|
1993
|
29 |
S6 |
p. S68-
1 p.
|
artikel
|
| 698 |
Location control of the primary tumor and patient survival
|
Suit, Herman
|
|
1993
|
29 |
S6 |
p. S33-
1 p.
|
artikel
|
| 699 |
Long outcome residual masses (RM) after chemotherapy (CHT) in non-seminomatous testicular tumours (NSTT): 13 YRS experience at a singel centre
|
Germa, JR
|
|
1993
|
29 |
S6 |
p. S241-
1 p.
|
artikel
|
| 700 |
Long survival-rate in patients with esophagus cancer treated with PDT
|
Corti, L.
|
|
1993
|
29 |
S6 |
p. S211-
1 p.
|
artikel
|
| 701 |
Long-term analysis of patients with Ewing's sarcoma (ES) surviving, progression-free, longer than 3 years
|
Lombardi, F.
|
|
1993
|
29 |
S6 |
p. S197-
1 p.
|
artikel
|
| 702 |
Long-term cytogenetic response to IFN-α, IFN-α followed by the association with low-dose ARA-C or high-dose chemotherapy in CML patients
|
Liberati, A.M.
|
|
1993
|
29 |
S6 |
p. S152-
1 p.
|
artikel
|
| 703 |
Long-term effect of progressive muscle relaxation with guided imagery in highly distressed cancer population
|
Baider, L
|
|
1993
|
29 |
S6 |
p. S17-
1 p.
|
artikel
|
| 704 |
Long term effect of treatment by tamoxifen in women treated for breast cancer. A retrospective study and comparaison with control subjects
|
Cals, L
|
|
1993
|
29 |
S6 |
p. S75-
1 p.
|
artikel
|
| 705 |
Long-term experience with cisplatin-based induction chemotherapy and concomitant chemoradiotherapy in locally advanced head and neck cancer (HNC)
|
Stupp, R
|
|
1993
|
29 |
S6 |
p. S146-
1 p.
|
artikel
|
| 706 |
Long term follow up of fertility in patients with testicular cancer
|
Zukerman, Z
|
|
1993
|
29 |
S6 |
p. S241-
1 p.
|
artikel
|
| 707 |
Long term follow-up of patients with Hodgkin's disease treated with exclusive radiotherapy (RT)
|
Soum, F.
|
|
1993
|
29 |
S6 |
p. S171-
1 p.
|
artikel
|
| 708 |
Long term morbidity and mortality after adjuvant chemotherapy and/or radiotherapy
|
Tursz, T.
|
|
1993
|
29 |
S6 |
p. S4-
1 p.
|
artikel
|
| 709 |
Long term outcome in patients with aggressive fibromatosis. A single institution analysis of 172 consecutive cases
|
Quagliuolo, V
|
|
1993
|
29 |
S6 |
p. S182-
1 p.
|
artikel
|
| 710 |
Long-term results of a regimen for treatment of AML
|
Goldschmidt, E
|
|
1993
|
29 |
S6 |
p. S149-
1 p.
|
artikel
|
| 711 |
Long-term results of surgery and cisplatin-based chemotherapy in advanced epithelial ovarian cancer
|
Nowrousian, M.R.
|
|
1993
|
29 |
S6 |
p. S135-
1 p.
|
artikel
|
| 712 |
Long term survival after chemotherapy in patients with advanced unresectable non small cell lung cancer (NSCLC): A report by the European lung cancer working party
|
Sculier, J.P.
|
|
1993
|
29 |
S6 |
p. S159-
1 p.
|
artikel
|
| 713 |
Long term survival of patients with epithelial ovarian carcinoma treated with multimodal therapy
|
Steiner, M.
|
|
1993
|
29 |
S6 |
p. S134-
1 p.
|
artikel
|
| 714 |
Long-term survival of patients with unresectable metastatic colorectal cancer treated with chronotherapy
|
Lévi, F.
|
|
1993
|
29 |
S6 |
p. S98-
1 p.
|
artikel
|
| 715 |
Lonidamine, alpha 2B interferon and high-dose epirubicin in advanced breast cancer
|
Iaffaioli, R.V.
|
|
1993
|
29 |
S6 |
p. S87-
1 p.
|
artikel
|
| 716 |
Low dose endobronchial radiotherapy for recurrent carcinoma of the bronchus previously treated with radical radiotherapy
|
Harrison, M
|
|
1993
|
29 |
S6 |
p. S164-
1 p.
|
artikel
|
| 717 |
Low dose imipenem in the treatment of febrile neutropenia
|
Green, MD
|
|
1993
|
29 |
S6 |
p. S211-
1 p.
|
artikel
|
| 718 |
Low dose rate in gynecological intracavitary brachytherapy
|
Van Limbergen, E.
|
|
1993
|
29 |
S6 |
p. S36-
1 p.
|
artikel
|
| 719 |
Low dose weekly anthracyclnes for advanced breast cancer: Is tolerance improved?
|
Castiglione, M.
|
|
1993
|
29 |
S6 |
p. S81-
1 p.
|
artikel
|
| 720 |
Low grade astrocytoma: Post surgical irradiation
|
Villà, S
|
|
1993
|
29 |
S6 |
p. S190-
1 p.
|
artikel
|
| 721 |
Lymphokine-activated killer (LAK) cells activity, phenotypic markers and mitogen responses of peripheral blood mononuclear cells (PBMC) isolated from melanoma patients undergoing combined immunotherapy and chemotherapy
|
Eisenthal, A
|
|
1993
|
29 |
S6 |
p. S180-
1 p.
|
artikel
|
| 722 |
Magnetic resonance imaging and computed tomography specificity in the detection of metastatic melanoma — Clinicopathological correlation
|
Apter, S
|
|
1993
|
29 |
S6 |
p. S181-
1 p.
|
artikel
|
| 723 |
Making a newly assumed R.N. Part of an oncological intensive care team
|
Allemano, M.C.
|
|
1993
|
29 |
S6 |
p. S258-
1 p.
|
artikel
|
| 724 |
Making breast screening work: Which tumours most need early detection?
|
Tabar, L.
|
|
1993
|
29 |
S6 |
p. S25-
1 p.
|
artikel
|
| 725 |
Male breast cancer-analysis of morphology, cell kinetics and follow-up
|
Niezabitowski, A.
|
|
1993
|
29 |
S6 |
p. S61-
1 p.
|
artikel
|
| 726 |
Male breast cancer (M.B.C.): Clinico-pathological characteristics and prognostic factors in 397 cases
|
Cutuli, B.
|
|
1993
|
29 |
S6 |
p. S58-
1 p.
|
artikel
|
| 727 |
Malignant diseases in patients with human immunodeficiency virus (HIV) infection
|
Hernández, DE
|
|
1993
|
29 |
S6 |
p. S45-
1 p.
|
artikel
|
| 728 |
Malignant fibrous histiocytoma, a surgical disease?
|
Taat, CW
|
|
1993
|
29 |
S6 |
p. S185-
1 p.
|
artikel
|
| 729 |
Malignant lymphoproliferative diseases (MLD) in patients seropositive for the HIV
|
Ribas, A
|
|
1993
|
29 |
S6 |
p. S45-
1 p.
|
artikel
|
| 730 |
Malignant uterine tumors (M.U.T.) after tamoxifen treatment for breast cancer (B.C.). A 22 cases report
|
Cutuli, B.
|
|
1993
|
29 |
S6 |
p. S73-
1 p.
|
artikel
|
| 731 |
Mammographic needle localization biopsy of non palpable breast lesions. A review of 197 patients with pathological correlation
|
Raveh, T.
|
|
1993
|
29 |
S6 |
p. S63-
1 p.
|
artikel
|
| 732 |
Management of intestinal obstruction in patients with advanced intraabdominal cancer
|
van Ooijen, B
|
|
1993
|
29 |
S6 |
p. S205-
1 p.
|
artikel
|
| 733 |
Management of the neck in no oral carcinoma
|
Brugere, J.
|
|
1993
|
29 |
S6 |
p. S138-
1 p.
|
artikel
|
| 734 |
Manipulation of the perioperative immunologic state in patients with colorectal tumors
|
Izzo, F.
|
|
1993
|
29 |
S6 |
p. S100-
1 p.
|
artikel
|
| 735 |
MDRl gene expression in acute myeloid leukemia
|
Pirker, R
|
|
1993
|
29 |
S6 |
p. S112-
1 p.
|
artikel
|
| 736 |
Measurement of the ganglioside FucGM1 in the sera of 157 patients with small cell lung cancer: Variation of the concentration before and during treatment
|
Drivsholm, L.
|
|
1993
|
29 |
S6 |
p. S249-
1 p.
|
artikel
|
| 737 |
Medroxyprogesterone- and megestrol acetate plasma levels after simultaneous oral administration in cancer patients
|
Camaggi, CM
|
|
1993
|
29 |
S6 |
p. S112-
1 p.
|
artikel
|
| 738 |
Medullarary carcinoma of the breast, prognostic importance of characteristic features evaluated in a multivariate cox analysis
|
Pedersen, L
|
|
1993
|
29 |
S6 |
p. S64-
1 p.
|
artikel
|
| 739 |
Megakaryocyie growth factors in sera of throbocytopenic patients undergoing chemotherapy, radiotherapy or allogeneic bone marrow transplantation
|
Deutsch, V.
|
|
1993
|
29 |
S6 |
p. S52-
1 p.
|
artikel
|
| 740 |
Megestrol acetate and veight loss in advanced cancer
|
Sancho Cuesta, J.F.
|
|
1993
|
29 |
S6 |
p. S204-
1 p.
|
artikel
|
| 741 |
Megestrol acetate (MGA) plus alpha 2A interferon (IFN) as second line therapy in patients (pts) with advanced breast cancer (a.b.c.): Preliminary results of a multicentric phase II trial
|
Amoroso, D.
|
|
1993
|
29 |
S6 |
p. S79-
1 p.
|
artikel
|
| 742 |
Metabolic markers in the assessment of treatment response-studies in vivo and in vitro
|
|
|
1993
|
29 |
S6 |
p. S27-
1 p.
|
artikel
|
| 743 |
Metastatic cancer with unknown primary
|
Steiner, M.
|
|
1993
|
29 |
S6 |
p. S103-
1 p.
|
artikel
|
| 744 |
Metastatic pattern (MTS), leukemoid reaction (LR) tumor specific fever (TSF), and bone marrow invasion (BMI) in undifferentiated carcinoma of nasopharyngeal type (UCNT) patients (Pts)
|
Cvitkovic, E.
|
|
1993
|
29 |
S6 |
p. S147-
1 p.
|
artikel
|
| 745 |
Metastatic patterns in squamous cell laryngeal and hypophryngeal carcinoma patients: IGR experience
|
Domenge, C.
|
|
1993
|
29 |
S6 |
p. S147-
1 p.
|
artikel
|
| 746 |
Metast, malig, melanoma (M. M. M.): Prelim, results of a trial with carboplatin (CB), cis-platinum (DDP), dacarbazine (DTIC), interferon-α (IFNα) and tamoxifen (TAM)
|
Isacson, R
|
|
1993
|
29 |
S6 |
p. S181-
1 p.
|
artikel
|
| 747 |
Methadone suppositories (MS) for the treatment of cancer pain
|
Fainsinger, Robin L.
|
|
1993
|
29 |
S6 |
p. S204-
1 p.
|
artikel
|
| 748 |
MIM (mitoxantrone, ifosfamide, methotrexate) salvage chemotherapy for resistant/relapsed intermediate grade NHL
|
Abate, G.
|
|
1993
|
29 |
S6 |
p. S176-
1 p.
|
artikel
|
| 749 |
Mine regimen in non-Hodgkin's lymphoma (NHL)
|
Kars, A
|
|
1993
|
29 |
S6 |
p. S176-
1 p.
|
artikel
|
| 750 |
Mitomycin C, Mitoxantrone and Methotrexate combination (3M) in advanced breast cancer: an effective second line therapy
|
Paveri, L.
|
|
1993
|
29 |
S6 |
p. S80-
1 p.
|
artikel
|
| 751 |
Mitomycin/vindesine in the treatment of advanced non-small-cell lung cancer -phase IV study
|
Koschel, G
|
|
1993
|
29 |
S6 |
p. S165-
1 p.
|
artikel
|
| 752 |
Mitoxantrone and methotrexate (MM) in elderly patients with metastatic breast cancer
|
Veelen van, H
|
|
1993
|
29 |
S6 |
p. S79-
1 p.
|
artikel
|
| 753 |
Mitoxantrone and vinorelbine in salvage chemotherapy of anthracycline-refractory advanced breast cancer
|
Silvestro, P.
|
|
1993
|
29 |
S6 |
p. S85-
1 p.
|
artikel
|
| 754 |
MMM as second line treatment for advanced breast cancer. Evidence of cross-resistance with antracyclines
|
Malmström, P
|
|
1993
|
29 |
S6 |
p. S84-
1 p.
|
artikel
|
| 755 |
Moderate dose intensification of carboplatin and etoposide as first line combination chemotherapy in small cell lung cancer
|
Ellis, P.A.
|
|
1993
|
29 |
S6 |
p. S155-
1 p.
|
artikel
|
| 756 |
Modification of hypoxia in radiotherapy overview of the problem
|
Overgaard, J
|
|
1993
|
29 |
S6 |
p. S19-
1 p.
|
artikel
|
| 757 |
Modified indication for surgery in AIDS associated gastrointestinal lymphomas
|
Horstmann, O.
|
|
1993
|
29 |
S6 |
p. S46-
1 p.
|
artikel
|
| 758 |
Modified M-vac as neoadjuvant chemotheraphy (CH) in bladder cancer
|
Hunis, Dr.A.P.
|
|
1993
|
29 |
S6 |
p. S230-
1 p.
|
artikel
|
| 759 |
Modulation of drug sensitivity of cancer cells by the stimulation and inhibition of protein kinase C
|
Csuka, O
|
|
1993
|
29 |
S6 |
p. S226-
1 p.
|
artikel
|
| 760 |
Modulation of oral tegafur (T) by oral folinic acid (FA) in patients with pretreated metastatic breast camcer (MBC): A phase II study
|
Albanell, J
|
|
1993
|
29 |
S6 |
p. S86-
1 p.
|
artikel
|
| 761 |
Modulation of photoreceptor and neural marker expression by cAMP and laminin in retinoblastoma cells
|
Fassina, G
|
|
1993
|
29 |
S6 |
p. S193-
1 p.
|
artikel
|
| 762 |
Modulation of radiation-induced growth factor production by beta interferon
|
Finkelstein, J
|
|
1993
|
29 |
S6 |
p. S51-
1 p.
|
artikel
|
| 763 |
Modulation of tumor growth, angiogenesis and metastatic capacity by heparin-like molecules
|
Vlodavsky, I.
|
|
1993
|
29 |
S6 |
p. S11-
1 p.
|
artikel
|
| 764 |
Molecular and biological characterization of acute promyelocytic leukaemia
|
Biondi, A.
|
|
1993
|
29 |
S6 |
p. S39-
1 p.
|
artikel
|
| 765 |
Molecular basis of the cellular response to ionizing radiation
|
Powell, Simon
|
|
1993
|
29 |
S6 |
p. S5-
1 p.
|
artikel
|
| 766 |
Molecular epidemiology of cancer
|
Cuzick, I.
|
|
1993
|
29 |
S6 |
p. S6-
1 p.
|
artikel
|
| 767 |
Molecular genetics in prostate carcinoma
|
Ekman, P.
|
|
1993
|
29 |
S6 |
p. S21-
1 p.
|
artikel
|
| 768 |
Molecular genetics of human lymphomas and leukemias
|
Croce, C.M.
|
|
1993
|
29 |
S6 |
p. S24-
1 p.
|
artikel
|
| 769 |
Molecular pathology of human neuroblastoma
|
Schweb, Manfred
|
|
1993
|
29 |
S6 |
p. S39-
1 p.
|
artikel
|
| 770 |
Monitoring tumour response to 5-fluorouracil in colorectal cancer liver metastases using positron emission tomography and F-18 deoxyglucose
|
Ellis, P
|
|
1993
|
29 |
S6 |
p. S93-
1 p.
|
artikel
|
| 771 |
Monoamines stimulationes in experimental carcinogenesis
|
Popov, I.
|
|
1993
|
29 |
S6 |
p. S88-
1 p.
|
artikel
|
| 772 |
Monoclonal antibodies in combination with cytokines in treatment of advanced colorectal carcinoma
|
Ragnhammar, P.
|
|
1993
|
29 |
S6 |
p. S54-
1 p.
|
artikel
|
| 773 |
Monoclonal antibodies (MoAbs) directed against the neural cell adhesion molecule (NCAM) improve the detection of small cell lung cancer (SCLC) metastasis in bone marrow aspirates (BMA) compared with conventional histology
|
Pasini, F.
|
|
1993
|
29 |
S6 |
p. S157-
1 p.
|
artikel
|
| 774 |
MOPP/EBVD +/− local RT for advanced Hodgkin's disease
|
Abate, G.
|
|
1993
|
29 |
S6 |
p. S171-
1 p.
|
artikel
|
| 775 |
Morbidity of combined surgery and interstitial and external beam radiotherapy in soft tissue sarcoma with poor prognosis and recurrent fibromatosis
|
Wijnmaalen, A.J.
|
|
1993
|
29 |
S6 |
p. S184-
1 p.
|
artikel
|
| 776 |
MTP-PE in liposomes as post-operative adjuvant therapy for colon cancer (Dukes' C): A pilot adjuvant phase II trial
|
Frohmüller, S
|
|
1993
|
29 |
S6 |
p. S93-
1 p.
|
artikel
|
| 777 |
Mucin like protein in breast cancer
|
Keydar, I
|
|
1993
|
29 |
S6 |
p. S31-
1 p.
|
artikel
|
| 778 |
Multi-cycle high dose chemotherapy with peripheral stem cells transplant in nasopharyngeal carcinoma
|
Yeung, A.W.
|
|
1993
|
29 |
S6 |
p. S139-
1 p.
|
artikel
|
| 779 |
Multidrug resistance and kinetics of drug transport
|
Skovsgaard, T.
|
|
1993
|
29 |
S6 |
p. S18-
1 p.
|
artikel
|
| 780 |
Multidrug resistance in human lung cancer
|
Baas, F
|
|
1993
|
29 |
S6 |
p. S18-
1 p.
|
artikel
|
| 781 |
Multifactorial analyasis of P53 alterations in human cancer
|
Soussi, T.
|
|
1993
|
29 |
S6 |
p. S24-
1 p.
|
artikel
|
| 782 |
Multiform glioblastoma combined therapy by radiation and A-interferon
|
Coliarakis, N.
|
|
1993
|
29 |
S6 |
p. S191-
1 p.
|
artikel
|
| 783 |
Multimedia and computer training in oncological nursing: Experiences and perspectives
|
Cernuschi, A.
|
|
1993
|
29 |
S6 |
p. S255-
1 p.
|
artikel
|
| 784 |
Multimodality treatment for soft tissue sarcomas
|
Azzarelli, Alberto
|
|
1993
|
29 |
S6 |
p. S4-
1 p.
|
artikel
|
| 785 |
Multiple endocrine neoplasia syndromes
|
Brandi, ML
|
|
1993
|
29 |
S6 |
p. S14-
1 p.
|
artikel
|
| 786 |
Multiple fractions per day with acceleration (MF) in extended radiotherapy of patients with Hodgkin's disease (HD)
|
Koritova, L.I.
|
|
1993
|
29 |
S6 |
p. S172-
1 p.
|
artikel
|
| 787 |
Multivariate analysis of the post-therapeutic complications in the treatment of lung carcinomas
|
Bernier, J.
|
|
1993
|
29 |
S6 |
p. S160-
1 p.
|
artikel
|
| 788 |
Multymodality staging for rectal cancer
|
Salvetti, M
|
|
1993
|
29 |
S6 |
p. S97-
1 p.
|
artikel
|
| 789 |
MVP chemotherapy + radiotherapy versus radiotherapy alone ± thymopentin in advanced non small cell lung cancer: A randomized Italian study
|
d'Aquino, S.
|
|
1993
|
29 |
S6 |
p. S165-
1 p.
|
artikel
|
| 790 |
Myofibrosis in chronic myeloid leukemia
|
Dascalescu, C.M.
|
|
1993
|
29 |
S6 |
p. S151-
1 p.
|
artikel
|
| 791 |
Nasopharyngeal cancer (NPC) in northern Israel
|
Kuten, A.
|
|
1993
|
29 |
S6 |
p. S144-
1 p.
|
artikel
|
| 792 |
Nasopharyngeal carcinoma: Survival analysis and prognostic factors
|
Özyar, E.
|
|
1993
|
29 |
S6 |
p. S148-
1 p.
|
artikel
|
| 793 |
National adjuvant chemotherapy protocol in stage II carcinoma of the breast. CMF versus CNF
|
Wigler, N.
|
|
1993
|
29 |
S6 |
p. S75-
1 p.
|
artikel
|
| 794 |
Navelbine (N) + mitomycin (M) in anthracyclines resistant or refractary advanced breast cancer (ABC). Prelinimary report
|
Santos, R.
|
|
1993
|
29 |
S6 |
p. S78-
1 p.
|
artikel
|
| 795 |
Navelbine (NVB) as a salvage treatment for advanced breast cancer pefractory to anthracyclines
|
Degardin, M.
|
|
1993
|
29 |
S6 |
p. S81-
1 p.
|
artikel
|
| 796 |
Navelbine plus 5-FU and folinic acid (FA) in pretreated colo-rectal cancer patients. Preliminary data
|
Iaffaioli, R.V.
|
|
1993
|
29 |
S6 |
p. S99-
1 p.
|
artikel
|
| 797 |
NCA clinical value in primary and relapsed breast cancer
|
Donadeo, A
|
|
1993
|
29 |
S6 |
p. S250-
1 p.
|
artikel
|
| 798 |
Needs and problems experienced by patients with gastrointestinal cancer receiving continuous ambulatory chemotherapy
|
Hutchison, G.
|
|
1993
|
29 |
S6 |
p. S252-
1 p.
|
artikel
|
| 799 |
Negative phase II with 5-fluorouracil (5-FU) plus low doses of leucovorin (LV) in refractory breast carcinoma(RBC)
|
Palacio, I
|
|
1993
|
29 |
S6 |
p. S87-
1 p.
|
artikel
|
| 800 |
Neo-adjuvant chemotherapy: A combination containing mitoxantrone for the treatment of locally advanced breast cancer. Randomized trial comparing an initial chemotherapy versus a chemotherapy/radiotherapy combination
|
Gervásio, H.
|
|
1993
|
29 |
S6 |
p. S71-
1 p.
|
artikel
|
| 801 |
Neoadjuvant chemotherapy (EAP) with r-melHuG-CSF (Filgrastim) for patients with locally advanced gastric cancer
|
Fink, U
|
|
1993
|
29 |
S6 |
p. S55-
1 p.
|
artikel
|
| 802 |
Neoadjuvant chemotherapy in locally advanced breast carcinoma
|
Yarom, I.
|
|
1993
|
29 |
S6 |
p. S79-
1 p.
|
artikel
|
| 803 |
Neo-adjuvant chemotherapy in operable esophageal squamous cell cancer; an interim report of a randomized controlled trial
|
Kok, TC
|
|
1993
|
29 |
S6 |
p. S104-
1 p.
|
artikel
|
| 804 |
Neoadjuvant chemotherapy (NCT) in locally advanced gastric carcinoma (LAGC)
|
Lasser, Ph
|
|
1993
|
29 |
S6 |
p. S107-
1 p.
|
artikel
|
| 805 |
Neoadjuvant chemotherapy of inflammatory breast cancer with cyclophosphamide, adriamycine and platinum (CAP)
|
Roth, A
|
|
1993
|
29 |
S6 |
p. S74-
1 p.
|
artikel
|
| 806 |
Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and ciclophosphamide (ADOC) in invasive thymomas, preliminary results
|
Berruti, A.
|
|
1993
|
29 |
S6 |
p. S177-
1 p.
|
artikel
|
| 807 |
Neo-adjuvant chemotherapy with cisplatin and methotrexate in bladder cancer
|
Leal Silva, J
|
|
1993
|
29 |
S6 |
p. S232-
1 p.
|
artikel
|
| 808 |
Neoadjuvant chemotherapy with 4 cycles of cisplatin (P) and 5 fluorouracil (F) in advanced head and neck cancer (AHNC)
|
Casal, J
|
|
1993
|
29 |
S6 |
p. S145-
1 p.
|
artikel
|
| 809 |
Neoadjuvant chemotherapy with high-dose methotrexate (HD-MTX) in the treatment of malignant fibrous histiocytoma (MFH) of bone
|
Hoekstra, H.
|
|
1993
|
29 |
S6 |
p. S184-
1 p.
|
artikel
|
| 810 |
Neoadjuvant M-vac in high grade-high stage transitional cell carcinoma (TCC) of the urinary bladder (UB)
|
Nussbaum, B.
|
|
1993
|
29 |
S6 |
p. S231-
1 p.
|
artikel
|
| 811 |
Neoadjuvant therapy for unresectable stage III non small cell lung cancer (NSCLC)
|
Pilstein, D.
|
|
1993
|
29 |
S6 |
p. S163-
1 p.
|
artikel
|
| 812 |
Neoadjuvant treatment for locally advanced bladder cancer: A randomized prospective clinical trial
|
|
|
1993
|
29 |
S6 |
p. S229-
1 p.
|
artikel
|
| 813 |
Neovascularization in human colorectal adenocarcinoma: A prospective and comparative study
|
Vermeulen, P.B.
|
|
1993
|
29 |
S6 |
p. S92-
1 p.
|
artikel
|
| 814 |
Neuroblastoma cell detection in peripheral blood by reverse transcriptase-polymerase chain reaction (RT-PCR)
|
Burchill, S.A.
|
|
1993
|
29 |
S6 |
p. S198-
1 p.
|
artikel
|
| 815 |
Neuroimmunomodulation(NIM) and IL-2 immunotherapy: A neuroe ndocrine combination with IL-2 and melatonin(MLT) in advan ced solid tumors
|
Lissoni, P.
|
|
1993
|
29 |
S6 |
p. S48-
1 p.
|
artikel
|
| 816 |
Neurological and cognitive impairment in long term survivors of small cell lung cancer (SCLC)
|
Cull, A
|
|
1993
|
29 |
S6 |
p. S154-
1 p.
|
artikel
|
| 817 |
Neurologic and neuropsychological support for patients with brain tumors
|
Sroka, H
|
|
1993
|
29 |
S6 |
p. S192-
1 p.
|
artikel
|
| 818 |
Neuromyotonia and malignant melanoma
|
Modolell, A
|
|
1993
|
29 |
S6 |
p. S181-
1 p.
|
artikel
|
| 819 |
Neuropathy during treatment with vindesine and carbo-platin in patients with adenocarcinoma of the lung
|
Borg, J
|
|
1993
|
29 |
S6 |
p. S166-
1 p.
|
artikel
|
| 820 |
Neurotoxicite (NTX) of long term oxaliplatin (L-ORP) therapy
|
Brienza, S.
|
|
1993
|
29 |
S6 |
p. S117-
1 p.
|
artikel
|
| 821 |
New approaches to cancer prevention
|
Levshin, V.
|
|
1993
|
29 |
S6 |
p. S263-
1 p.
|
artikel
|
| 822 |
New approaches to overcome radiobiological hypoxia clinical experience
|
Bernier, J.
|
|
1993
|
29 |
S6 |
p. S19-
1 p.
|
artikel
|
| 823 |
New approaches to overcome radiobiological hypoxia: Experimental experience
|
Denekamp, J
|
|
1993
|
29 |
S6 |
p. S19-
1 p.
|
artikel
|
| 824 |
New developments in cancer treatment
|
Dubbelman, R
|
|
1993
|
29 |
S6 |
p. S251-
1 p.
|
artikel
|
| 825 |
New modalities in cancer therapy
|
Trainin, N
|
|
1993
|
29 |
S6 |
p. S251-
1 p.
|
artikel
|
| 826 |
New perspective: Home treatment of Kahler patients
|
Egger, RC
|
|
1993
|
29 |
S6 |
p. S253-
1 p.
|
artikel
|
| 827 |
New prognostic factors by immuno-histochemistry
|
|
|
1993
|
29 |
S6 |
p. S31-
1 p.
|
artikel
|
| 828 |
New qualities in cancer nursing
|
Milović, Lj.
|
|
1993
|
29 |
S6 |
p. S255-
1 p.
|
artikel
|
| 829 |
Nicotinamide combined with radiation therapy in glioblastoma multiforme
|
Cartei, F
|
|
1993
|
29 |
S6 |
p. S220-
1 p.
|
artikel
|
| 830 |
No correlation between chemotherapy dose and treatment outcome in advanced ovarian cancer
|
Mandigers, CMPW
|
|
1993
|
29 |
S6 |
p. S134-
1 p.
|
artikel
|
| 831 |
No increased risk for foetal neoplasms from X-ray examinations durin pregnancy in Sweden
|
Lillemor, Laurén
|
|
1993
|
29 |
S6 |
p. S126-
1 p.
|
artikel
|
| 832 |
Non-Hodgkin's lymphoma — best treatment in 1993
|
Cavalli, F.
|
|
1993
|
29 |
S6 |
p. S7-
1 p.
|
artikel
|
| 833 |
Noninvasive diagnosis of nephrotoxic effects of chemotherapy with cis- and carboplatin
|
Hobisch, A.
|
|
1993
|
29 |
S6 |
p. S240-
1 p.
|
artikel
|
| 834 |
Non palpable breast lesions: Analysis of 952 operated cases
|
Sacchini, V.
|
|
1993
|
29 |
S6 |
p. S66-
1 p.
|
artikel
|
| 835 |
Non-resectable stage IIIA-B lung carcinoma: A phase II study on continuous infusion of cisplatin and concurrent radiotherapy (plus adjuvant surgery)
|
Ravasi, G
|
|
1993
|
29 |
S6 |
p. S166-
1 p.
|
artikel
|
| 836 |
Non-testicular germ cell tumors in children: Treatment results of makei 89P/89
|
Göbel, U
|
|
1993
|
29 |
S6 |
p. S197-
1 p.
|
artikel
|
| 837 |
Non toxic combination chemotherapy for 115 patients with carcinomas of unknown primary (CUP) site
|
Mousseau, M.
|
|
1993
|
29 |
S6 |
p. S106-
1 p.
|
artikel
|
| 838 |
[No title]
|
Saran, F.
|
|
1993
|
29 |
S6 |
p. S219-
1 p.
|
artikel
|
| 839 |
Novel schedule for administration of topotecan (TPT): 21 Day low dose continuous infusion (CI)
|
Hochster, H
|
|
1993
|
29 |
S6 |
p. S118-
1 p.
|
artikel
|
| 840 |
N.S.E. in testicular germ cell tumors
|
Neumann, A.
|
|
1993
|
29 |
S6 |
p. S242-
1 p.
|
artikel
|
| 841 |
Nucleotide excision repair, transcription and human repair syndromes
|
Hoeijmakers, JHJ
|
|
1993
|
29 |
S6 |
p. S32-
1 p.
|
artikel
|
| 842 |
Nurses' knowledge and compliance with safe handling of antineoplastic drugs
|
Nieweg, M.B.
|
|
1993
|
29 |
S6 |
p. S262-
1 p.
|
artikel
|
| 843 |
Nursing activity in the oncologic day-hospital of Santa Chiara hospital in Pisa, Italy
|
Limborgh Meyer, H.J.
|
|
1993
|
29 |
S6 |
p. S261-
1 p.
|
artikel
|
| 844 |
Nursing care for acute myeloid leukemia patients who suffer from emesis caused by chemotherapy
|
de Hullu, M.C.
|
|
1993
|
29 |
S6 |
p. S255-
1 p.
|
artikel
|
| 845 |
Nursing diagnoses in an oncology population
|
Mw, A.M.
|
|
1993
|
29 |
S6 |
p. S258-
1 p.
|
artikel
|
| 846 |
Oesophageal cancer: Diagnosis and preoperative staging
|
Taal, B.G.
|
|
1993
|
29 |
S6 |
p. S29-
1 p.
|
artikel
|
| 847 |
Oesophagectomy by thoracoscopy: Pros and cons
|
Lerut, T.
|
|
1993
|
29 |
S6 |
p. S20-
1 p.
|
artikel
|
| 848 |
Oligoclonal immunoglobulins: A possible index of B cell lymphoma in AIDS
|
Laurijssens, M
|
|
1993
|
29 |
S6 |
p. S45-
1 p.
|
artikel
|
| 849 |
Oncology nurses in a CCPPRB (ethical committee)
|
Astoul, C.
|
|
1993
|
29 |
S6 |
p. S258-
1 p.
|
artikel
|
| 850 |
“On line” collection quality of life (QL) items in the oncological hospital at home (OHH): A new approach
|
Glordani, S.
|
|
1993
|
29 |
S6 |
p. S215-
1 p.
|
artikel
|
| 851 |
On the estimation of long-term relative survival rates
|
Hakulinen, T.
|
|
1993
|
29 |
S6 |
p. S124-
1 p.
|
artikel
|
| 852 |
On the influence of alpha-2 interferon (roferon-a) on remission duration in patients with stages III and IV low grade malignant non-Hodgkin's lymphoma
|
Meerwaldt, J.H.
|
|
1993
|
29 |
S6 |
p. S173-
1 p.
|
artikel
|
| 853 |
Optimal treatment with tropisetron (TRO) in acute and delayed chemotherapy-induced emesis (CIE)
|
Bruntsch, U
|
|
1993
|
29 |
S6 |
p. S211-
1 p.
|
artikel
|
| 854 |
Optimized radiotherapy planning in inoperable uterus carcinoma
|
Hombrink, J.
|
|
1993
|
29 |
S6 |
p. S130-
1 p.
|
artikel
|
| 855 |
Oral etoposide, carboplatin and vincristne in the treatment of small-cell lung cancer
|
Alonso, V.
|
|
1993
|
29 |
S6 |
p. S158-
1 p.
|
artikel
|
| 856 |
Oral etoposide in the management of malignant pleural mesotheliomas phase II study
|
Kaukel, E
|
|
1993
|
29 |
S6 |
p. S165-
1 p.
|
artikel
|
| 857 |
Oral tropisetron (TRO) in the prophylaxis of dacarbazine (DTIC) induced nausea and emesis
|
Tilgen, W
|
|
1993
|
29 |
S6 |
p. S180-
1 p.
|
artikel
|
| 858 |
Organization of a new medical intensive care unit (ICU): Nursing experience in a cancer institute
|
Markiewicz, E.
|
|
1993
|
29 |
S6 |
p. S252-
1 p.
|
artikel
|
| 859 |
Organ preservation in rectal cancer
|
Minsky, B.
|
|
1993
|
29 |
S6 |
p. S16-
1 p.
|
artikel
|
| 860 |
Organ preservation of bladder cancer
|
Horwich, A.
|
|
1993
|
29 |
S6 |
p. S16-
1 p.
|
artikel
|
| 861 |
Original preoperative radiotherapy improves survival in gastric cancer patients
|
Skoropad, V.Yu.
|
|
1993
|
29 |
S6 |
p. S224-
1 p.
|
artikel
|
| 862 |
Ototoxicity following therapy for testicular cancer
|
Bokemeyer, C
|
|
1993
|
29 |
S6 |
p. S241-
1 p.
|
artikel
|
| 863 |
Our experience in the use of granulocytecolony-stimulating factor (G-CSF)
|
Ordónez, A.
|
|
1993
|
29 |
S6 |
p. S54-
1 p.
|
artikel
|
| 864 |
Outcome of stage III Hodgkin's disease. A retrospective analysis after a median follow up of 13 years
|
Stupp, R
|
|
1993
|
29 |
S6 |
p. S168-
1 p.
|
artikel
|
| 865 |
Outpatient continuous infusion of chemotherapy; An alternative treatment modality
|
Biermans-van Leeuwe, DMJ
|
|
1993
|
29 |
S6 |
p. S253-
1 p.
|
artikel
|
| 866 |
Outpatient nursing clinic (ONC) in Italy: Still a dream?
|
Belli, L.
|
|
1993
|
29 |
S6 |
p. S270-
1 p.
|
artikel
|
| 867 |
Ovarian ablation (OO) versus zoladex (Z) ± tamoxifen (T) in preperimenopausal patients (pts) with advanced breast cancer: Results of a multicentric randomized trial
|
Boccardo, F.
|
|
1993
|
29 |
S6 |
p. S77-
1 p.
|
artikel
|
| 868 |
Overexpression of beta2-integrins in invasive breast carcinomas
|
Guriec, N.
|
|
1993
|
29 |
S6 |
p. S243-
1 p.
|
artikel
|
| 869 |
Oxaliplatin (L-OHP®): A new platinum analog: Active in refractory/relapsed intermediate and low crade non-Hodgkin lymphoma (NHL): A phase I–II study
|
Gastiaburu, J.
|
|
1993
|
29 |
S6 |
p. S176-
1 p.
|
artikel
|
| 870 |
Paegocytic functions in patients with colorectal adenocarcinoma treated with fluorouracil
|
Kusic, Z.
|
|
1993
|
29 |
S6 |
p. S91-
1 p.
|
artikel
|
| 871 |
Paget's disease of the nipple
|
Farfarelos, C.
|
|
1993
|
29 |
S6 |
p. S68-
1 p.
|
artikel
|
| 872 |
Pain control in palliative surgery
|
Poulain, P.
|
|
1993
|
29 |
S6 |
p. S37-
1 p.
|
artikel
|
| 873 |
Pain killing with calcitonin nasal spray
|
Szántó, J.
|
|
1993
|
29 |
S6 |
p. S202-
1 p.
|
artikel
|
| 874 |
Palliation of dysphagia. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment
|
Cwikiel, M
|
|
1993
|
29 |
S6 |
p. S205-
1 p.
|
artikel
|
| 875 |
Palliative bromchoscopic electrosurgery in lung cancer
|
Sutedja, T
|
|
1993
|
29 |
S6 |
p. S163-
1 p.
|
artikel
|
| 876 |
Palliative care: A right for everyone
|
Wouters, B.
|
|
1993
|
29 |
S6 |
p. S267-
1 p.
|
artikel
|
| 877 |
Palliative care education — An interactive approach to symptom control and communication skills
|
Boothroyd, W.
|
|
1993
|
29 |
S6 |
p. S204-
1 p.
|
artikel
|
| 878 |
Palliative care through education
|
Davis, Carole
|
|
1993
|
29 |
S6 |
p. S268-
1 p.
|
artikel
|
| 879 |
Palliative surgery, a concern for nurses
|
Biesheuvel, AEL
|
|
1993
|
29 |
S6 |
p. S268-
1 p.
|
artikel
|
| 880 |
Palliative surgery — How much palliation
|
Pichlmaier, H.
|
|
1993
|
29 |
S6 |
p. S37-
1 p.
|
artikel
|
| 881 |
Palliative surgical therapy (PST) in esophageal cancer (EC)
|
Jaśkiewicz, J.
|
|
1993
|
29 |
S6 |
p. S29-
1 p.
|
artikel
|
| 882 |
Palliative treatment of AIDS-associated kaposi's sarcoma by radiotherapy
|
Saran, F.
|
|
1993
|
29 |
S6 |
p. S46-
1 p.
|
artikel
|
| 883 |
p53 and Ki-ras alterations in colorectal adenocarcinomas
|
Papola, F
|
|
1993
|
29 |
S6 |
p. S99-
1 p.
|
artikel
|
| 884 |
Papilloma viruses and human cancers
|
Hausen, Harald zur
|
|
1993
|
29 |
S6 |
p. S2-
1 p.
|
artikel
|
| 885 |
Parameters of the immune reaction as prognostic factors in lung cancer
|
Body, JJ
|
|
1993
|
29 |
S6 |
p. S243-
1 p.
|
artikel
|
| 886 |
Parenteral nutrition influence on tolerance and effect of anticancer chemotherapy in children
|
Perek, D.
|
|
1993
|
29 |
S6 |
p. S198-
1 p.
|
artikel
|
| 887 |
Pathobiology of preneoplasia and incipient neoplasia of the liver
|
Schaff, ZS
|
|
1993
|
29 |
S6 |
p. S39-
1 p.
|
artikel
|
| 888 |
Pathological results following re-excision in breast conserving surgery
|
Grimard, L
|
|
1993
|
29 |
S6 |
p. S68-
1 p.
|
artikel
|
| 889 |
Patient administration management system (PAMS) A preliminary report
|
Jongkind, H
|
|
1993
|
29 |
S6 |
p. S258-
1 p.
|
artikel
|
| 890 |
Patient documentation as an essential tool for quality assurance in the management of breast cancer
|
Vantongelen, K.
|
|
1993
|
29 |
S6 |
p. S41-
1 p.
|
artikel
|
| 891 |
Patient perception of the side effects of chemotherapy; the influence of the introduction of 5TH3 antagonists
|
de Boer, M.
|
|
1993
|
29 |
S6 |
p. S264-
1 p.
|
artikel
|
| 892 |
Patients as subjects of experiments, the nurse's role?
|
Rasmussen, A.
|
|
1993
|
29 |
S6 |
p. S256-
1 p.
|
artikel
|
| 893 |
Patient satisfaction with the oncology day care unit at the Hadassah hospital in Jerusalem
|
Ochayon, L
|
|
1993
|
29 |
S6 |
p. S269-
1 p.
|
artikel
|
| 894 |
Patients' general condition under dacarbazine treatment and antiemetic prophylaxis with tropisetron
|
Drechsler, S
|
|
1993
|
29 |
S6 |
p. S214-
1 p.
|
artikel
|
| 895 |
Patterns of diagnosis of breast carcinoma in a specialised symptomatic breast clinic
|
Borovik, R
|
|
1993
|
29 |
S6 |
p. S60-
1 p.
|
artikel
|
| 896 |
Patterns of relapse and survival in patients with non Hodgkin lymphomas. A multivariate study
|
Noya, J
|
|
1993
|
29 |
S6 |
p. S173-
1 p.
|
artikel
|
| 897 |
PCR RB gene studies in high grade osteosarcomas: Could it be a prognostic factor?
|
Feugeas, O.
|
|
1993
|
29 |
S6 |
p. S244-
1 p.
|
artikel
|
| 898 |
p65 detection in sera and tissue in breast cancer patients. Preliminary report
|
Klijanienko, J.
|
|
1993
|
29 |
S6 |
p. S247-
1 p.
|
artikel
|
| 899 |
Peculiarities of subtotal human body irradiations technologies by treatment of lymphomas
|
Masarsky, L.I.
|
|
1993
|
29 |
S6 |
p. S221-
1 p.
|
artikel
|
| 900 |
Peg-application in cancer patients undergoing radiotherapie—Is there really any profit with regard to nutritional status?
|
Blumstein, N.M.
|
|
1993
|
29 |
S6 |
p. S210-
1 p.
|
artikel
|
| 901 |
PEG-L-asparaginase — New anticancer agent for treatment of relapses or resistant malignant non-Hodgkin's lymphoma in adults
|
Poddubnaja, I.
|
|
1993
|
29 |
S6 |
p. S176-
1 p.
|
artikel
|
| 902 |
Pelvic and aortic dissection by laparoscopy
|
Querleu, D
|
|
1993
|
29 |
S6 |
p. S20-
1 p.
|
artikel
|
| 903 |
Pericardial metastases in small cell lung cancer-patients new approaches to the diagnosis and treatment
|
Fijałkowska, A.
|
|
1993
|
29 |
S6 |
p. S155-
1 p.
|
artikel
|
| 904 |
Peripheral blood involvement in non-Hodgkin's lymphoma (NHL) detected by clonal gene rearrangement as a biological prognostic marker
|
Brada, M
|
|
1993
|
29 |
S6 |
p. S172-
1 p.
|
artikel
|
| 905 |
Peripheral blood progenitor cell (PBPC) transplantation with a single apheresis
|
Pettengell, R
|
|
1993
|
29 |
S6 |
p. S173-
1 p.
|
artikel
|
| 906 |
Peripheral blood stem cells (PBSC) as a source for hemopoietic recovery following autologous bone marrow transplantation (ABMT) in childhood malignancy
|
Yaniv, I
|
|
1993
|
29 |
S6 |
p. S34-
1 p.
|
artikel
|
| 907 |
Peripheral blood stem cell transplantation (PBSCT): A nursing and patient perspective
|
Morton, C
|
|
1993
|
29 |
S6 |
p. S252-
1 p.
|
artikel
|
| 908 |
Peripheral T-cell lymphoma (PTCL): The milan cancer institute experience
|
Balzarotti, M
|
|
1993
|
29 |
S6 |
p. S176-
1 p.
|
artikel
|
| 909 |
Persistence of efficacy of ondansetrom (DMD) plus dexanethasone (DEX) VS metoclopramide (MTC) plus dex and diphennydramine (DIP) in acute emesis during three consecutive cycles of cisplatin (CDDP) chemotherapy (CT)
|
Roila, F.
|
|
1993
|
29 |
S6 |
p. S207-
1 p.
|
artikel
|
| 910 |
p53 Expression correlates with differentiation but not survival in human ovarian cancer
|
Green, JA
|
|
1993
|
29 |
S6 |
p. S194-
1 p.
|
artikel
|
| 911 |
Pharmacokinetic and pharmacodynamic of rectal methadone in opioid-naive cancer patients with pain
|
Ripamonti, C.
|
|
1993
|
29 |
S6 |
p. S203-
1 p.
|
artikel
|
| 912 |
Pharmacokinetics and toxicity of etoposide in combination with carboplatin in patients with small cell lung cancer (SCLC)
|
Strömgren, A
|
|
1993
|
29 |
S6 |
p. S110-
1 p.
|
artikel
|
| 913 |
Pharmacokinetics of droloxifen compared to tamoxifen
|
Breitbach, GP
|
|
1993
|
29 |
S6 |
p. S110-
1 p.
|
artikel
|
| 914 |
Pharmacokinetics of etoposide: Correlation of pharmacokinetic with clinical conditions
|
Pflueger, K-H
|
|
1993
|
29 |
S6 |
p. S111-
1 p.
|
artikel
|
| 915 |
Pharmacokinetics of high dose methotrexate (HDMTX) infusion in adult ostoesarcoma
|
Pignon, T
|
|
1993
|
29 |
S6 |
p. S111-
1 p.
|
artikel
|
| 916 |
Pharmacokinetics of tropisetron (TRO) in children
|
Gaedicke, G
|
|
1993
|
29 |
S6 |
p. S200-
1 p.
|
artikel
|
| 917 |
Phase I clinical study and pharmacological evaluation of oral etoposide phosphate (BMY-40481)
|
D'Incalci, M.
|
|
1993
|
29 |
S6 |
p. S118-
1 p.
|
artikel
|
| 918 |
Phase I–II feasibility trial of the addition of cisplatinum to epirubicin-vinorelbine combination (PEV) in metastatic breast cancer (MBC)
|
Turpin, F.
|
|
1993
|
29 |
S6 |
p. S84-
1 p.
|
artikel
|
| 919 |
Phase I-II study of the somatostatin analogue somatulin in hormone refractory prostatic cancer (HRPC)
|
Maulard, C
|
|
1993
|
29 |
S6 |
p. S237-
1 p.
|
artikel
|
| 920 |
Phase III trial of cisplatin (DDP), dacarbazine (DTIC), BCNU, interferon-alfa-2A (IFN) and tamoxifen (TAM) in the treatment of disemineated malignant melanoma (MM)
|
Galvez, C.A.
|
|
1993
|
29 |
S6 |
p. S182-
1 p.
|
artikel
|
| 921 |
Phase I–II trial of intensification of the maid regimen with lenograstim (rHuG-CSF) in patients (pts) with advanced soft tissue sarcoma (STS)
|
Bui, B.N.
|
|
1993
|
29 |
S6 |
p. S57-
1 p.
|
artikel
|
| 922 |
Phase II study in patients (PTS) with metastatic breast cancer (MBC)
|
Giocomi, N.
|
|
1993
|
29 |
S6 |
p. S81-
1 p.
|
artikel
|
| 923 |
Phase II study of a combination of actinomycin (A) and etoposide (E) in good risk (GR) trophoblastic disease (TD)
|
Lhommé, C.
|
|
1993
|
29 |
S6 |
p. S128-
1 p.
|
artikel
|
| 924 |
Phase II study of a short course of weekly cisplatin (C) combined with oral etoposide (E) in pleural mesothelioma
|
Planting, A.
|
|
1993
|
29 |
S6 |
p. S184-
1 p.
|
artikel
|
| 925 |
Phase II study of a short course of weekly cisplatin (C) in locally advanced squamous cell carcinoma (SCC) of the head and neck
|
Planting, A.
|
|
1993
|
29 |
S6 |
p. S141-
1 p.
|
artikel
|
| 926 |
Phase-II-study of fotemustine, cisplatin and high-dose tamoxifen in metastatic malignant melanoma
|
Semb, K.A.
|
|
1993
|
29 |
S6 |
p. S179-
1 p.
|
artikel
|
| 927 |
Phase II study of fotemustine—Cisplatin (CDDP) combination on brain metastasis of non small cell lung cancer (NSCLC): Interim report
|
Trillet-Lenoir, V.
|
|
1993
|
29 |
S6 |
p. S161-
1 p.
|
artikel
|
| 928 |
Phase II study of fotemustine-5 fulederfoline (FU-FOL) in metastatic colorectal carcinomas (CRC): Preliminary results
|
Fabri, M.C.
|
|
1993
|
29 |
S6 |
p. S98-
1 p.
|
artikel
|
| 929 |
Phase II study of fotermustine in the treatment of inoperable non small cell lung carcinoma (NSCLC): Finalreport
|
Le Chevalier, T.
|
|
1993
|
29 |
S6 |
p. S161-
1 p.
|
artikel
|
| 930 |
Phase II study of four-drug concomitant chemoradiotherapy in advanced head and neck carcinoma (AH&NC): Preliminary results
|
Michel-langlet, P.
|
|
1993
|
29 |
S6 |
p. S140-
1 p.
|
artikel
|
| 931 |
Phase II study of gemcitabine in patients with advanced pancreatic cancer
|
Camichael, J.
|
|
1993
|
29 |
S6 |
p. S101-
1 p.
|
artikel
|
| 932 |
Phase II study of mitoxantrone in locally advanced or metastatic adenoid cystic carcinomas (ACC) of the head and neck
|
Verweij, J.
|
|
1993
|
29 |
S6 |
p. S141-
1 p.
|
artikel
|
| 933 |
Phase II study of oxaliplatin (L-OHP) in patients with advanced non small cell lung cancer (NSCLC): Preliminary results
|
Monnet, I.
|
|
1993
|
29 |
S6 |
p. S163-
1 p.
|
artikel
|
| 934 |
Phase II study of taxotere in refractory metastatic breast cancer (RMBC)
|
Valero, V.
|
|
1993
|
29 |
S6 |
p. S83-
1 p.
|
artikel
|
| 935 |
Phase II study of the eortc breast group with vorozole (R 83842), a new non-steroidal aromatase inhibitor in metastatic breast cancer (MBC) — preliminary results
|
Paridaens, R.
|
|
1993
|
29 |
S6 |
p. S86-
1 p.
|
artikel
|
| 936 |
Phase II study of topotecan in patients with non-small cell lung cancer
|
Perez-Soler, R
|
|
1993
|
29 |
S6 |
p. S162-
1 p.
|
artikel
|
| 937 |
Phase II study of weekly administration of vinorelbine in heavily pretreated Hodgkin's disease
|
Devizzi, L.
|
|
1993
|
29 |
S6 |
p. S171-
1 p.
|
artikel
|
| 938 |
Phase II study with liposomal muramyl tripeptide phophatidylethanolamine (MTP/PE) in soft tissue sarcomas (STS)
|
Verweij, J.
|
|
1993
|
29 |
S6 |
p. S184-
1 p.
|
artikel
|
| 939 |
Phase II study with methotrexate (M), carboplatin (C), mitoxantrone (N) and vinblastine (V) in avanced bladder carcinoma (ABC)
|
Casal, J
|
|
1993
|
29 |
S6 |
p. S231-
1 p.
|
artikel
|
| 940 |
Phase II study with taxotere(RP56976) in advanced soft tissue sarcomas of the adult
|
van Hoesel, OGCM
|
|
1993
|
29 |
S6 |
p. S183-
1 p.
|
artikel
|
| 941 |
Phase II study with topotecan in colorectal cancer
|
Verweij, J.
|
|
1993
|
29 |
S6 |
p. S92-
1 p.
|
artikel
|
| 942 |
Phase II trial of adding reconsinant alfa-2 interferon (IFN) (intron AR) for progressive lung metastases in patients with advanced colorectal cancer (CRC) pretreated with 5-fluorouracil (5-FU) and leucovorin (LV)
|
Görg, C
|
|
1993
|
29 |
S6 |
p. S97-
1 p.
|
artikel
|
| 943 |
Phase II trial of 5-fluorouracil(F), etoposide (E) and cisplatin (P) in 5 days (FEP-5) for advanced gastric cancer (GC)
|
Constela, M
|
|
1993
|
29 |
S6 |
p. S108-
1 p.
|
artikel
|
| 944 |
Phase II trial of 5-fluoro-uracil (5FU), folinic acid (FA) and cisplatinum (CDDP) in the treatment of pancreatic adenocarcinoma
|
Andre, T
|
|
1993
|
29 |
S6 |
p. S103-
1 p.
|
artikel
|
| 945 |
Phase II trial of mitomycin C(Mit) plus 5-FU in refractory ovarian cancer(ROC)
|
Peláez, I
|
|
1993
|
29 |
S6 |
p. S137-
1 p.
|
artikel
|
| 946 |
Phase II trial of oxaliplatin: L-OHP® in patients with colorectal carcinoma (CRC) previously resistant to 5 fluoruracil (5 FU) and folinic acid (FA)
|
Machover, D.
|
|
1993
|
29 |
S6 |
p. S96-
1 p.
|
artikel
|
| 947 |
Phase II trial of topotecan in advanced pancreatic cancer
|
Scher, R
|
|
1993
|
29 |
S6 |
p. S101-
1 p.
|
artikel
|
| 948 |
Phase II trial with navelbine (NVB) in advanced breast cancer (ABC) as first line therapy
|
García-Conde, J.
|
|
1993
|
29 |
S6 |
p. S85-
1 p.
|
artikel
|
| 949 |
Phase II trial with weekly cisplatin (CDDP) and continously oral etoposide (VP-16) in advanced non-small cell lung cancer (NSCLC)
|
Lopez, R.
|
|
1993
|
29 |
S6 |
p. S162-
1 p.
|
artikel
|
| 950 |
Phase I studies of gemcitabine
|
Fossella, FV
|
|
1993
|
29 |
S6 |
p. S119-
1 p.
|
artikel
|
| 951 |
Phase I studies with biological response modifiers (BRM)
|
Wagstaff, J.
|
|
1993
|
29 |
S6 |
p. S35-
1 p.
|
artikel
|
| 952 |
Phase I study of carboplatin, epirubicin and VP-16 plus G-CSF in extensive small cell lung cancer (SCLC)
|
Gridelli, C.
|
|
1993
|
29 |
S6 |
p. S156-
1 p.
|
artikel
|
| 953 |
Phase I study of taxol plus doxorubicin plus granulocyte colony-stimulating factor (G-CSF) in patients with metastatic breast cancer
|
O'Shaughnessy, JA
|
|
1993
|
29 |
S6 |
p. S117-
1 p.
|
artikel
|
| 954 |
Phase I study of the distamycin derivative FCE 24517
|
Armand, JP
|
|
1993
|
29 |
S6 |
p. S120-
1 p.
|
artikel
|
| 955 |
Phase I study of the mitomycin C analogue BMY 25067
|
Talbot, DC
|
|
1993
|
29 |
S6 |
p. S120-
1 p.
|
artikel
|
| 956 |
Phase I study on EO9 given every 3 weeks
|
Verweij, J.
|
|
1993
|
29 |
S6 |
p. S117-
1 p.
|
artikel
|
| 957 |
Phase I study on 4-weekly 6 hour infusion of BMY-25067 in patients (PTS) with solid tumors
|
Verweij, J.
|
|
1993
|
29 |
S6 |
p. S119-
1 p.
|
artikel
|
| 958 |
Phase I trial and pharmacokinetic study of a new orally administered platinum anticancer drug JM 216 [AF-bis(acetato)-B-ammine-CD-dichloro-E-cyclohexylamine platinum(IV)]
|
Judson, I
|
|
1993
|
29 |
S6 |
p. S118-
1 p.
|
artikel
|
| 959 |
Phase I trial of adriamycin (A) + taxol (T) in metastatic breast cancer (MBC)
|
Sledge, GW
|
|
1993
|
29 |
S6 |
p. S81-
1 p.
|
artikel
|
| 960 |
Phase I trial of buthionine sulfoximine (BSO) in combination with melphalan
|
O'Dwyer, PJ
|
|
1993
|
29 |
S6 |
p. S119-
1 p.
|
artikel
|
| 961 |
Phase I trial of pixy321 in combination with cyclophosphamide (Cy) and carboplatin (Carb) in women with ovarian cancer (OC)
|
Speyer, J
|
|
1993
|
29 |
S6 |
p. S52-
1 p.
|
artikel
|
| 962 |
Phase study: Mavelbine (N) + etoposide (E) + cisplatin (C) in non operable non small cell lung cancer (NSCLC)
|
Richardet, E.
|
|
1993
|
29 |
S6 |
p. S161-
1 p.
|
artikel
|
| 963 |
Phorbol-12,13-dibutyrate improves quality of cytogenetic preparation in lymphoid malignancies
|
Pirc-Danoewinata, H
|
|
1993
|
29 |
S6 |
p. S178-
1 p.
|
artikel
|
| 964 |
Photodynamic therapy in squamous cell lung cancer
|
Sutedja, T
|
|
1993
|
29 |
S6 |
p. S212-
1 p.
|
artikel
|
| 965 |
Photodynamic therapy (PDT) for superficial skin malignancies using topical 5-amino-levulinic acid
|
Meijnders, PJN
|
|
1993
|
29 |
S6 |
p. S212-
1 p.
|
artikel
|
| 966 |
Photodynamic therapy (PDT) in AIDS related cutaneous kaposis sarcoma (KS)
|
Hebeda, KM
|
|
1993
|
29 |
S6 |
p. S211-
1 p.
|
artikel
|
| 967 |
Photodynamic therapy (PDT) with chlorins
|
Zhavrid, E.
|
|
1993
|
29 |
S6 |
p. S212-
1 p.
|
artikel
|
| 968 |
Physicians difficulties and coping strategies in cancer care
|
Andrae, M
|
|
1993
|
29 |
S6 |
p. S213-
1 p.
|
artikel
|
| 969 |
Pilot study: A phase II clinical trial to test the ability of pilocarpine to reduce the oral complications of radiotherapy to the head and neck region
|
Adler, A
|
|
1993
|
29 |
S6 |
p. S141-
1 p.
|
artikel
|
| 970 |
Pilot study of reaferon R-IFN-2A (R), adriamycin (ADR) and whole - body hyperthermia (WBH) in patients with metastatic renal cell carcinoma (RCC): Preliminary results
|
Zhavrid, E.
|
|
1993
|
29 |
S6 |
p. S235-
1 p.
|
artikel
|
| 971 |
Piparubicin and 5 fluorouracil in the treatment of hormone resistant metastatic prostate cancer
|
Bouillet, Th
|
|
1993
|
29 |
S6 |
p. S238-
1 p.
|
artikel
|
| 972 |
Piperacillin-tazobactam and amikacin (PT-A) as empirical therapy for fever in granulocytopenic cancer patients (PTS)
|
Sousa, AB
|
|
1993
|
29 |
S6 |
p. S207-
1 p.
|
artikel
|
| 973 |
Platelets, granulocytes and hair growth factor effect of the new immunomodulator AS101 in chemotherapy treated lung cancer patients
|
Shani, A
|
|
1993
|
29 |
S6 |
p. S52-
1 p.
|
artikel
|
| 974 |
pO2 Changes in tumours after carbogen administration in patients and after carbogen and/or perflubron administration in mice bearing human tumour xenografts
|
Lartigau, E.
|
|
1993
|
29 |
S6 |
p. S216-
1 p.
|
artikel
|
| 975 |
Polish experience in palliative/hospice care
|
Łuczak, J.
|
|
1993
|
29 |
S6 |
p. S37-
1 p.
|
artikel
|
| 976 |
Polychemotherapy in the treatment of recurrent carcinoma of the paranasal sinuses
|
Brando, V
|
|
1993
|
29 |
S6 |
p. S145-
1 p.
|
artikel
|
| 977 |
Polymer-drug conjugates: Challenges for phase I
|
Duncan, R.
|
|
1993
|
29 |
S6 |
p. S35-
1 p.
|
artikel
|
| 978 |
Populational impact of adjuvant chemotherapy for early breast cancer: An overview from a European community sponsored mass screening programme
|
Illarramendi, J.
|
|
1993
|
29 |
S6 |
p. S76-
1 p.
|
artikel
|
| 979 |
Positive correlation between tumour drug disposition and the activity of doxorubicin microspheres: Implications for the drugs in vivo mechanism of action
|
Cummings, J
|
|
1993
|
29 |
S6 |
p. S115-
1 p.
|
artikel
|
| 980 |
Possibilities and limitations of non-homogeneous dose distributions
|
Söderström, S
|
|
1993
|
29 |
S6 |
p. S28-
1 p.
|
artikel
|
| 981 |
Possible lack of full cross-resistance between 5HT3 antagonists, a pilot experience
|
Wit de, R.
|
|
1993
|
29 |
S6 |
p. S206-
1 p.
|
artikel
|
| 982 |
Possible role of thymidylate synthase level in human colo rectal carcinoma: A new prognostic factor?
|
Sanguedolce, R.
|
|
1993
|
29 |
S6 |
p. S92-
1 p.
|
artikel
|
| 983 |
Post-ablative reconstruction following head and neck cancer surgery with microvascular free flaps
|
Župevc, A.
|
|
1993
|
29 |
S6 |
p. S144-
1 p.
|
artikel
|
| 984 |
Post-irradiation hearing loss
|
Wanders, S.L
|
|
1993
|
29 |
S6 |
p. S222-
1 p.
|
artikel
|
| 985 |
Post — Operative HDR brachytherapy in the treatment of poor prognosis soft tissue sarcoma
|
Donath, D.
|
|
1993
|
29 |
S6 |
p. S185-
1 p.
|
artikel
|
| 986 |
Postoperative radiation therapy in soft tissue sarcomas
|
Moya, J
|
|
1993
|
29 |
S6 |
p. S188-
1 p.
|
artikel
|
| 987 |
Postoperative radiotherapy(PRT), pulmonary function and gas exchange in patients with non small cell lung cancer (NSCLC)
|
Mantini, G
|
|
1993
|
29 |
S6 |
p. S167-
1 p.
|
artikel
|
| 988 |
Postoperative use of ultraviolet irradiation of the blood (UVIB), plasmapheresis (PP) and DAH-complex in patients with rectal cancer
|
Korytsky, G
|
|
1993
|
29 |
S6 |
p. S91-
1 p.
|
artikel
|
| 989 |
Post radiation hyperprolactinemia
|
Weiss, A.
|
|
1993
|
29 |
S6 |
p. S222-
1 p.
|
artikel
|
| 990 |
Potential oncosuppressor genes in breast
|
Imam, SA
|
|
1993
|
29 |
S6 |
p. S197-
1 p.
|
artikel
|
| 991 |
P53 Protein and antibodies to p53 in primary brain tumors. Results from a newly developed luminometric assay for p53 compared to immuno-histochemistry
|
Lennerstrand, J
|
|
1993
|
29 |
S6 |
p. S196-
1 p.
|
artikel
|
| 992 |
Prad-1 gene amplification in head and neck squamous cell carcinoma
|
Klijanienko, J.
|
|
1993
|
29 |
S6 |
p. S144-
1 p.
|
artikel
|
| 993 |
Pre and post operative values of cyfra 21-1, CEA, SCC, TPA and NSE in primary lung cancer
|
Rastel, D.
|
|
1993
|
29 |
S6 |
p. S247-
1 p.
|
artikel
|
| 994 |
Pre-chemotherapy nervousness as a marker for anticipatory nausea: A case of a non-causal predictor
|
Kvale, G
|
|
1993
|
29 |
S6 |
p. S210-
1 p.
|
artikel
|
| 995 |
Preclinical evidence for the anti-cancer effect induced by zilascorb(2H) — A reversible protein synthesis inhibitor with minor toxic effects
|
Domish, JM
|
|
1993
|
29 |
S6 |
p. S121-
1 p.
|
artikel
|
| 996 |
Predicting potential of c-erbB-2 orcoprotein and laminin receptor expression on primary breast cancer
|
Coinaghi, M.I.
|
|
1993
|
29 |
S6 |
p. S31-
1 p.
|
artikel
|
| 997 |
Prediction of breast carcinoma response to preoperative chemotherapy
|
Briffod, M
|
|
1993
|
29 |
S6 |
p. S74-
1 p.
|
artikel
|
| 998 |
Predictive assays in radiotherapy
|
Streffer, C
|
|
1993
|
29 |
S6 |
p. S8-
1 p.
|
artikel
|
| 999 |
Predictive value of DNA content in head and neck carcinoma (HNC) treated with hyperfrationated radiotherapy (HRT)
|
Martínez, E.
|
|
1993
|
29 |
S6 |
p. S149-
1 p.
|
artikel
|
| 1000 |
Prednimustine — clinical activity in low grade NHL refractory to chlorambucil and prednisolone
|
Juliá, A.
|
|
1993
|
29 |
S6 |
p. S178-
1 p.
|
artikel
|
Tijdschrift beschrijving